http://qxclear.com/Insights/ag-feature/analysis-group-forum/2015-year-in-review/wolf-pack-activism--a-quick-look/2019-12-13T19:33:18+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/2015-year-in-review/assessing-commercial-success-at-the-u.s.-patent-trial-and-appeal-board/2019-12-13T19:33:23+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/2015-year-in-review/statistics-and-sports--deflategate/2019-12-13T19:32:21+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/2015-year-in-review/forecasting-corporate-failure--a-look-at-statistical-and-theoretical-approaches/2020-11-09T17:14:35+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/2015-year-in-review/the-myth-of-divided-antitrust-economics/2019-12-13T19:32:55+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/2015-year-in-review/a-closer-look-at-the-use-of-consumer-surveys-in-litigation/2019-12-13T19:33:40+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/2015-year-in-review/the-reality-of-u.s.-pharmaceutical-spending/2019-12-13T19:33:01+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/2015-year-in-review/assessing-the-epas-clean-power-plan/2019-12-13T19:33:13+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/analysis-group-forum/can-epidemiology-be-applied-to-auto-safety-analysis-/2018-11-01T15:16:43+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/analysis-group-forum/analyzing-causation-damages-in-data-breaches/2018-11-01T15:16:43+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/analysis-group-forum/common-threads-in-mortgage-backed-securities-cases/2018-10-12T14:17:42+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/analysis-group-forum/changes-ahead-for-credit-rating-agencies/2018-11-14T15:32:55+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/analysis-group-forum/economic-solutions-to-water-conflicts/2018-11-01T15:16:42+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/analysis-group-forum/a-look-at-patent-litigation-and-valuation-post-reform/2018-11-01T15:16:42+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/analysis-group-forum/where-policy-economics-intersect/2018-11-01T15:16:42+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/analysis-group-forum/a-new-approach-to-regression-analysis-and-antitrust-litigation/2018-11-01T15:16:42+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/analysis-group-forum/assessing-financial-issues-in-tribal-trust-fund-litigation/2018-11-01T15:16:41+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/customer-behavior-and-class-actions/customer-behavior-and-class-actions/2018-11-05T14:38:36+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/fall-2014/the-cost-of-disclosure--audit-fees-and-liability-claims-may-be-on-the-rise/2019-01-09T13:48:24+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/fall-2014/patent-litigation-and-the-innovation-economy/2020-01-09T18:42:45+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/fall-2014/anticipating-exclusion--upward-pricing-pressure-in-vertical-transactions/2018-11-01T15:16:40+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/fall-2014/consolidation-coordination-and-competition---a-challenging-prescription-for-health-care/2018-11-01T15:16:40+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/fall-2014/what-is-a-prudent-investment--using-simulation-to-evaluate-investment-selections/2018-11-01T15:16:40+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/fall-winter-2013/an-inside-look-at-itcs-expedited-investigations-pilot-program/2018-11-01T15:16:39+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/fall-winter-2013/international-enforcement-in-a-global-economy/2019-06-24T19:48:28+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/fall-winter-2013/reconsidering-the-hypothetical-negotiation/2018-11-01T15:16:37+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/fall-winter-2013/what-is-water-worth-/2018-11-01T15:16:36+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/fall-winter-2013/the-role-of-clinical-trials-in-mass-torts-and-related-shareholder-suits/2018-11-01T15:16:34+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2017/using-machine-learning-in-litigation/2019-12-13T19:31:14+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2017/qand-a-with-affiliate-austan-goolsbee/2019-12-13T19:31:18+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2017/implications-of-the-tyson-ruling-for-class-certification/2019-12-13T19:31:24+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2017/qand-a-with-affiliate-david-dranove/2019-12-13T19:31:30+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2017/the-biosimilar-revolution-is-just-beginning-in-the-u.s/2019-12-13T19:31:37+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2017/affiliate-spotlight--oliver-hart/2020-11-09T17:13:08+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2017/will-expanded-eeo-1-data-collection-yield-new-insights-into-discrimination-/2019-12-13T19:31:42+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2017/affiliate-roundtable--privacy-and-data-security/2019-12-13T19:31:47+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2017/data-corner--resolution-of-federal-privacy-and---data-security-cases--19992016/2019-12-13T19:31:57+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2017/evaluating-potential-development-of-a-broader-market-for-co2-allowance-trading/2019-12-13T19:32:02+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/economic-analysis-in-erisa-litigation/economic-analysis-in-erisa-litigation/2018-11-01T15:16:41+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/perspectives-on-investment-management-disputes/perspectives-on-investment-management-disputes/2018-11-01T15:16:34+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2013/the-causes-and-consequences-of-currency-wars/2018-11-01T15:16:25+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2013/when-consumer-confusion-leads-to-lawsuits/2018-11-01T15:16:23+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2013/assessing-the-duration-of-damages-in-food-safety-cases/2018-11-01T15:16:21+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2013/investigating-adverse-effects-using-epidemiology/2018-11-01T15:16:19+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/presenting-demand-models-in-antitrust-litigation/presenting-demand-models-in-antitrust-litigation/2018-11-01T15:16:34+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/the-missing-data-challenge/the-missing-data-challenge--using-clinical-trials-results/2018-11-01T15:16:19+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/winter-2013-forum/when-all-natural-may-not-be/2018-11-01T15:16:18+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/winter-2013-forum/when-price-fixing-is-alleged/2018-11-01T15:16:18+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/winter-2013-forum/royalty-payments-bundled-goods-and-chicago-style-red-hots/2018-11-01T15:16:18+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/winter-2013-forum/mobile-broadband--competition-spectrum-and-consumers/2018-11-01T15:16:18+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/the-role-of-the-economic-expert-in-class-certification/the-role-of-the-economic-expert-in-class-certification/2018-11-01T15:16:19+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/biologics-biosimilars-and-generics/biologics-biosimilars-and-generics/2018-11-01T15:16:09+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2013/behind-the-headlines-in-pharmaceutical-investigations/2018-11-01T15:16:09+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2013/using-epidemiology-to-identify-unmet-need/2018-11-01T15:16:09+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2013/using-canadian-provincial-health-plan-claims/2018-11-01T15:16:09+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2013/evaluating-international-marketing-access/2018-11-01T15:16:08+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2013/global-consequences-of-local-pricing-decisions/2018-11-01T15:16:08+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2014/big-data-in-health-care/2018-11-01T15:16:08+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2014/assessing-the-economic-burden-of-alzheimers-disease/2018-11-01T15:16:07+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2014/monitoring-online-signals--implications-of-internet-data-in-pharmacovigilance/2018-11-01T15:16:07+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2014/addressing-health-care-demand-and-big-data-in-china/2019-08-07T16:39:10+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2014/a-look-inside-health-care-big-data/2020-03-06T17:45:41+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2014/diagnostics-and-next-generation-genetic-sequencing/2018-11-01T15:16:07+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2014/improper-promotion-and-kickback-allegations/2019-03-18T20:29:36+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2014/the-depth-of-provider-data/2018-12-11T19:50:38+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2016/the-biosimilar-revolution-is-just-beginning-in-the-u.s/2018-11-30T20:56:23+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2016/viewing-recent-opioid-regulations-in-context/2018-11-01T15:15:57+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2016/economic-burden-of-schizophrenia-in-the-u.s.-exceeded-$155-billion-in-2013/2018-11-30T21:03:46+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2016/machine-learning-algorithms-in-health-care-litigation/2018-11-21T15:49:24+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2016/the-myth-of-price-disconnects-in-u.s.-pharma-markets/2018-11-01T15:15:56+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2016/payments-to-doctors--causal-inferences-require-a-closer-look/2018-11-01T15:15:56+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2016/recent-trends-in-affordable-care-act-insurance/2018-11-01T15:15:56+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2016/evaluating-real-world-effectiveness-in-prescription-coverages/2018-11-08T16:25:42+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2016/new-academic-affiliate--dr.-john-e.-ware-jr.-renowned-pro-expert/2018-11-01T15:15:55+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-2018/making-the-right-call--som-for-prescription-opioids/2018-11-02T19:58:58+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-2018/abuse-deterrent-opioids-and-the-economic-costs-of-abuse/2018-11-05T02:38:47+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-2018/why-biosimilar-introduction-may-be-different/2018-11-01T15:15:51+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-2018/causation-in-product-liability--taking-a-new-look/2018-11-01T15:15:51+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-2018/patient-reported-outcomes--emerging-developments-and-innovative-approaches/2018-11-01T15:15:49+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-2018/biopharma-value-based-pricing--how-to-make-it-work-/2018-11-01T15:23:33+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-2018/spotlight-on-europe/2018-11-01T15:15:49+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-2018/a-new-landscape-for-comparative-effectiveness-research/2019-02-04T18:15:41+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-2018/making-more-precise-health-care-decisions-with-machine-learning/2018-11-21T16:07:37+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-2018/planting-trees-to-reduce-health-related-costs/2018-11-01T15:15:48+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-2018/analysis-group-expert-david-dranove-highlighted-in-historic-health-care-merger-review/2018-11-01T15:15:48+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2015/the-growing-economic-burden-of-depression-in-the-united-states/2018-11-01T15:16:05+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2015/developments-in-medical-big-data-research---what-makes-data-different-today-/2019-04-08T13:30:23+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2015/new-challenges-and-initiatives-in-big-data-processing/2018-11-01T15:16:04+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2015/the-obesity-epidemic--a-new-look-at-the-urgency-challenges-and-opportunities/2018-11-01T15:16:03+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2015/update-on-out-of-network-provider-balance-billing/2018-11-01T15:16:03+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2015/anti-obesity-drug-development-risks-and-expectations/2018-11-01T15:16:02+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/the-biosimilar-challenge/the-biosimilar-challenge/2018-11-01T15:15:54+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-spring-2012/enhancing-product-value-propositions-in-the-pipeline/2018-11-01T15:15:48+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-spring-2012/methods-for-indirect-comparisons-in-outcomes-research/2018-12-11T18:51:32+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2014/also-on-analysisgroup.com/2018-10-15T21:41:44+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2013/also-on-analysisgroup.com/2020-02-06T21:29:09+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2015/also-on-analysisgroup.com/2019-06-25T18:08:44+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2016/also-on-analysisgroup.com/2018-10-15T21:42:58+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-2018/also-on-analysisgroup.com/2020-02-06T21:29:18+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/fall-2014/also-on-analysisgroup.com/2020-02-06T21:29:22+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/fall-2014/featured-engagements/2020-02-06T21:30:23+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/fall-winter-2013/also-on-analysisgroup.com/2020-02-06T21:29:14+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/fall-winter-2013/featured-engagements/2020-02-06T21:30:19+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2013/In-this-Issue/2019-12-13T19:49:37+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2013/recent-litigation/2019-12-13T19:49:06+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/winter-2013-forum/featured-engagements/2019-12-13T19:51:08+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/winter-2013-forum/featured-publishing/2019-12-13T19:52:00+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/2015-year-in-review/recent-litigation/2019-12-13T19:45:17+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/2015-year-in-review/also-on-analysisgroup.com/2019-12-06T18:20:38+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2017/also-on-analysisgroup.com/2019-12-13T19:42:45+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2017/featured-engagements/2020-02-06T21:29:30+00:00weekly0.5http://qxclear.com/about/locations/beijing/cn/heor/2020-07-27T15:48:27+00:00weekly0.5http://qxclear.com/about/locations/beijing/cn/market-access/2020-07-27T15:50:11+00:00weekly0.5http://qxclear.com/about/locations/beijing/cn/epidemiology/2020-07-27T15:49:25+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2018/recent-case-highlights/2018-10-31T20:33:52+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2018/contributions-to-recently-published-books/2018-10-31T20:34:51+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winterspring-2019/also-on-analysisgroup.com/2020-01-03T19:09:27+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winterspring-2019/applying-data-science-to-meet-real-world-health-care-challenges/2019-10-22T20:53:52+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winterspring-2019/synthesizing-evidence-secure-coverage-reimbursement/2019-10-22T20:53:32+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winterspring-2019/expanded-role-real-world-evidence/2019-10-22T20:53:24+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winterspring-2019/recalibrating-predictions-survival-benefits-novel-cancer-therapies/2019-10-22T20:53:12+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winterspring-2019/precision-medicine-to-market/2019-10-22T20:53:03+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winterspring-2019/new-payment-strategies/2019-10-22T20:52:51+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2018/economic-consulting-in-the-data-science-era/2019-12-13T19:29:02+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2018/how-data-scientists-can-leverage-online-reviews-in-ip-and-antitrust-disputes/2019-12-13T19:29:45+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2018/the-ongoing-evolution-of-cryptocurrency-regulation-and-litigation/2019-12-13T19:29:56+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2018/exclusionary-abuses-and-multi-sided-platforms/2019-12-13T19:30:06+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2018/will-retail-debt-and-financial-distress-continue-to-grow-/2020-11-09T17:16:29+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2018/the-outlook-for-resilience-in-electricity-generation-and-distribution/2019-12-13T19:30:34+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2018/lng-contracts-taking-new-shape-in-europe-and-globally/2019-12-13T19:30:41+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2018/challenges-and-opportunities--suspicious-order-monitoring-of-prescription-opioids/2019-12-13T19:30:45+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2018/more-than-dollars-and-cents--prescription-drug-pricing-and-value/2019-12-13T19:30:53+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2018/building-a-foundation-for-essentiality-in-standard-essential-patents/2019-12-13T19:31:09+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2018/introducing-surveys-into-evidence--how-to-avoid-bias/2019-12-13T19:30:58+00:00weekly0.5http://qxclear.com/about/locations/montreal/fr/economie-sante/2018-11-05T13:57:47+00:00weekly0.5http://qxclear.com/about/locations/montreal/fr/institutions-financieres/2018-11-05T13:58:36+00:00weekly0.5http://qxclear.com/about/locations/montreal/fr/economie-du-travail/2018-11-05T13:59:36+00:00weekly0.5http://qxclear.com/about/locations/montreal/fr/energie-environnement-et-ressources-naturelles/2018-11-05T14:01:17+00:00weekly0.5http://qxclear.com/about/locations/montreal/fr/antitrust-et-concurrence/2018-11-05T14:02:27+00:00weekly0.5http://qxclear.com/about/locations/montreal/fr/cases/2018-12-11T18:24:04+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winterspring-2019/asia-spotlight-beijing-forum/2019-10-22T20:52:38+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2019/the-tyranny-of-market-shares-incorporating-survey-based-evidence-into-merger-analysis/2019-07-05T12:56:50+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2019/using-machine-learning-to-estimate-the-prevalence-and-onset-of-a-disease/2019-07-15T20:36:27+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2019/whats-in-the-record-implications-of-the-asacol-case-for-pharmaceutical-class-actions/2019-07-05T12:56:29+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2019/recent-case-highlights/2019-12-13T19:41:58+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2019/leveraging-cap-and-trades-market-incentives-in-climate-policies/2019-07-05T12:56:16+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2019/taxing-questions-managing-the-taxation-complexities-of-smart-contracts/2020-10-26T18:48:34+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2019/similar-but-not-the-same-charting-the-course-of-biosimilar-ip-litigation-in-the-us/2019-07-05T12:55:47+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2019/valuation-in-international-arbitration-a-growing-topic-in-investor-state-disputes/2019-07-05T12:55:32+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2019/franchise-no-poach-agreements-face-antitrust-scrutiny/2019-07-15T15:24:46+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2019/how-much-is-enough-applying-the-rule-of-reason-to-data-security/2019-07-05T12:55:06+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2019/symposium-examines-critical-economic-issues-in-life-sciences-litigation/2019-07-05T12:54:55+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-20192020/a-new-way-to-quantify-quality-of-life/2020-08-07T19:01:01+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-20192020/protecting-access-encouraging-innovation-a-discussion-about-drug-pricing/2020-08-07T19:26:17+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-20192020/a-collaboration-to-advance-hematology-research/2020-08-07T19:28:20+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-20192020/also-on-analysisgroup.com/2020-01-22T18:33:41+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-20192020/interactive-shortcut/2020-01-21T19:16:34+00:00weekly0.5http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-20192020/artificial-intelligence-can-open-the-door-to-better-learning-better-care-and-better-coverage/2020-08-07T18:51:51+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/contracts-and-crisis-nobel-laureate-oliver-hart-on-contract-theory-and-the-world-of-the-pandemic/2020-11-09T17:13:32+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/learning-from-lehman-lessons-for-today/2020-11-09T17:15:05+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/recent-case-highlights/2020-10-21T13:58:24+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/contributions-to-recently-published-books/2020-06-03T17:49:53+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/note-from-martha-s-samuelson/2020-10-21T17:13:15+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/in-combatting-a-global-pandemic-build-public-confidence-first/2020-08-07T20:40:58+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/zombie-over-levered-or-shocked-but-sound-pandemic-induced-bankruptcies-and-related-valuation-questions/2020-11-09T17:25:51+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/will-there-be-another-mortgage-crisis-lessons-from-the-great-recession/2020-08-07T20:45:17+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/challenges-of-analyzing-health-care-data-in-the-covid-19-era/2020-08-07T20:51:38+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/financial-impacts-for-hospitals-from-covid-19/2020-08-14T20:54:46+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/innovation-drug-pricing-and-the-pandemic-a-qa-with-craig-garthwaite/2020-08-14T20:44:39+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/shutdowns-joblessness-and-a-tentative-recovery-jesse-rothstein-on-the-impact-of-the-coronavirus-on-the-us-labor-market/2020-08-17T15:24:53+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/outlook-for-oil-prices-and-the-industry-in-turbulent-times-a-qa-with-philip-k.-verleger/2020-08-07T17:20:39+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/assessing-the-evidence-from-covid-19-deaths-a-qa-with-christopher-knittel/2020-08-07T20:50:25+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/forward-looking-statements-and-transparency-esther-mills-on-accounting-for-pandemic-related-losses/2020-09-09T19:21:58+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/powering-through--and-beyond--the-crisis/2020-08-26T15:24:36+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/matthew-grennan-on-concentration-in-medical-supply-markets-considerations-from-the-coronavirus-pandemic/2020-08-26T15:24:18+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/platforms-competition-and-the-crisis-arun-sundararajan-on-how-restaurants-have-adapted-during-the-pandemic/2020-09-28T17:02:20+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/staffing-tracking-and-testing-for-covid-19-in-elder-care-facilities-a-qa-with-david-grabowski/2020-09-28T17:42:18+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/accounting-for-the-coronavirus-subjectivity-and-judgment-during-times-of-crisis/2020-09-28T17:46:08+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/seeing-is-not-the-same-thing-as-looking-anupam-b.-jena-m.d.-ph.d.-on-learning-from-natural-experiments/2020-10-21T13:52:13+00:00weekly0.5http://qxclear.com/Insights/ag-feature/analysis-group-forum/forum-2020/covid-19-and-bottom-line-impacts-in-trademark-litigation-a-qa-with-joel-steckel/2020-10-21T13:37:51+00:00weekly0.5http://qxclear.com/careers/why-analysis-group/our-people/erica-vansant/2020-10-09T14:19:39+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/ngoc-pham/2020-08-21T15:09:35+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/anandi-gupta/2020-10-09T13:59:02+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/james-bernard/2020-08-21T19:30:54+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/jensen-duy-vu/2020-10-09T16:02:25+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/andrea-di-miceli/2020-10-09T14:16:09+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/nisha-hazra/2020-11-03T20:00:53+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/amanda-giunta/2020-11-06T17:29:58+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/using-economics-in-policymaking-for-digital-platforms-a-qa-with-jeffrey-t.-prince/2020-11-24T23:02:04+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/anne-catherine-faye/2020-12-14T21:41:25+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/alexia-sahue/2020-12-14T22:41:45+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/glenn-camilien/2020-12-15T22:14:07+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/markets-data-and-the-value-of-high-tech-patents-a-qa-with-christopher-knittel/2020-10-09T16:29:51+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/sam-goldenshtein/2020-09-01T15:18:05+00:00weekly0.6http://qxclear.com/about/locations/paris/etude-economique/2021-01-15T00:59:01+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/william-engellenner/2020-08-18T13:54:07+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/mario-luca/2020-08-18T13:53:29+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/stefano-parravano/2020-08-18T13:53:54+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/garrett-sahlin/2020-08-18T13:52:53+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/sedge-lucas/2020-08-18T13:53:49+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/belinda-oloughlin/2020-08-18T13:53:17+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/lamiya-sheikh/2020-08-20T13:54:34+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/kari-dudley/2020-08-20T21:28:32+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/peter-chen/2020-08-18T13:53:39+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/shelby-cameron/2020-08-20T21:34:01+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/a-discussion-with-dr.-serena-koenig-about-the-why-when-and-how-of-novel-coronavirus-testing/2020-08-07T20:39:10+00:00weekly0.6http://qxclear.com/news-and-events/press-releases/french/groupe-danalyse-participe-a-leffort-devaluation-des-risques-lies-a-la-reprise-de-lactivite-economique-au-quebec/2020-07-09T19:40:44+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/managing-information-security-and-data-in-the-modern-business/2020-08-07T17:25:42+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/conjoint-surveys-can-lead-to-inflated-values-of-minor-product-features/2020-08-07T20:06:51+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/mayo-setting-the-record-straight/2020-08-07T19:33:11+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/schuyler-livingston/2020-12-21T19:48:01+00:00weekly0.6http://qxclear.com/careers/what-we-do/meet-the-humira-team/humira-case-study-1/2020-09-28T15:15:39+00:00weekly0.6http://qxclear.com/careers/what-we-do/meet-the-humira-team/humira-case-study-2/2020-06-10T15:17:53+00:00weekly0.6http://qxclear.com/careers/what-we-do/meet-the-humira-team/humira-case-study-3/2020-06-10T15:18:19+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/does_acquihiring_lead_to_better_outcomes/2019-12-19T18:27:15+00:00weekly0.6http://qxclear.com/Insights/ag-feature/health-care-bulletin/winterspring-2019/2019-03-06T17:01:07+00:00weekly0.6http://qxclear.com/Insights/ag-feature/analysis-group-forum/spring-2019/2019-06-14T17:13:14+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/anshika/2020-06-10T17:10:35+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/catherine-nguyen/2020-06-10T17:10:11+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/the-use-of-reverse-termination-fees-in-merger-reviews/2019-09-19T18:42:17+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/jordan/2020-12-21T19:45:34+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/david-glick/2020-12-21T19:44:16+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/elizabeth/2020-12-21T19:44:54+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/michael/2020-12-21T19:47:09+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/ishita/2020-06-29T19:19:59+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/luke/2019-10-17T13:10:38+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/maral/2020-06-10T18:54:40+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/elyse/2020-06-10T17:20:27+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/rajeev/2020-06-10T19:21:09+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/statistical-approaches-to-pay-equity-issues--a-qand-a-with-affiliate-anthony-losasso/2019-10-18T13:35:18+00:00weekly0.6http://qxclear.com/Insights/ag-feature/infrastructure/energy-technology-and-the-future-a-conversation-with-ferc-commissioner-cheryl-lafleur-and-former-epa-administrator-gina-mccarthy/2018-11-21T14:22:08+00:00weekly0.6http://qxclear.com/Insights/ag-feature/infrastructure/perspectives-on-the-future-of-the-u.s.-power-grid/2018-11-30T20:27:38+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/yao-lu/2021-01-05T21:55:19+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/career-path/manager/2020-12-21T19:38:47+00:00weekly0.6http://qxclear.com/about/locations/brussels/fr/2019-06-19T20:54:43+00:00weekly0.6http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2018/2018-10-05T20:23:06+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/career-path/administrative/2020-06-10T15:45:39+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/career-path/summer-analyst-intern/2020-12-21T19:42:51+00:00weekly0.6http://qxclear.com/about/locations/paris/fr/2020-09-10T20:58:15+00:00weekly0.6http://qxclear.com/careers/what-we-do/meet-the-lcd-team/analyst-insights/2020-12-21T19:36:37+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/career-path/associate/2020-12-21T19:42:38+00:00weekly0.6http://qxclear.com/careers/what-we-do/meet-the-lcd-team/direct-purchasers/2020-12-21T19:36:47+00:00weekly0.6http://qxclear.com/careers/what-we-do/meet-the-lcd-team/indirect-purchasers/2020-12-21T19:36:56+00:00weekly0.6http://qxclear.com/careers/what-we-do/meet-the-lcd-team/private-litigation/2020-12-21T19:37:08+00:00weekly0.6http://qxclear.com/careers/what-we-do/meet-the-alliance-team/oversight-and-coordination/2020-12-21T19:37:28+00:00weekly0.6http://qxclear.com/careers/what-we-do/meet-the-alliance-team/securities-issues/2020-06-10T15:39:38+00:00weekly0.6http://qxclear.com/careers/what-we-do/meet-the-alliance-team/corporate-governance/2020-12-21T19:37:41+00:00weekly0.6http://qxclear.com/careers/what-we-do/meet-the-alliance-team/financial-accounting/2020-06-10T15:41:36+00:00weekly0.6http://qxclear.com/careers/what-we-do/meet-the-alliance-team/portfolio-theory/2020-12-21T19:37:54+00:00weekly0.6http://qxclear.com/careers/what-we-do/meet-the-alliance-team/damages-rebuttal/2020-12-21T19:38:04+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/career-path/analyst/2020-12-08T19:27:57+00:00weekly0.6http://qxclear.com/Insights/ag-feature/infrastructure/also-on-analysisgroup.com/2018-11-29T19:56:42+00:00weekly0.6http://qxclear.com/Insights/ag-feature/health-care-bulletin/biologics-biosimilars-and-generics/2018-10-05T20:23:06+00:00weekly0.6http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-2018/2018-10-05T20:23:06+00:00weekly0.6http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2016/2018-10-05T20:23:06+00:00weekly0.6http://qxclear.com/Insights/ag-feature/health-care-bulletin/winter-spring-2012/2018-10-05T20:23:06+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/cap-and-trade-and-allowance-allocations/2018-11-01T15:15:44+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/harnessing-economics-to-respond-to-new-fuel-economy-standards/2018-11-01T15:15:44+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/reading-the-tea-leaves-in-mand-a-litigation/2018-11-01T15:15:43+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/reinstatement-and-bankruptcy-litigation/2020-11-09T17:15:58+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/the-real-story-behind-mutual-fund-fees/2018-11-01T15:15:42+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/antitrust-experts-discuss-a-state-of-the-art-merger-tool/2018-11-01T15:15:41+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/a-focus-on-proxy-puts--change-of-control-provisions-in-perspective/2020-11-09T17:07:39+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/is-big-data-a-true-source-of-market-power-/2018-11-01T15:15:40+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/the-impact-of-data-breaches-and-hacking/2018-11-01T15:15:39+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/consumer-class-action-litigation--understanding-consumer-decision-making-can-make-the-difference/2018-10-12T19:16:54+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/privacy-and-cybersecurity--the-corporate-perspective/2018-11-01T15:15:39+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/labor-and-employment-issues-in-the-gig-economy--qand-a-with-professor-paul-oyer/2018-11-01T15:15:39+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/gender-identity-discrimination-in-the-greater-boston-housing-market/2018-11-01T15:15:39+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/examining-key-economic-issues-in-anti-poaching-and-pay-equity-litigation/2018-11-01T15:15:38+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/blockchain-economics-and-litigation/2018-11-01T15:15:38+00:00weekly0.6http://qxclear.com/Insights/ag-feature/q-and-a/materialization-of-risk-in-securities-event-driven-fraud-class-actions/2018-11-01T15:15:38+00:00weekly0.6http://qxclear.com/Insights/ag-feature/infrastructure/transformation-of-the-nation-s-electric-infrastructure-and-implications-for-reliability/2020-07-01T14:54:58+00:00weekly0.6http://qxclear.com/Insights/ag-feature/infrastructure/assessing-transmission-for-renewables-projects/2018-11-01T15:15:46+00:00weekly0.6http://qxclear.com/Insights/ag-feature/infrastructure/performance-and-economic-analyses-to-support-the-siting-approval-of-a-new-natural-gas-peaker-plant/2020-07-01T14:54:40+00:00weekly0.6http://qxclear.com/Insights/ag-feature/infrastructure/assessing-market-needs-to-evaluate-natural-gas-pipeline-development/2020-07-01T14:55:28+00:00weekly0.6http://qxclear.com/Insights/ag-feature/infrastructure/capacity-market-impacts-of-future-resources-scenarios-in-the-iso-ne-system/2018-11-01T15:15:45+00:00weekly0.6http://qxclear.com/Insights/ag-feature/infrastructure/the-economics-of-different-ownership-structures-for-water-utilities/2018-11-01T15:15:44+00:00weekly0.6http://qxclear.com/Insights/ag-feature/infrastructure/revisiting-the-debate-over-natural-gas-pipeline-certifications/2018-11-06T14:48:24+00:00weekly0.6http://qxclear.com/Insights/ag-feature/settlement-in-microsoft-iowa-litigation/settlement-in-microsoft-iowa-litigation--overview/2018-11-01T15:15:37+00:00weekly0.6http://qxclear.com/Insights/ag-feature/settlement-in-microsoft-iowa-litigation/settlement-in-microsoft-iowa-litigation--working-with-academic-experts/2018-11-01T15:15:37+00:00weekly0.6http://qxclear.com/Insights/ag-feature/settlement-in-microsoft-iowa-litigation/settlement-in-microsoft-iowa-litigation--key-concepts-in-the-litigation/2018-11-01T15:15:36+00:00weekly0.6http://qxclear.com/Insights/ag-feature/when-specialized-expertise-is-required/when-specialized-expertise-is-required---unique-insights/2018-11-21T21:21:09+00:00weekly0.6http://qxclear.com/Insights/ag-feature/when-specialized-expertise-is-required/when-specialized-expertise-is-required---identification-preparation-of-experts/2018-10-12T18:26:38+00:00weekly0.6http://qxclear.com/Insights/ag-feature/health-care-bulletin/the-biosimilar-challenge/2018-10-05T20:23:06+00:00weekly0.6http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2015/2018-10-05T20:23:06+00:00weekly0.6http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2014/2018-10-05T20:23:06+00:00weekly0.6http://qxclear.com/Insights/ag-feature/health-care-bulletin/fall-2013/2018-10-05T20:23:06+00:00weekly0.6http://qxclear.com/Insights/ag-feature/analysis-group-forum/winter-2013-forum/2018-10-05T20:23:06+00:00weekly0.6http://qxclear.com/Insights/ag-feature/deal-metrics/a-quick-look-at-topping-bids/2019-01-02T18:59:35+00:00weekly0.6http://qxclear.com/Insights/ag-feature/deal-metrics/go-shops-and-topping-bids/2019-01-02T19:31:04+00:00weekly0.6http://qxclear.com/Insights/ag-feature/deal-metrics/on-the-hot-seat-in-delaware/2020-11-09T17:15:29+00:00weekly0.6http://qxclear.com/Insights/ag-feature/energy-and-environment/alleged-market-manipulation-in-energy-markets/2018-11-06T22:00:34+00:00weekly0.6http://qxclear.com/Insights/ag-feature/energy-and-environment/energy-and--environment-litigation-case-examples/2018-11-06T22:05:46+00:00weekly0.6http://qxclear.com/Insights/ag-feature/energy-and-environment/health-related-cost-impacts-from-pollutant-reductions/2019-04-08T13:36:58+00:00weekly0.6http://qxclear.com/Insights/ag-feature/energy-and-environment/analyzing-competition-in-the-low-level-radioactive-waste-llrw-market/2018-11-01T15:16:11+00:00weekly0.6http://qxclear.com/Insights/ag-feature/analysis-group-forum/the-role-of-the-economic-expert-in-class-certification/2018-10-05T20:23:06+00:00weekly0.6http://qxclear.com/Insights/ag-feature/analysis-group-forum/the-missing-data-challenge/2018-10-05T20:23:06+00:00weekly0.6http://qxclear.com/Insights/ag-feature/analysis-group-forum/presenting-demand-models-in-antitrust-litigation/2018-10-05T20:23:06+00:00weekly0.6http://qxclear.com/Insights/ag-feature/analysis-group-forum/fall-2014/2018-10-05T20:23:06+00:00weekly0.6http://qxclear.com/Insights/ag-feature/analysis-group-forum/summer-2013/2018-10-05T20:23:06+00:00weekly0.6http://qxclear.com/Insights/ag-feature/analysis-group-forum/perspectives-on-investment-management-disputes/2018-10-05T20:23:06+00:00weekly0.6http://qxclear.com/Insights/ag-feature/analysis-group-forum/fall-winter-2013/2018-10-05T20:23:06+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/khalilah-jones/2020-12-17T17:01:11+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/brian-masunda/2021-01-08T18:16:26+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/kristin-casavant/2020-11-06T17:29:43+00:00weekly0.6http://qxclear.com/Insights/ag-feature/analysis-group-forum/economic-analysis-in-erisa-litigation/2018-10-05T20:23:06+00:00weekly0.6http://qxclear.com/Insights/ag-feature/analysis-group-forum/2015-year-in-review/2018-10-05T20:23:06+00:00weekly0.6http://qxclear.com/Insights/ag-feature/analysis-group-forum/customer-behavior-and-class-actions/2018-11-05T14:37:46+00:00weekly0.6http://qxclear.com/Insights/ag-feature/analysis-group-forum/analysis-group-forum/2018-10-05T20:23:06+00:00weekly0.6http://qxclear.com/practices/health-care/health-economics-and--outcomes-research-heor/burden-of-illness-research/2020-02-06T23:20:41+00:00weekly0.6http://qxclear.com/practices/health-care/health-economics-and--outcomes-research-heor/comparative-effectiveness-research/2020-02-06T23:20:41+00:00weekly0.6http://qxclear.com/practices/health-care/health-economics-and--outcomes-research-heor/patient-reported-outcomes/2020-02-06T23:20:41+00:00weekly0.6http://qxclear.com/practices/health-care/health-economics-and--outcomes-research-heor/clinical-research-and--study-design/2020-02-06T23:20:41+00:00weekly0.6http://qxclear.com/practices/health-care/health-economics-and--outcomes-research-heor/personalized-medicine/2020-02-06T23:20:41+00:00weekly0.6http://qxclear.com/practices/health-care/health-economics-and--outcomes-research-heor/rare-disease-and--orphan-drug-research/2020-02-06T23:20:41+00:00weekly0.6http://qxclear.com/practices/health-care/litigation-services/antitrust-litigation/2020-02-06T23:20:41+00:00weekly0.6http://qxclear.com/practices/health-care/litigation-services/drug-safety-litigation/2020-02-06T23:20:41+00:00weekly0.6http://qxclear.com/practices/health-care/litigation-services/government-investigations-and--qui-tam-litigation/2020-02-06T23:20:41+00:00weekly0.6http://qxclear.com/practices/health-care/litigation-services/intellectual-property-disputes/2020-02-06T23:20:41+00:00weekly0.6http://qxclear.com/practices/health-care/litigation-services/payer-disputes/2020-02-06T23:20:41+00:00weekly0.6http://qxclear.com/practices/health-care/modeling-and--analytics/big-data-research/2020-02-06T23:20:41+00:00weekly0.6http://qxclear.com/practices/health-care/modeling-and--analytics/health-technology-assessment-hta/2020-02-06T23:20:41+00:00weekly0.6http://qxclear.com/practices/health-care/modeling-and--analytics/machine-learning-in-health-care/2020-02-06T23:20:41+00:00weekly0.6http://qxclear.com/practices/health-care/market-access-and--commercial-strategy/value-proposition-and--evidence-strategy/2020-02-06T23:20:41+00:00weekly0.6http://qxclear.com/practices/health-care/market-access-and--commercial-strategy/forecasting-and--modeling/2020-02-06T23:20:41+00:00weekly0.6http://qxclear.com/practices/health-care/market-access-and--commercial-strategy/payer-provider-and--other-stakeholder-research/2020-02-06T23:20:41+00:00weekly0.6http://qxclear.com/practices/health-care/market-access-and--commercial-strategy/pricing-contracting-and--reimbursement/2020-02-06T23:20:41+00:00weekly0.6http://qxclear.com/practices/health-care/market-access-and--commercial-strategy/evidence-dossiers-and--communication-tools/2020-02-06T23:20:41+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/lisa/2020-06-10T18:48:07+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/jim/2020-06-10T17:23:35+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/anita/2020-07-01T21:30:34+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/david-s/2020-12-21T19:44:38+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/camille/2020-06-10T17:08:41+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/adam/2020-06-09T17:24:24+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/ajay/2020-06-10T15:48:24+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/bruce/2020-06-10T17:07:52+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/laura/2020-06-10T18:43:40+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/lauren/2020-06-10T18:44:20+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/david/2021-01-05T21:36:17+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/wendy/2021-01-06T22:22:56+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/mark/2020-06-10T18:56:44+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/na/2020-06-10T19:00:38+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/rebecca/2020-06-10T19:21:51+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/almudena/2020-06-10T15:50:21+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/andrew/2020-06-10T15:51:13+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/jeffrey/2020-06-10T17:22:45+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/lee/2020-06-10T18:44:57+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/martha/2020-06-10T18:57:32+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/patrick/2020-06-10T19:16:36+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/liz/2020-06-10T18:49:15+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/Natacha/2020-06-10T19:02:22+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/megan/2020-06-10T18:58:21+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/rachel/2020-06-29T19:18:46+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/priyanka/2020-06-10T19:19:01+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/charles/2020-06-29T19:17:18+00:00weekly0.6http://qxclear.com/careers/why-analysis-group/our-people/darren/2020-06-10T17:13:56+00:00weekly0.6http://qxclear.com/about/locations/beijing/cn/2020-07-27T15:51:21+00:00weekly0.6http://qxclear.com/about/locations/chicago/2020-02-14T16:01:13+00:00weekly0.7http://qxclear.com/about/locations/dallas/2019-07-24T20:20:16+00:00weekly0.7http://qxclear.com/about/locations/denver/2018-11-15T16:54:16+00:00weekly0.7http://qxclear.com/about/locations/los-angeles/2020-02-14T16:01:45+00:00weekly0.7http://qxclear.com/about/locations/menlo-park/2020-01-22T21:30:43+00:00weekly0.7http://qxclear.com/about/locations/washington-dc/2020-05-11T15:29:37+00:00weekly0.7http://qxclear.com/about/locations/new-york/2019-08-12T12:54:26+00:00weekly0.7http://qxclear.com/about/locations/san-francisco/2018-11-15T16:57:04+00:00weekly0.7http://qxclear.com/about/locations/beijing/2020-07-27T15:44:17+00:00weekly0.7http://qxclear.com/experts-and-consultants/principals/david-n--mishol/2020-02-06T23:01:22+00:00weekly0.7http://qxclear.com/experts-and-consultants/principals/dave-nellesen/2020-02-06T23:01:22+00:00weekly0.7http://qxclear.com/experts-and-consultants/principals/paul-j--hibbard/2021-01-14T14:56:33+00:00weekly0.7http://qxclear.com/experts-and-consultants/principals/almudena-arcelus/2020-08-18T16:55:56+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/elizabeth-a--eccher/2020-10-26T16:22:00+00:00weekly0.7http://qxclear.com/experts-and-consultants/principals/robert-l--vigil/2021-01-06T14:45:26+00:00weekly0.7http://qxclear.com/experts-and-consultants/principals/marnie-a--moore/2020-02-06T23:01:22+00:00weekly0.7http://qxclear.com/experts-and-consultants/principals/david-w--sosa/2020-11-09T16:31:30+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/antoine-chapsal/2020-10-12T18:06:04+00:00weekly0.7http://qxclear.com/about/locations/montreal/2019-06-03T20:16:59+00:00weekly0.7http://qxclear.com/about/locations/london/2019-06-03T20:25:29+00:00weekly0.7http://qxclear.com/about/locations/brussels/2019-06-19T20:54:59+00:00weekly0.7http://qxclear.com/about/locations/paris/2020-01-15T22:15:01+00:00weekly0.7http://qxclear.com/careers/why-analysis-group/our-people/2021-01-08T18:18:36+00:00weekly0.7http://qxclear.com/practices/antitrust-competition/collusion/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/antitrust-competition/mergers-and--acquisitions/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/antitrust-competition/monopolization-and--exclusionary-practices/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/antitrust-competition/vertical-restraints/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/about/locations/boston/2020-02-14T15:58:44+00:00weekly0.7http://qxclear.com/practices/class-certification/types-of-class-actions/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/class-certification/industry-experience/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/orlando-visbal/2020-10-26T16:26:28+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/george-kosicki/2020-03-06T16:57:03+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/laura-boothman-stamm/2020-10-26T16:24:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/robert-s--pindyck/2020-10-26T16:05:06+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/dennis-j--aigner/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/laurence-c--baker/2020-11-04T17:33:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/ray-ball/2020-10-28T13:46:17+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/edward-p--kahn/2020-03-25T14:30:00+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/stanley-i--ornstein/2020-03-25T13:56:17+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/lawrence-m--benveniste/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/patricia-chadwick/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/judith-a--chevalier/2020-05-13T20:18:39+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/dwight-b--crane/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/michael-r--darby/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/francis-x--diebold/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/mark-s--grinblatt/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/r--glenn-hubbard/2020-11-20T20:50:06+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/philippe-jorion/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/k--ramesh/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/meir-statman/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/peter-tufano/2020-10-26T16:27:08+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/lawrence-p--weiner/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/susan-e--woodward/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/karen-hopper-wruck/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/robert-a--sherwin/2020-10-26T16:32:24+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/arnold-i--barnett/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/sebastian-edwards/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/kathleen-m--eisenhardt/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/steven-d--eppinger/2020-07-22T17:13:22+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/marshall-l--fisher/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/pierre-fortin/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/brian-j--hall/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/john-r--hauser/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/donna-l--hoffman/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/luis-m--huete/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/ronald-c--kessler/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/william-h--lehr/2020-03-04T14:54:55+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/burton-g--malkiel/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/john-w--mayo/2020-08-07T19:33:45+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/j--f--philip-merrigan/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/randolph-bucklin/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/george-foster/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/robert-e--hall/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/barry-m--massarsky/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/shmuel-s--oren/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/sharon-m--oster/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/timothy-j--riddiough/2020-11-09T16:18:25+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/john-a--rizzo/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/louis-f--rossiter/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/robert-stavins/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/ashley-j--stevens/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/kerry-dean-vandell/2020-10-26T16:23:33+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/roman-l--weil/2020-10-26T16:32:57+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/lawrence-j--white/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/john-m--lacey/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/michael-f--koehn/2020-03-25T13:53:16+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/nicholas-e--piggott/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/a--mitchell-polinsky/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/steven-shavell/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/lori-pressman/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/robert-c--blattberg/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/michael-w--maher/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/stephen-g--ryan/2020-10-28T17:31:08+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/walter-n--thurman/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/marcel-boyer/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/laura-t--starks/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/barry-k--goodwin/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/henry-g--grabowski/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/frank-sloan/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/edward-a--snyder/2020-08-25T21:37:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/john-chalmers/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/lucian-a--bebchuk/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/erik-brynjolfsson/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/chris-f--kemerer/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/chinese/eric-wu/2020-10-19T19:04:00+00:00weekly0.7http://qxclear.com/experts-and-consultants/chinese/gordon-liu/2020-02-06T22:56:57+00:00weekly0.7http://qxclear.com/experts-and-consultants/chinese/jun-liu/2020-02-06T22:56:57+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/jimmy-royer/2020-02-06T23:00:29+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/lisa-b--pinheiro/2020-11-03T18:57:36+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/patrick-lefebvre/2020-04-23T20:04:05+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/marc-van-audenrode/2020-07-30T14:36:38+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/paul-e--greenberg/2020-02-06T23:00:29+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/pierre-y--cremieux/2020-02-06T23:00:29+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/marissa-ginn/2020-02-06T23:00:29+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/markus-von-wartburg/2020-02-06T23:00:29+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/eric-qiong-wu/2020-02-06T23:00:29+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/benoit-d-udekem/2020-10-13T15:05:47+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/richard-m--starfield/2020-11-09T16:32:18+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/emmanuel-frot/2020-02-06T23:00:29+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/benoit-d-udekem---paris/2020-10-13T15:06:06+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/eric-qiong-wu---paris/2020-02-06T23:00:29+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/jimmy-royer---brussels/2020-02-06T23:00:29+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/lisa-b--pinheiro---brussels/2020-11-03T19:08:38+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/marc-van-audenrode---paris/2020-07-30T14:35:15+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/pierre-y--cremieux---brussels/2020-02-06T23:00:29+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/richard-m--starfield---paris/2020-02-06T23:00:29+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/laura-o-laughlin/2020-12-09T15:51:44+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/christine-bieri/2020-02-06T23:00:53+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/caroline-korves/2020-10-14T19:43:25+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/ludmila-rovba/2020-02-06T23:00:53+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/anne-catherine-faye/2020-09-23T19:49:03+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/rajeev-ayyagari/2020-12-28T21:28:39+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/martin-cloutier/2020-12-31T18:03:43+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/daniel-andersen/2020-02-06T23:00:53+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/elyse-swallow/2020-09-29T20:22:22+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/min-yang/2021-01-12T14:04:08+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/smit-shrestha/2020-02-06T23:00:53+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/ivan-maryanchyk/2020-05-13T19:46:23+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/wendy-cheng/2021-01-06T22:25:49+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/eileen-lu/2020-11-20T20:50:06+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/jenny-zhou/2020-12-30T22:33:01+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/shogo-hamasaki/2020-08-31T21:01:25+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/andrew-clarke/2020-05-13T20:18:39+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/peter-fabbrucci/2020-10-26T16:55:36+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/urvi-desai/2021-01-07T18:53:21+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/raluca-ionescu-ittu/2020-12-09T18:34:56+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/stephen-kiebzak/2020-02-06T23:00:53+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/murat-ilgen/2020-02-06T23:00:53+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/lynn-huynh/2020-12-21T21:46:22+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/david-smith/2021-01-05T21:42:37+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/nishi-sinha/2020-10-26T17:26:44+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/mark-berberian/2020-05-22T19:47:52+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/anne-larue/2020-05-22T19:47:52+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/kristof-zetenyi/2021-01-07T16:46:33+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/joel-wiles/2020-12-28T19:21:35+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/nathan-trujillo/2021-01-06T18:18:26+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/david-toniatti/2020-10-13T16:23:47+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/yan-song/2021-01-07T14:53:43+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/jinlin-song/2020-11-23T22:19:38+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/jeremy-smith/2020-08-26T16:10:34+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/dominic-pilon/2021-01-07T16:56:00+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/elizabeth-milsark/2021-01-06T22:39:11+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/jeffrey-hulbert/2020-02-06T23:00:53+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/anna-gumen/2020-05-22T19:47:52+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/maral-dersarkissian/2020-12-30T22:18:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/tracy-danner/2021-01-07T14:48:27+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/stacey-chan/2020-02-06T23:00:53+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/todor-stoyanov/2020-10-26T17:27:31+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/nick-dadson/2020-05-18T16:31:39+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/juliette-caminade/2021-01-06T21:55:55+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/ashley-zhou/2020-10-26T17:29:59+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/megan-accordino/2020-02-06T23:00:53+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/federico-mantovanelli/2020-09-11T19:32:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/yao-lu/2021-01-05T21:54:11+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/fan-mu/2020-12-28T20:05:02+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/catherine-alford/2021-01-06T18:50:31+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/andrew-j--ungerer/2020-10-28T13:46:17+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/michael-schreck/2020-05-21T15:17:00+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/marjolaine-gauthier-loiselle/2020-12-31T18:03:43+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/thomas-zimmerfaust/2020-02-06T23:00:53+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/ryan-marsh/2020-11-16T17:03:02+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/joshua-levine/2020-02-06T23:00:53+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/lucia-tiererova/2020-11-09T16:32:53+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/gautam-sajeev/2020-12-09T22:03:37+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/keziah-cook/2021-01-07T19:18:31+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/emi-terasawa/2020-12-28T21:28:39+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/patrick-lefebvre/2020-12-23T21:41:17+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/michael-holland/2020-11-09T14:37:57+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/aaron-yeater/2020-10-06T17:47:09+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/lisa-b--pinheiro/2020-11-23T15:16:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/crystal-pike/2020-10-26T17:24:06+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/dov-rothman/2021-01-14T19:11:29+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/james-signorovitch/2020-12-23T21:56:08+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/pierre-y--cremieux/2020-12-01T16:51:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/brian-s--gorin/2020-11-09T16:22:14+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/jeffrey-h--kinrich/2020-12-07T16:02:17+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/john-c--jarosz/2020-08-31T21:01:25+00:00weekly0.7http://qxclear.com/experts-and-consultants/senior-advisors/keith-r--ugone/2020-10-26T17:28:37+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/marc-van-audenrode/2020-11-12T17:20:50+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/paul-e--greenberg/2020-12-23T21:56:59+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/rebecca-kirk-fair/2020-11-09T21:27:59+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/bruce-f--deal/2020-10-26T16:53:55+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/r--jeffrey-malinak/2020-10-26T17:20:05+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/alan-g--white/2020-12-29T19:42:55+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/bruce-a--strombom/2020-02-06T23:01:08+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/carla-s--mulhern/2020-06-15T13:14:13+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/t--christopher-borek/2020-12-22T18:39:30+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/edward-tuttle/2020-10-01T21:13:25+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/laurits-r--christensen/2020-11-09T14:35:05+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/d--lee-heavner/2020-11-20T20:50:06+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/mark-h--egland/2020-10-26T16:55:14+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/richard-m--starfield/2020-11-09T16:32:32+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/maureen-m--chakraborty/2020-11-09T14:34:37+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/nicholas-i--crew/2020-11-09T16:24:35+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/mei-sheng-duh/2020-12-30T22:18:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/justin-n--mclean/2020-12-10T17:16:18+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/gaurav-jetley/2020-11-09T14:43:35+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/mark-howrey/2020-10-26T16:58:48+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/eric-q--wu/2021-01-12T14:04:08+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/martha-s--samuelson/2020-12-02T13:41:03+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/bruce-e--stangle/2020-11-09T16:31:48+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/adam-decter/2020-11-09T16:21:50+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/andrew-wong/2020-11-09T16:33:07+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/michael-beauregard/2020-11-20T20:50:06+00:00weekly0.7http://qxclear.com/experts-and-consultants/senior-advisors/anita-j--chawla/2020-09-04T18:54:04+00:00weekly0.7http://qxclear.com/experts-and-consultants/senior-advisors/jeffrey-a--cohen/2020-03-09T13:25:27+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/coreen-mccool/2020-11-15T22:58:05+00:00weekly0.7http://qxclear.com/experts-and-consultants/senior-advisors/susan-f--tierney/2021-01-14T14:56:33+00:00weekly0.7http://qxclear.com/experts-and-consultants/senior-advisors/genia-long/2020-12-03T21:49:34+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/michael-j--quinn/2020-03-06T16:59:48+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-effectiveness-of-rhuepo-in-oncology/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/anemia-related-costs-for-cancer-patients/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-costs-of-cancer-to-a-major-employer-in-the-united-states--a-case-control-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/understanding-the-pharmacoeconomic-profile-of-cancer/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-of-outpatient-blood-transfusion-in-cancer-patients/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/costs-associated-with-anemia-and-cancer/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/depression-and-fibromyalgia--treatment-and-cost-when-diagnosed-separately-or-concurrently/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-implications-of-treatment-resistant-depression-among-employees/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-depression-in-the-united-states--how-did-it-change-between-1990-and-2000-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economics-of-women-and-depression--an-employer-perspective/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-anxiety-and-stress-disorders/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-of-depression--current-assessment-and-future-directions/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/assessing-the-economic-impact-of-psychiatric-disorders--where-to-begin-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/management-of-major-depression-in-the-workplace--impact-on-employee-work-loss/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-impact-of-antidepressant-use-on-social-functioning--reboxetine-versus-fluoxetine/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-anxiety-disorders-in-the-1990s/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economics-of-clinical-depression/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/direct-and-indirect-costs-of-rheumatoid-arthritis-to-an-employer/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-depression-in-1990/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/lower-respiratory-tract-infections--impact-on-the-workplace/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-of-respiratory-infections-in-an-employed-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/direct-and-indirect-costs-of-asthma-to-an-employer/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/lack-of-intraocular-pressure-effect-of-budesonide-inhalation-therapy-in-a-mixed-asthmatic-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-of-stress-urinary-incontinence--a-claims-data-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-consequences-of-irritable-bowel-syndrome--a-us-employer-perspective/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/productivity-and-medical-costs-of-diabetes-in-a-large-employer-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-effects-of-chronic-medical-conditions-on-work-loss-and-work-cutback/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/descriptive-epidemiology-of-acute-liver-enzyme-abnormalities-in-the-general-population-of-central-massachusetts/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/interpretation-of-the-weight-matrix-in-an-artificial-neural-network/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/linking-administrative-claims-data-with-archival-productivity-measures-to-inform-employer-decision-making/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/administrative-claims-data--a-valuable-tool-in-pharmaceutical-litigation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/using-healthcare-claims-data-for-outcomes-research-and-pharmacoeconomic-analyses/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/public-and-private-pharmaceutical-spending-as-determinants-of-health-outcomes-in-canada/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-regulatory-perspective-on-productivity-claims--implications-for-future-productivity-research/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/pharmaceutical-spending-and-health-outcomes-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/david-j--denis/2020-11-09T14:37:21+00:00weekly0.7http://qxclear.com/Insights/publishing/diagnosing-the-illness/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/stuart-a--gabriel/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/health-care-spending-as-determinants-of-health-outcomes/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/michael-k--wohlgenant/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/tackling-costs-one-disease-at-a-time/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/pharmacoeconomics-and-health-policy--current-applications-and-prospects-for-the-future/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/roger-ware/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/calculating-return-on-investment-from-reducing-workplace-costs-of-illness/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-next-phase-of-managed-care--targeting-investments-in-employee-health/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/price-growth-of-prescription-pharmaceutical-preparations--an-update-and-extension-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/joel-h--steckel/2020-12-17T15:48:16+00:00weekly0.7http://qxclear.com/Insights/publishing/consolidation-is-a-tonic-for-health-care-providers--trend-toward-managed-care-and-ascent-of-information-technology-fuel-restructuring-of-an-industry/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-consequences-of-illness-in-the-workplace/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/james-w--hughes/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/charlotte-chamberlain/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/lorraine-eden/2020-11-09T14:54:57+00:00weekly0.7http://qxclear.com/Insights/publishing/your-patent-is-about-to-expire--what-now-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/hospital-cost-flexibility-in-the-presence-of-many-outputs--a-public-private-comparison/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/oliver-hart/2020-11-09T14:58:18+00:00weekly0.7http://qxclear.com/Insights/publishing/product-liability-in-the-pharmaceutical-industry/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/omitted-variable-bias-and-hospital-costs/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/atulya-sarin/2020-10-26T16:03:27+00:00weekly0.7http://qxclear.com/Insights/publishing/hospital-cost-function-in-a-non-market-health-care-system/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/hospital-consolidation--optimal-strategy-for-a-two-hospital-town/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/richard-l--smith/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-depression--societal-and-patient-perspectives/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economics-of-anxiety-disorders/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/depression-in-the-workplace--effects-on-short-term-disability/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/robin-cooper/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/how-much-does-depression-cost-society-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-cost-and-epidemiological-characteristics-of-patients-with-fibromyalgia-claims/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/sanjiv-r--das/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/calculating-the-workplace-cost-of-chronic-disease/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/thomas-lys/2020-10-26T16:34:11+00:00weekly0.7http://qxclear.com/Insights/publishing/consolidation-and-restructuring--the-next-step-in-managed-care/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/douglas-j--skinner/2020-11-09T14:48:23+00:00weekly0.7http://qxclear.com/Insights/publishing/clinical-and-economic-value-of-cardiovascular-nuclear-medicine/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/valuing-a-business-in-a-litigation-context/2020-10-26T19:30:25+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/william-j--chambers/2020-11-06T22:07:55+00:00weekly0.7http://qxclear.com/Insights/publishing/options-as-an-alternative-to-cost-sharing/2020-10-26T20:57:49+00:00weekly0.7http://qxclear.com/Insights/publishing/hedging-long-term-commodity-commitments-with-short-dated-futures-contracts/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/stock-option-expense-and-cost-sharing--a-comment/2020-10-26T19:26:35+00:00weekly0.7http://qxclear.com/Insights/publishing/securities-act-violations--estimation-of-damages/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/hedge-funds--risk-and-return/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/lee-jen-wei/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/unemployment-insurance-and-job-search-productivity/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/canada-unemployment-gap-truly-large--a-labor-flow-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/mergers-and-bargaining-in-the-us-airline-industry/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/donna-hitscherich/2020-11-09T14:58:44+00:00weekly0.7http://qxclear.com/Insights/publishing/why-strike-insurance-is-unilateral--evidence-from-the-airline-industry-s-mutual-aid-pact/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-analysis-of-intellectual-property/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/robert-grien/2020-11-09T14:37:37+00:00weekly0.7http://qxclear.com/Insights/publishing/discounted-cash-flow-analysis-in-patent-infringement-litigation/2020-10-26T19:02:56+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-damages-in-patent-infringement-cases/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/james-levinsohn/2020-11-12T14:28:59+00:00weekly0.7http://qxclear.com/Insights/publishing/damage-measures-in-patent-infringement-actions/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/analysis-and-measurement-of-damages-in-patent-infringement-actions/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/trademark-misuse/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/considering-taxes-in-the-computation-of-lost-business-profits/2020-10-26T18:57:20+00:00weekly0.7http://qxclear.com/Insights/publishing/taxes-and-lost-profits/2020-10-26T19:28:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/thomas-buchmueller/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/pre-tax-versus-after-tax-patent-damages--do-the-courts-have-it-right-/2020-10-26T19:25:28+00:00weekly0.7http://qxclear.com/Insights/publishing/the-cafc-and-its-patent-damages-awards/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-panduit-lost-profits-test-after-bic-leisure-v--windsurfing/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/harold-w--furchtgott-roth/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/damages-in-patent-and-trademark-infringement/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/intellectual-property-valuation-and-hughes-aircraft-v--the-united-states--a-giant-leap-for-mankind-or-lost-in-space-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/use-of-the-25-per-cent-rule-in-valuing-ip/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/toby-e--stuart/2020-03-09T15:49:21+00:00weekly0.7http://qxclear.com/Insights/publishing/book-review--the-lesi-guide-to-licensing-best-practices--strategic-issues-and-contemporary-realities/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/boards-of-directors--does-independence-matter-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/preparing-the-financial-expert-or-economist/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/martin-zimmerman/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/challenges-to-the-admissibility-of-financial-expert-witness-testimony/2020-10-26T18:56:54+00:00weekly0.7http://qxclear.com/Insights/publishing/financial-expert-witness-challenges-and-exclusions--results-and-trends-in-federal-and-state-cases-since-kumho-tire/2020-10-26T19:09:29+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/david-s--scharfstein/2020-11-09T16:18:53+00:00weekly0.7http://qxclear.com/Insights/publishing/estimating-the-cost-of-capital/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/forensic-accounting-and-litigation-consulting-services/2020-10-26T19:11:46+00:00weekly0.7http://qxclear.com/Insights/publishing/the-myth-of-the-universal-market/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/andrew-metrick/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/the-myth-of-simple-market-solutions/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-myths-of-market-prices-and-efficiencies/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/michael-klausner/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/a-better-climate-change-agreement/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/michael-s--weisbach/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/markets-can-make-fisheries-sustainable/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/regulating-by-vintage--let-s-put-a-cork-in-it/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/b--espen-eckbo/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/using-market-prices-to-regulate-the-costs-of-a-utility-s-inputs/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/datawars--computer-models-in-the-federal-government/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-nuclear-waste-controversy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/nabil-n--el-hage/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/massachusetts--pre-approval-approach-to-prudence-in-massachusetts/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/foreword--using-consensus-building-to-improve-utility-regulation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/roberto-rigobon/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/regional-issues-in-restructuring-the-electric-industry/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/research-support-for-the-power-industry/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-better-co2-rule/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/siting-power-plants-in-the-new-electric-industry-structure--lessons-from-california-and-best-practices-for-other-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/jonathan-f--foster/2020-11-09T14:55:19+00:00weekly0.7http://qxclear.com/Insights/publishing/the-political-economy-of-long-term-generation-adequacy--why-an-icap-mechanism-is-needed-as-part-of-standard-market-design/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/uncertainty-and-the-distribution-of-benefits-from-utility-conservation-programs/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/designing-purpa-power-purchase-auctions--theory-and-practice/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparison-of-production-simulation-implementations/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/steven-m--shugan/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/regional-transmission-groups--how-should-they-be-structured-and-what-should-they-do-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/john-j--richard/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/preparing-for-the-inevitable--the-nationalization-of-the-u-s--nuclear-industry-in-a-competitive-electricity-market/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-efficiency-of-market-coordination--evidence-from-wholesale-electric-power-pools/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/e--han-kim/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/competition-and-institutional-change-in-u-s--electric-power-regulation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/introduction/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/gordon-liu/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/binding-constraints-on-electricity-restructuring--an-inventory/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/walter-torous/2020-11-09T16:19:25+00:00weekly0.7http://qxclear.com/Insights/publishing/an-engineering-economic-approach-to-estimating-the-price-elasticity-of-residential-electricity-demand/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-effects-of-conservation-programs-on-electric-utility-earnings--results-of-two-case-studies/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-tax-reform-on-renewable-energy-and-cogeneration-projects/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/integrated-analysis-of-demand-side-programs/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/catherine-e--tucker/2020-08-14T15:52:17+00:00weekly0.7http://qxclear.com/Insights/publishing/an-integrated-economic-analysis-of-commercial-thermal-energy-storage/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/proxy-plant-valuation-methods-for-demand-side-utility-programs/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/peter-s--fader/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/comparative-assessment-of-the-demand-side-management-plans-for-four-new-york-utilities/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/competitive-bidding-for-electric-power--comparing-evaluation-methods/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/auctions-for-purpa-purchases--a-simulation-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/jun-s--liu/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/structural-evolution-in-the-electric-utility-industry/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/why-are-vickrey-auctions-rare-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/alternative-approaches-to-competitive-bidding/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/kathleen-m--sutcliffe/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/evaluation-of-front-loading-in-auctions-for-wholesale-power/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/optimization-methods-for-evaluating-competitive-bids-from-private-producers/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/auction-markets-for-dispatchable-power--how-to-score-the-bids/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/risks-in-independent-power-contracts--an-empirical-survey/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/evaluating-dispatchability-features-in-competitive-bidding/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/on-amir/2021-01-07T22:25:55+00:00weekly0.7http://qxclear.com/Insights/publishing/integrating-market-processes-into-utility-resource-planning/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/transmission-planning-issues-in-a-competitive-economic-environment/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/coordination-in-the-wholesale-market--where-does-it-work-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/ravi-dhar/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/coal-gasification-in-a-de-integrated-electricity-industry/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/shane-frederick/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/reactive-power-is-a-cheap-constraint/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/kevin-l--keller/2020-05-22T19:47:52+00:00weekly0.7http://qxclear.com/Insights/publishing/regulation-by-simulation--the-role-of-production-cost-models-in-electricity-planning-and-pricing/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-linear-model-of-voltage-limited-transmission-interface-constraints/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-power-purchases-from-non-utilities-on-the-utility-cost-of-capital/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-electricity-industry-in-spain/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-performance-of-the-u-s--market-for-independent-electricity-generation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/peter-e--rossi/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/the-production-tax-credit-for-wind-turbine-powerplants-is-an-ineffective-incentive/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/market-power-in-california-electricity-markets/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/jiwoong-shin/2020-03-16T16:50:43+00:00weekly0.7http://qxclear.com/Insights/publishing/retail-access-pilot-programs--where-s-the-beef-/2020-11-03T15:23:10+00:00weekly0.7http://qxclear.com/Insights/publishing/can-nuclear-power-become-an-ordinary-commercial-asset-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/olivier-toubia/2020-03-16T16:50:17+00:00weekly0.7http://qxclear.com/Insights/publishing/introducing-competition-to-the-electricity-industry-in-spain--the-role-of-initial-conditions/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/numerical-techniques-for-analyzing-market-power-in-electricity/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/price-forecasting-in-spot-markets--hidden-risks-in-single-part-bidding/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/michael-a--carrier/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/a-folklorist-s-guide-to-the-used-power-plant-market/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-quantitative-analysis-of-pricing-behavior-in-california-s-wholesale-electricity-market-during-summer-2000/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/performance-incentives-for-transmission/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/e--scott-peterson/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/electric-utility-planning-and-regulation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/international-comparisons-of-electricity-regulation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/john-r--minahan/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/estimating-damages-using-forecasting-techniques/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/dull-witnesses/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/damages-on-the-internet/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/susan-mangiero/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/conflicting-rulings-about-conflicts/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/engagement-letters-for-litigation-services--business-valuation-and-forensic---litigation-services-practice-aid-04-1/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/vertical-enclosure--vertical-integration-and-the-reluctance-to-purchase-from-a-competitor/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/free-radicals--why-industry-leaders-fail-to-harness-disruptive-technologies/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-comprehensive-approach-to-corporate-venturing/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/matthew-g--nagler/2020-03-16T16:51:36+00:00weekly0.7http://qxclear.com/Insights/publishing/concentration-and-profits--a-rejoinder/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/antitrust-policy-and-market-forces-as-determinants-of-industry-structure--case-histories-in-beer-and-distilled-spirits/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/price-and-income-elasticities-of-demand-in-alcoholic-beverages/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/keith-m--schappert/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/efficiency-considerations-in-joint-ventures/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-federal-trade-commission-s-antitrust-attack-on-advertising/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/brendan-sheehy/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/resale-price-maintenance-and-cartels/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/resale-price-maintenance--output-increasing-or-restricting--the-case-of-distilled-spirits-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/william-mcgivney/2020-07-07T15:54:20+00:00weekly0.7http://qxclear.com/Insights/publishing/exclusive-dealing-and-antitrust/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/liquor--an-evaluation-of-resale-price-maintenance/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/exclusive-dealing-and-full-line-forcing/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-extent-of-the-market/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/predicting-the-price-effect-of-mergers-with-polynomial-logit-demand/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/presenting-economic-expert-testimony-to-a-jury--five-golden-rules/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/charles-porten/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/preparing-for-daubert-challenges-in-antitrust-cases/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/network-costs-and-the-regulation-of-wholesale-competition-in-electric-power/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/hedonic-price-indexes-for-personal-computer-operating-systems-and-productivity-suites/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/david-j--reibstein/2020-07-01T14:34:17+00:00weekly0.7http://qxclear.com/Insights/publishing/red-blood-cell-transfusion-and-ventilator-associated-pneumonia--a-potential-link-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-effectiveness-of-surgery-on-the-treatment-of-acute-spinal-cord-injury-and-its-relationship-with-pharmacological-treatment/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/what-does-hospice-cost-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/stephen-j--hoch/2020-10-26T16:18:41+00:00weekly0.7http://qxclear.com/Insights/publishing/an-alternative-in-terminal-care--results-of-the-national-advice-on-hospice-care-for-benefits-design/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/robert-p--navarro/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/an-alternative-in-terminal-care--results-of-the-national-hospice-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/russell-f--peppet/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-costs-of-community-acquired-pneumonia-in-an-employed-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/daniel-o--scharfstein/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/roberts-w--brokaw-iii/2020-11-09T14:54:26+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/deborah-haas-wilson/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/myron-s--glucksman/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/ira-g--kawaller/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/charles-jones/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/john-j--mcconnell/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/claire-tsai/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/zachary-y--dyckman/2020-03-06T17:03:14+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/russell-r--wermers/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/david-gal/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/rangarajan-k--sundaram/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/willy-c--shih/2020-07-22T17:12:41+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/paul-b--ginsburg/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/juanjuan-zhang/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/daniel-bauer/2020-05-13T19:23:17+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/christopher-r--knittel/2020-11-12T14:22:22+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/steven-tadelis/2020-08-18T17:21:17+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/steven-k--gissiner/2020-11-20T20:50:06+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/joel-peress/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/charles-i--plosser/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/peter-n--golder/2020-07-27T21:43:13+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/michael-siegel/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/nathan-novemsky/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/robert-zeithammer/2020-03-16T16:49:36+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/natalie-mizik/2020-03-16T16:51:56+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/austan-goolsbee/2020-08-07T20:42:20+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/john-e--ware/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/anja-lambrecht/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/shannon-w--anderson/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/john-contino/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/randal-s--milch/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/paul-oyer/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/jesse-rothstein/2020-08-17T15:25:24+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/hanming-fang/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/david-dranove/2020-09-11T19:32:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/scott-f--meadow/2020-03-09T13:35:38+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/sylvia-manning/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/steven-n--stern/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/jonathan-levav/2020-03-16T16:52:42+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/gary-h--stern/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/michael-d--mitzenmacher/2020-06-12T21:05:55+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/joseph-willett/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/alex-edmans/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/jean-pierre-landau/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/jura-liaukonyte/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/ronald-c--goodstein/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/kurt-carlson/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/jeffrey-t--prince/2020-11-11T17:06:48+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/peter-sterpe/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/scott-bradner/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/shlomo-hershkop/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/steven-weber/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/justin-seitz/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/luis-de-la-calle/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/francis-a--longstaff/2020-11-20T19:29:07+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/william-m--mohl/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/moshe-buchinsky/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/margaret-k--kyle/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/wei-tan/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/lewis-j--allen/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/fabio-savoldelli/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/alan-grigoletto/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/craig-garthwaite/2020-08-14T20:45:14+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/christianna-wood/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/edward-r--morrison/2020-11-09T16:18:08+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/anupam-b--jena/2020-10-13T17:32:30+00:00weekly0.7http://qxclear.com/practices/valuation/financial-instrument-valuation/2020-07-10T17:33:30+00:00weekly0.7http://qxclear.com/practices/valuation/business-enterprise-valuation/2020-07-10T18:13:36+00:00weekly0.7http://qxclear.com/practices/valuation/intellectual-property-valuation/2020-07-16T17:04:14+00:00weekly0.7http://qxclear.com/practices/valuation/valuation-of-other-assets/2020-07-16T17:12:01+00:00weekly0.7http://qxclear.com/experts-and-consultants/senior-advisors/tamar-sisitsky/2020-09-08T21:01:52+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/james-rosberg/2020-10-26T17:24:26+00:00weekly0.7http://qxclear.com/experts-and-consultants/principals/mark-a--gustafson/2020-08-27T14:05:01+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/john-m--browning/2020-10-09T16:22:24+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/na-dawson/2020-02-06T23:01:40+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/kevin-gold/2020-02-06T23:01:40+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/peter-hess/2020-07-17T20:56:38+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/mike-nguyen/2020-02-06T23:01:40+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/peter-p--simon/2020-02-06T23:01:40+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/ajay-jyoti/2020-10-26T17:09:01+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/steven-s--saeger/2020-10-27T15:04:55+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/ching-tai-watson/2020-02-06T23:01:40+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/michael-cliff/2020-11-12T13:56:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/niall-macmenamin/2020-02-06T23:01:40+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/andrea-okie/2020-11-09T16:30:41+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/andrew-stichman/2020-02-06T23:01:40+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/brian-ellman/2021-01-06T16:39:21+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/marissa-ginn/2021-01-15T19:41:28+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/xinyu-ji/2020-11-09T16:29:31+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/mark-j--lewis/2020-08-25T21:37:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/shannon-n--seitz/2020-02-06T23:01:40+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/jipan-xie/2020-12-30T22:02:49+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/divya-mathur/2020-07-15T15:13:02+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/rebeccah-w--filsoof/2020-11-20T20:50:06+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/minh-p--doan/2020-10-05T18:45:32+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/lauren-r--kindler/2020-11-16T17:03:02+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/kristen-comeaux/2020-12-16T16:08:15+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/eric-korman/2020-02-06T23:01:40+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/kristina-shampanier/2020-03-12T20:46:52+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/mihran-yenikomshian/2020-12-02T21:09:57+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/peter-finch/2020-08-25T21:37:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/stephen-fink/2020-11-12T13:56:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/rene-befurt/2020-12-17T15:48:16+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/laura-comstock/2020-08-07T20:23:21+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/brad-rice/2020-12-29T19:42:55+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/ahmer-nabi/2020-10-26T17:23:30+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/peter-rybolt/2020-10-28T13:41:56+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/lindsay-greenbaum/2020-11-09T16:24:04+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/jonathan-borck/2020-08-07T20:46:29+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/lauren-hunt/2020-10-28T13:46:17+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/laura-o-laughlin/2020-12-09T15:50:22+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/eric-b--nguyen/2020-11-20T20:50:06+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/keith-betts/2020-12-21T16:48:25+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/emily-cotton/2020-11-09T21:27:59+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/pavel-darling/2020-12-29T14:32:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/chris-feige/2020-11-09T16:29:09+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/kenneth-weinstein/2020-02-06T23:01:40+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/hongbo-yang/2020-12-09T20:15:15+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/f--michael-nolan/2020-02-06T23:01:40+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/federico-temerlin/2020-10-26T17:27:57+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/markus-von-wartburg/2020-10-23T19:41:02+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/kevin-gallagher/2020-10-26T16:55:59+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/hristina-bojadzieva-bartlett/2020-11-20T20:50:06+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/duncan-fung/2020-02-06T23:01:40+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/john-drum/2020-10-28T17:31:08+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/samir-warty/2020-02-06T23:01:40+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/maria-garibotti/2021-01-06T16:39:21+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/aaron-fix/2020-09-16T20:24:55+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/carletta-wong/2020-06-12T21:05:55+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/jee-yeon-lehmann/2020-09-29T16:28:58+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/sumon-mazumdar/2020-10-26T17:21:53+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/benoit-d-udekem/2020-10-26T16:53:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/joshua-white/2020-09-10T15:40:39+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/emmanuel-frot/2020-10-06T18:20:28+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/claudio-calcagno/2020-09-10T15:40:39+00:00weekly0.7http://qxclear.com/Insights/publishing/navigating-the-changing-tides-of-managed-care-and-health-reform/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-health-care-system-in-canada/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/antitrust-policy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-minimization-analysis-of-once-weekly-versus-thrice-weekly-epoetin-alfa-for-chemotherapy-related-anemia/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/exploring-economic-models-using-excel/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/proving-damages--issues-to-consider-in-pursuing-and-defending-the-damages-case/2020-10-26T19:25:47+00:00weekly0.7http://qxclear.com/Insights/publishing/the-business-of-economic-consulting/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/discussion-of-the-value-relevance-of-intangibles--the-case-of-software-capitalization/2020-10-26T19:04:05+00:00weekly0.7http://qxclear.com/Insights/publishing/fair-value-disclosures-by-bank-holding-companies/2020-10-26T19:05:13+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-estimation/2020-10-26T20:58:29+00:00weekly0.7http://qxclear.com/Insights/publishing/what-baseball-can-teach-policymakers/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/assessing-the-clinical-benefits-of-erythropoietic-agents-using-area-under-the-hemoglobin-change-curve/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-schizophrenia-in-the-united-states-in-2002/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/market-efficiency-versus-behavioral-finance/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/energy-and-environmental-policy-in-the-united-states--synergies-and-challenges-in-the-electric-industry/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-effects-of-federal-participation-in-terrorism-risk/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-importance-of-federal-participation-in-terrorism-risk/2020-08-07T12:26:37+00:00weekly0.7http://qxclear.com/Insights/publishing/does-econ-analysis-shortchange-future-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/benefits-associated-with-an-early-hemoglobin-response-to-epoetin-alfa-therapy-in-the-treatment-of-chemotherapy-related-anemia/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/some-straight-talk-needed-about-csr/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-utility-safety-valve-for-cutting-co2/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/hedge-funds-today--caveat-emptor/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/is-benefit-cost-analysis-helpful-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/application-of-game-theory-to-intellectual-property-royalty-negotiations/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/pedestrian-and-motor-vehicle-post-stop-data-analysis-report/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-cost-benefit-assessment-of-wholesale-electricity-restructuring-and-competition-in-new-england/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/calculating-damages-in-broker-raiding-cases/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/prevalence-and-effects-of-mood-disorders-on-work-performance-in-a-nationally-representative-sample-of-u-s--workers/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-impact-analysis--proposition-71---california-stem-cell-research-and-cures-initiative/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/estimated-costs-of-prescription-opioid-analgesic-abuse-in-the-united-states-in-2001--a-societal-perspective-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-market-for-follow-on-biologics--how-will-it-evolve-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/dosing-patterns-and-costs-of-erythropoietic-agents-in-patients-with-chronic-kidney-disease-not-on-dialysis-in-managed-care-organizations/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/relationship-between-hemoglobin-level-and-quality-of-life-in-anemic-patients-with-chronic-kidney-disease-receiving-epoetin-alfa/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/clinical-benefits-of-once-weekly-epoetin-alfa-in-anemic-patients-with-colorectal-cancer-receiving-chemotherapy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/what-role-for-u-s--co2-sequestration-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/live-prices-and-stale-quantities--t-1-accounting-and-mutual-fund-mispricing/2020-10-26T19:13:10+00:00weekly0.7http://qxclear.com/Insights/publishing/off-label-marketing-investigations-in-the-pharmaceutical-industry/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/dosing-patterns-and-treatment-costs-of-erythropoietic-agents-in-elderly-patients-with-pre-dialysis-chronic-kidney-disease-in-managed-care-organisations/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/roundtable-discussion--importance-of-causation-analysis-in-mass-tort-cases/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-value-of-antihypertensive-drugs--a-perspective-on-medical-innovation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/policies-can-work-in-strange-ways/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-relative-dosing-of-epoetin-alfa-and-darbepoetin-alfa-in-chronic-kidney-disease/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/dose-conversion-and-cost-effectiveness-of-erythropoietic-therapies-in-chemotherapy-related-anemia--a-canadian-application/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/too-good-to-be-true--an-examination-of-three-economic-assessments-of-california-climate-change-policy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/digital-media-patents-for-profit/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/risk-of-clinical-fractures-after-gonadotropin-releasing-hormone-agonist-therapy-for-prostate-cancer/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-cost-benefit-analysis-of-the-new-york-independent-system-operator--the-initial-years/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/do-authorized-generic-drugs-deter-paragraph-iv-certifications--recent-evidence/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/pharmaceutical-spending-and-health-outcomes/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/competition-between-generic-and-branded-drugs/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/antihypertensive-drugs--a-perspective-on-the-value-of-improved-blood-pressure-control-in-the-usa/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/lifetime-and-12-month-prevalence-of-bipolar-spectrum-disorder-in-the-national-comorbidity-survey-replication/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/lost-earnings-of-persons/2020-10-26T19:15:00+00:00weekly0.7http://qxclear.com/Insights/publishing/economics-of-cost-pass-through-and-damages-in-indirect-purchaser-antitrust-cases/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/tradable-permits--fly-in-the-ointment-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/free-ghg-cuts--too-good-to-be-true-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/mapping-fact-p-and-eortc-qlq-c30-to-the-eq-5d-health-utility-in-metastatic-hormone-refractory-prostate-cancer-patients/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/short-term-economic-impact-of-body-weight-change-among-patients-with-type-2-diabetes-treated-with-antidiabetic-agents/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/use-of-inhaled-corticosteroids-and-healthcare-costs-in-mild-persistent-asthma/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/retrospective-economic-and-outcomes-analysis-using-international-databases--a-review/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/estimated-prevalence-of-peripheral-neuropathy-and-associated-pain-in-adults-with-diabetes-in-france/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-cardiometabolic-risk-factor-clusters-on-health-related-quality-of-life-in-the-us/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/annual-prevalence-of-diagnosed-schizophrenia-in-the-usa--a-claims-data-analysis-approach/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/development-of-a-copd-severity-score/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-effectiveness-of-duloxetine-versus-routine-treatment-for-u-s--patients-with-diabetic-peripheral-neuropathic-pain/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/lifetime-costs-of-patients-with-clinically-detected-uterine-fibroids--an-employer-s-perspective/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-stroke-on-health-related-quality-of-life-in-the-noninstitutionalized-population-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/annual-costs-associated-with-diagnosis-of-uterine-leiomyomata/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/health-care-and-work-loss-costs-associated-with-persistent-asthma-patients-in-a-privately-insured-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/employees-with-overactive-bladder--work-loss-burden/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/china-s-urban-health-insurance-reform-experiment-in-zhenjiang--cost-and-utilization-analyses/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/was-the-fairness-doctrine-a--chilling-effect---evidence-from-the-postderegulation-radio-market/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/regulatory-issues-in-deploying-wireless-voip/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/telecom-antitrust-handbook/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/look-to-markets-for-next-gen-success/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-impact-of-allowing-local-telephone-companies-to-enter-long-distance-voice-and-data-markets/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-evolving-competitive-landscape-in-wireless-internet-markets/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/-chilling--the-internet--lessons-from-fcc-regulation-of-radio-broadcasting/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-effect-on-federal-spending-of-legislation-creating-a-regulatory-framework-for-follow-on-biologics--key-issues-and-assumptions/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/what-is-the-future-of-u-s--coal-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/misconceptions-about-h2o-pricing/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-national-perspective-on-allocating-the-costs-of-new-transmission-investment--practice-and-principles/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/tips-from-the-experts--getting-the-most-out-of-your-experts/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-sensible-way-to-cut-co2-emissions/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-u-s--cap-and-trade-system-to-address-global-climate-change/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-role-of-epidemiology-in-drug-safety-litigations/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cap-and-trade-or-a-carbon-tax-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-analytic-model-to-determine-the-least-costly-inpatient-erythropoiesis-stimulating-therapy-regimen/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/psychometric-validation-of-the-patient-symptom-assessment-in-lung-cancer-instrument-for-small-cell-lung-cancer/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/dose-and-cost-comparison-of-erythropoietic-agents-in-the-inpatient-hospital-setting/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-direct-and-indirect-cost-burden-of-atopic-dermatitis--an-employer-payer-perspective/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/linking-a-u-s--cap-and-trade-system-for-greenhouse-gas-emissions/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/free-greenhouse-gas-cuts--too-good-to-be-true-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/drug-utilization-and-costs-of-erythropoietic-stimulating-agents-in-chronic-kidney-disease-patients-not-receiving-dialysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/is-there-a-difference-in-the-cost-effectiveness-of-erythropoietic-therapies-for-the-treatment-of-anemia-in-patients-receiving-hcv-combination-therapy-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-impact-of-epoetin-alfa-therapy-on-delaying-time-to-dialysis-in-elderly-patients-with-chronic-kidney-disease/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/costs-associated-with-intravenous-chemotherapy-administration-in-patients-with-small-cell-lung-cancer--a-retrospective-claims-database-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/linking-tradable-permit-systems/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/intangible-assets--valuation-and-economic-benefit/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/where-does-it-go--spending-by-the-financially-constrained/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/drug-safety-and-risk-management-practice--what-drug-companies-can-do/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/enviro-justice-and-cap-and-trade/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/winning-initiative-campaigns-with-economic-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/csr-through-an-economic-lens/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-consequences-of-generic-substitution-for-antiepileptic-drugs-in-a-public-payer-setting--the-case-of-lamotrigine/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/clinical-consequences-of-generic-substitution-of-lamotrigine-for-patients-with-epilepsy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-impact-of-generic-substitution-of-lamotrigine--projected-costs-in-the-united-states-using-findings-in-a-canadian-setting/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/competitive-procurement-of-retail-electricity-supply--recent-trends-in-state-policies-and-utility-practices/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-study-on-the-economic-impact-of-bariatric-surgery/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/valuation-of-bankrupt-firms/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/ongoing-drivers-of-wetlands-depletion/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-impact-of-psoriasis-on-health-care-costs-and-patient-work-loss/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-importance-of-supply-side-effects-in-antitrust-analyses/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/does-generic-substitution-always-make-sense-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/ercot-texas-s-competitive-power-experience--a-view-from-the-outside-looking-in/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-value-of-formal-quantitative-assessment-of-uncertainty-in-regulatory-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/five-minutes-with----the-economic-impact-of-bariatric-surgery-study-investigators/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/data-exclusivity-periods-for-biologics--updating-prior-analyses-and-responding-to-critiques/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/land-use-change-and-carbon-sinks/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/opportunity-for-a-defining-moment/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/anaemia-and-the-risk-of-injurious-falls-in-a-community-dwelling-elderly-population-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/erythropoiesis-stimulating-agents-in-the-treatment-of-anemia-in-myelodysplastic-syndromes--a-meta-analysis-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/management-of-anaemia--a-critical-and-systematic-review-of-the-cost-effectiveness-of-erythropoiesis-stimulating-agents-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/direct-and-indirect-costs-of-pain-therapy-for-osteoarthritis-in-an-insured-population-in-the-united-states-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/retrospective-claims-data-analysis-of-dosage-adjustment-patterns-of-tnf-antagonists-among-patients-with-rheumatoid-arthritis-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/costs-and-resource-use-of-mild-persistent-asthma-patients-initiated-on-controller-therapy-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/symptom-assessment-in-relapsed-small-cell-lung-cancer--cross-validation-of-the-patient-symptom-assessment-in-lung-cancer-instrument-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-impact-of-pre-dialysis-epoetin-alfa-on-health-care-and-work-loss-costs-in-chronic-kidney-disease--an-employer-s-perspective/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/loss-of-treatment-response-to-infliximab-maintenance-therapy-in-crohn-s-disease--a-payor-perspective/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-costs-of-crohn-s-disease-in-the-united-states-and-other-western-countries--a-systematic-review/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparison-of-escitalopram-versus-citalopram-for-the-treatment-of-major-depressive-disorder-in-a-geriatric-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/direct-and-indirect-costs-among-employees-with-diabetic-retinopathy-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/beyond-lifecycle-management---optimizing-performance-following-patent-expiry/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-analysis-in-off-label-promotion-cases/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/generic-competition-in-the-u-s--pharmaceutical-industry/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/simulating-electricity-restructuring-in-california--interactions-with-the-regional-market/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/workplace-burden-of-depression--case-study-in-social-functioning-using-employer-claims-data/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/depression-in-the-workplace--an-economic-perspective/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/depression--a-neglected-major-illness/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/institutions-and-individuals/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/challenges-in-rif-analyses/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/disease-related-and-all-cause-health-care-costs-of-elderly-patients-with-gout/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-of-care-for-patients-with-rheumatoid-arthritis-receiving-tnf-antagonist-therapy-using-claims-data/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/mapping-fact-p-and-eortc-qlq-c30-to-patient-health-status-measured-by-eq-5d-in-metastatic-hormone-refractory-prostate-cancer-patients/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-risk-of-renal-impairment-in-hormone-refractory-prostate-cancer-patients-with-bone-metastases-treated-with-zoledronic-acid/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/productivity-costs-associated-with-cardiometabolic-risk-factor-clusters-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comment-on--the-relative-dosing-of-epoetin-alfa-and-darbepoetin-alfa-in-chronic-kidney-disease/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/retrospective-economic-and-outcomes-analyses-using-non-us-databases--a-review/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/considering-the-costs-of-bipolar-depression/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/compulsory-generic-switching-of-antiepileptic-drugs--high-switchback-rates-to-branded-compounds-compared-with-other-drug-classes/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/do-drugs-reduce-utilisation-of-other-healthcare-resources-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/foundations-of-opioid-risk-management/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/actual-versus-predicted-first-year-utilization-patterns-of-teriparatide-in-patients-with-employer-sponsored-health-insurance/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/medical-costs-of-untreated-anemia-in-elderly-patients-with-predialysis-chronic-kidney-disease/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/dose-conversion-ratio-for-epoetin-alfa-and-darbepoetin-alfa-in-chemotherapy-patients-with-anemia-and-cancer/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/healthcare-and-workloss-costs-associated-with-patients-with-persistent-asthma-in-a-privately-insured-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/risk-of-cancer-treatment-associated-bone-loss-and-fractures-among-women-with-breast-cancer-receiving-aromatase-inhibitors/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/assessing-the-economic-impact-of-chronic-conditions-in-postmenopausal-women/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-of-illness-for-employees-with-painful-conditions/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-and-co-morbidities-of-atrial-fibrillation-in-a-privately-insured-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/direct-costs-of-opioid-abuse-in-an-insured-population-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-depression-in-the-us--societal-and-patient-perspectives/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/dose-conversion-and-cost-effectiveness-of-erythropoietic-therapies-in-chemotherapy-related-anaemia--a-meta-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-cost-effectiveness-of-weekly-epoetin-alfa-relative-to-weekly-darbepoetin-alfa-in-patients-with-chemotherapy-induced-anemia/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-effectiveness-of-epoetin-alfa-and-darbepoetin-alfa-in-patients-with-chemotherapy-related-anemia/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/alkaline-phosphatase-predicts-survival-in-patients-with-metastatic-neuroendocrine-tumors/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/dose-conversion-from-epoetin-alfa-to-darbepoetin-alfa-for-patients-with-chronic-kidney-disease-receiving-hemodialysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-impact-of-olanzapine-plus-fluoxetine-combination-therapy-among-patients-treated-for-depression--a-pilot-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-depression-with-painful-symptoms/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-relationship-between-technology-availability-and-health-care-spending/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/relationship-between-changes-in-hemoglobin-level-and-quality-of-life-during-chemotherapy-in-anemic-cancer-patients-receiving-epoetin-alfa-therapy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/statistical-explanations-for-a-community-based-study-of-once-weekly-epoetin-alfa-therapy-in-patients-receiving-chemotherapy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-costs-of-cancer--cancer-related-conditions-can-add-dramatically-to-overall-costs-of-care/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/hospital-technology-in-a-non-market-health-care-system/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/use-of-statistical-sampling-in-litigation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/an-evaluation-of-the-mccullough-research-report-on-new-york-s-wholesale-power-market/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-stimulus-and-green-jobs/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-growing-role-of-economic-analysis-in-off-label-promotion-cases/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-risks-and-costs-of-multiple-generic-substitution-of-topiramate/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/proving-patent-damages/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-impact-of-drug-vintage-on-patient-survival--a-patient-level-analysis-using-quebec-s-provincial-health-plan-data/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/projected-economic-impact-of-clinical-findings-of-generic-entry-of-topiramate-on-g4-european-countries/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/drug-utilization-and-cost-considerations-of-erythropoiesis-stimulating-agents-in-oncology-patients-receiving-chemotherapy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/direct-all-cause-health-care-costs-associated-with-chronic-kidney-disease-in-patients-with-diabetes-and-hypertension--a-managed-care-perspective/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-limiting-erythropoiesis-stimulating-agent-use-for-chemotherapy-induced-anemia-on-the-united-states-blood-supply-margin/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/erythropoietin-therapy-and-left-ventricular-mass-index-in-ckd-and-esrd-patients--a-meta-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/an-assessment-of-erythroid-response-to-epoetin-alfa-as-a-single-agent-versus-in-combination-with-granulocyte--or-granulocyte-macrophage-colony-stimulating-factor-in-myelodysplastic-syndromes-using-a-m/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/no-free-lunch-at-the-auto-cafe/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/measuring-the-capacity-impacts-of-demand-response/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/determinants-of-direct-cost-differences-among-us-employees-with-major-depressive-disorders-using-antidepressants/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/depression-and-work-productivity--the-comparative-costs-of-treatment-versus-nontreatment/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/identification-of-diabetes-patients-using-claims-data--an-economic-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-illness-and-its-treatment-on-workplace-costs--regulatory-and-measurement-issues/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/actual-and-perceived-impacts-of-tobacco-regulation-on-restaurants-and-firms/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/measuring-alzheimer-s-disease-progression-with-transition-probabilities--estimates-from-cerad/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-of-pneumonia-in-an-employed-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-home-infusion-therapy_relative-benefit-index--summary-of-an-analysis-using-insurance-claims-data/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/workplace-performance-effects-from-chronic-depression-and-its-treatment/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/epidemiologic-interpretation-of-artificial-neural-networks/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/prediction-and-cross-validation-of-neural-networks-versus-logistic-regression--using-hepatic-disorders-as-an-example/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/improvement-in-subjective-work-performance-after-treatment-of-chronic-depression--some-preliminary-results/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-effectiveness-of-surgery-on-the-treatment-of-acute-spinal-cord-injury-and-its-relation-to-pharmacological-treatment/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impacts-of-the-new-york-long-term-home-health-care-program/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/home-care-in-hospices/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/managing-programs-for-the-elderly--design-of-a-social-information-system/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-determinants-of-nursing-home-operating-costs-in-new-york-state/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/medicare-legislation-for-hospice-care--implications-of-national-hospice-study-data/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/national-hospice-study-analysis-plan/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/why-do-nursing-home-costs-vary--the-determinants-of-nursing-home-costs/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/wonderful-politics-of-cap-and-trade/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/legal-and-economic-perspectives-concerning-u-s--government-investigations-of-alleged-off-label-promotion-by-drug-manufacturers/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-effect-of-statutory-indemnity-on-securities-class-action-litigation-settlements--a-first-look/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/aba-pharmaceutical-industry-antitrust-handbook/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/licensing-in-the-presence-of-technology-standards/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/addressing-environmental-justice-concerns-in-the-design-of-california-s-climate-policy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/evolving-ghg-trading-systems-outside-its-borders--how-should-california-respond--6442447901/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/strategic-options-for-investment-in-transmission-in-support-of-offshore-wind-development-in-massachusetts/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/worried-about-competitiveness--6442447033/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/competition-and-title-insurance-rates-in-california/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/angel-finance--the-other-venture-capital/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/assessing-the-relationship-between-compliance-with-antidepressant-therapy-and-employer-costs-among-employees-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/combating-stat-abuse/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/patent-auctions--how-far-have-we-come-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-shrinking-merger-arbitrage-spread--reasons-and-implications/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/voluntary-agreements-with-industries--participation-incentives-with-industry-wide-targets/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-new-york-independent-system-operator--a-ten-year-review/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/next-steps-for-california-climate-policy-ii--moving-ahead-under-uncertain-circumstances/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-mutual-fund-industry--competition-and-investor-welfare/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/left-behind--latin-america-and-the-false-promise-of-populism/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-of-transfusional-iron-overload-in-patients-with-myelodysplastic-syndrome-or-severe-anemia--data-from-multicenter-clinical-practices/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-implications-of-iv-versus-oral-anti-angiogenesis-therapies-in-patients-with-advanced-renal-cell-carcinoma--retrospective-claims-database-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-consequences-of-not-recognizing-bipolar-disorder-patients--a-cross-sectional-descriptive-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/proof-of-common-impact-in-antitrust-litigation--the-value-of-regression-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/securities-class-action-doesn-t-suit-us/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-impact-of-exacerbations-of-chronic-obstructive-pulmonary-disease-and-exacerbation-definition--a-review/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-impact-of-proton-pump-inhibitor-compliance-on-health-care-resource-utilization-and-costs-in-patients-with-gastroesophageal-reflux-disease/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-new-approach-to-antitrust-class-certification/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-cost-of-disability-and-medically-related-absenteeism-among-employees-with-multiple-sclerosis-in-the-us/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-compliance-with-proton-pump-inhibitors-on-nsaid-treatment/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/development-of-a-budget-impact-model-to-quantify-potential-cost-savings-from-prescription-opioids-designed-to-deter-abuse-or-ease-of-extraction/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-utility-of-adalimumab-versus-infliximab-maintenance-therapies-in-the-united-states-for-moderately-to-severely-active-crohn-s-disease/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/risk-of-renal-impairment-after-treatment-with-ibandronate-versus-zoledronic-acid--a-retrospective-medical-records-review/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/resource-utilization-and-costs-of-schizophrenia-patients-treated-with-olanzapine-versus-quetiapine-in-a-medicaid-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparing-the-treatment-patterns-of-patients-with-schizophrenia-treated-with-olanzapine-and-quetiapine-in-the-pennsylvania-medicaid-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/workplace-impacts-of-anti-tnf-therapies-in-rheumatoid-arthritis--review-of-the-literature/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/antidepressant-treatment-patterns-and-costs-among-us-employees/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-nonadherence-to-antiepileptic-drugs-on-health-care-utilization-and-costs--findings-from-the-ransom-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-impact-of-multiple-sclerosis-disease-modifying-drugs-in-an-employed-population--direct-and-indirect-costs/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparison-of-two-adalimumab-treatment-schedule-strategies-for-moderate-to-severe-crohn-s-disease--results-from-the-charm-trial/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparison-of-health-care-use-and-costs-in-newly-diagnosed-and-established-patients-with-fibromyalgia/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-of-psoriasis-compared-to-the-general-population-and-stratified-by-disease-severity/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/direct-and-indirect-costs-associated-with-epileptic-partial-onset-seizures-among-the-privately-insured-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/healthcare-utilization-and-costs-incurred-by-patients-with-major-depression-after-being-switched-from-escitalopram-to-another-ssri-for-non-medical-reasons/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-adalimumab-on-symptoms-of-psoriatic-arthritis-in-patients-with-moderate-to-severe-psoriasis--a-pooled-analysis-of-randomized-clinical-trials/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-effect-of-adalimumab-on-reducing-depression-symptoms-in-patients-with-moderate-to-severe-psoriasis--a-randomized-clinical-trial/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/coronary-heart-disease-and-stroke-risk-in-patients-with-psoriasis--retrospective-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/high-prevalence-of-potential-drug-drug-interactions-for-psoriasis-patients-prescribed-methotrexate-or-cyclosporine-for-psoriasis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/societal-cost-of-rheumatoid-athritis-patients-in-the-us/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/direct-costs-associated-with-initiating-nph-insulin-versus-glargine-in-patients-with-type-2-diabetes--a-retrospective-database-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/inhaled-corticosteroids-or-long-acting-beta-agonists-alone-or-in-fixed-dose-combinations-in-asthma-treatment--a-systematic-review-of-fluticasone-budesonide-and-formoterol-salmeterol/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/analytic-models-to-identify-patients-at-risk-for-prescription-opioid-abuse/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/age-differences-in-the-prevalence-and-co-morbidity-of-dsm-iv-major-depressive-episodes--results-from-the-who-world-mental-health-survey-initiative/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cardiovascular-and-economic-outcomes-after-initiation-of-lipid-lowering-therapy-with-atorvastatin-vs-simvastatin-in-an-employed-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-effectiveness-of-adalimumab-for-the-maintenance-of-remission-in-patients-with-crohn-s-disease/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/employer-model-of-workplace-impacts-of-anti-tnf-therapy-for-rheumatoid-arthritis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-implications-of-generic-substitution-of-antiepileptic-drugs--a-review-of-recent-evidence/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/do-electric-cars-make-economic-sense-for-the-mass-market-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-u-s--electric-car-race--what-do-consumers-really-want-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-uneasy-case-for-product-liability/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/costs-associated-with-angiogenesis-inhibitor-therapies-for-metastatic-renal-cell-carcinoma-in-clinical-practice--results-from-a-medical-chart-review-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/predictors-of-response-to-sequential-sunitinib-and-the-impact-of-prior-vegf-targeted-drug-washout-in-patients-with-metastatic-clear-cell-renal-cell-carcinoma/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/renal-toxicity-in-patients-with-multiple-myeloma-receiving-zoledronic-acid-vs--ibandronate--a-retrospective-medical-records-review/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-of-epilepsy-among-the-privately-insured-in-the-us/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/taming-a-whale-lurking-in-pension-financing/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/can-we-afford-to-cut-carbon-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-path-forward-for-climate-talks/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/two-countries-key-to-progress-in-2010/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/state-eyes-on-the-climate-policy-prize/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/beware-scorched-earth-strategies/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/what-investors-really-want/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/healthcare-resource-utilization-and-costs-associated-with-non-adherence-to-imatinib-treatment-in-chronic-myeloid-leukemia-patients/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-25-percent-rule-lives-on/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/risk-of-hepatotoxicity-related-hospitalizations-among-patients-treated-with-opioid-acetaminophen-combination-prescription-pain-medications/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/introducing-perspectives-on-comparative-effectiveness-research/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/perspectives-on-comparative-effectiveness-research--views-from-diverse-constituencies/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-role-of-experts-in-antitrust-class-certification/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-impact-of-the-clinical-benefits-of-bariatric-surgery-in-diabetes-patients-with-bmi-is-great-than-equal-35-kg-per-m2/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/generic-antiepileptic-drugs-and-associated-medical-resource-utilization-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-changing-landscape-for-credit-ratings/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-fruits-of-comparative-effectiveness/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/in-defense-of-pollution-markets/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/wind-integration-studies--optimization-vs--simulation/2020-11-13T21:46:53+00:00weekly0.7http://qxclear.com/Insights/publishing/the-price-isn-t-right--event-studies-in-m-a-suits/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/data-exclusivity-for-biologics/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/an-effective-way-to-quantify-the-safety-profile-of-a-drug-or-device-when-background-toxicity-rates-are-low/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-role-of-public-sector-research-in-the-discovery-of-drugs-and-vaccines/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/fcc-media-ownership-study--5--station-ownership-and-programming-in-radio/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-role-of-firm-size-in-bilateral-bargaining--a-study-of-the-cable-television-industry/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/horizontal-integration-for-bargaining-power--evidence-from-the-cable-television-industry/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/reading-of-biosimilar-law-could-mean-one-day-or-years-until-competitors-on-market/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/president-reignites-biologics-exclusivity-battle-with-proposal-for-seven-years/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/consumption-inequality-and-intra-household-allocations/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/pros-and-cons-of-statistical-sampling/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-guide-to-economic-and-policy-analysis-of-epa-s-transport-rule/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/can-a-reasonable-royalty-ever-be-zero-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cardiovascular-and-economic-outcomes-after-initiation-of-atorvastatin-versus-simvastatin-in-an-employed-population-stratified-by-cardiovascular-risk/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/removal-of-opioid-acetaminophen-combination-prescription-pain-medications--assessing-the-evidence-for-hepatotoxicity-and-consequences-of-removal/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/managing-care-and-costs--the-sustained-cost-impact-of-reduced-hospitalizations-in-a-partnership-measurement-model-of-disease-management/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/risk-benefit-analysis-of-adalimumab-versus-traditional-non-biologic-therapies-for-patients-with-crohn-s-disease/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/methodological-issues-in-a-meta-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/direct-and-indirect-costs-of-employees-with-treatment-resistant-and-non-treatment-resistant-major-depressive-disorder/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/descriptive-analysis-of-medicaid-patients-with-postherpetic-neuralgia-treated-with-lidocaine-patch-5-percent/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparative-effectiveness-without-head-to-head-trials--a-method-for-matching-adjusted-indirect-comparisons-applied-to-psoriasis-treatment/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/evaluation-of-compliance-and-health-care-utilization-in-patients-treated-with-single-pill-vs--free-combination-antihypertensives/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/chart-review-of-patients-on-valsartan-based-single-pill-combinations-vs--arb-based-free-combinations-for-bp-goal-achievement/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/benefit-risk-analysis-of-adalimumab-vs-methotrexate-and-placebo-in-the-treatment-of-moderate-to-severe-psoriasis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-impact-of-bariatric-surgery-on-comorbidities-and-medication-use-among-obese-patients/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comment--the-impact-of-methodological-approach-on-cost-findings-in-comparison-of-epoetin-alfa-with-darbepoetin-alfa/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/clinical-outcomes-and-medical-care-costs-among-medicare-beneficiaries-receiving-therapy-for-peripheral-arterial-disease/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/commercial-importation-of-prescription-drugs-in-the-united-states--short-run-implications/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/generation-fleet-turnover-in-new-england--modeling-energy-market-impacts/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/retirement-is-coming--preparing-for-new-england-s-capacity-transition/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/resale-price-maintenance-following-leegin--u-s--and-canadian-perspectives/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-initiation-timing-of-ssri-or-snri-on-depressed-adolescent-health-care-utilization-and-costs/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/an-economic-framework-for-analyzing-covenants-not-to-compete/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/does-the-route-of-administration-for-estrogen-hormone-therapy-impact-the-risk-of-venous-thromboembolism-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/anemia-and-the-risk-of-injurious-falls-in-a-community-dwelling-elderly-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-impact-of-switching-from-valsartan-to-other-angiotensin-receptor-blockers-in-patients-with-hypertension/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/costs-associated-with-cardiovascular-events-in-patients-with-hypertension-in-u-s--managed-care-settings/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-effects-of-adalimumab-treatment-and-psoriasis-severity-on-self-reported-work-productivity-and-activity-impairment-for-patients-with-moderate-severe-psoriasis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/efficacy-and-safety-of-adalimumab-among-patients-with-moderate-to-severe-psoriasis-with-co-morbidities/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/effects-of-adalimumab-versus-placebo-on-risk-of-symptom-worsening-in-psoriasis-and-subsequent-impacts-on-health-related-quality-of-life/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-of-comorbidities-in-patients-with-psoriasis-is-substantial/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-survey-based-assessment-of-the-prevalence-and-severity-of-chronic-hand-dermatitis-in-a-managed-care-organization/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparative-efficacy-of-vildagliptin-and-sitagliptin-in-japanese-patients-with-type-2-diabetes--a-matching-adjusted-indirect-comparison-of-randomized-trials/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/achieving-glycemic-goal-with-initial-versus-sequential-combination-therapy-using-metformin-and-pioglitazone-in-type-2-diabetes-mellitus/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/systematic-review--the-costs-of-ulcerative-colitis-in-western-countries/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/effects-of-adalimumab-therapy-on-incidence-of-hospitalization-and-surgery-in-crohn-s-disease--results-from-the-charm-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-outcomes-of-switching-treatment-in-major-depressive-disorder-patients/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/savings-estimate-for-a-medicare-insured-group/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/red-blood-cell-transfusions-and-the-risk-of-ards-among-critically-ill--a-cohort-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/remission-of-major-depressive-disorder-without-adverse-events--a-comparison-of-escitalopram-versus-serotonin-norepinephrine-reuptake-inhibitors/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-impact-of-therapeutic-substitution-of-a-brand-selective-serotonin-reuptake-inhibitor-with-an-alternative-generic-selective-serotonin-reuptake-inhibitor/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/use-of-antipsychotic-drugs-in-patients-with-alzheimer-s-disease-treated-with-rivastigmine-versus-donepezil/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/medical-and-work-loss-burden-of-pre-dialysis-chronic-kidney-disease-and-related-anemia--an-employer-s-perspective/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/assessing-the-risk-of-clinical-fracture-in-men-with-non-metastatic-prostate-cancer-receiving-gonadotropin-releasing-hormone-agonist-therapy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/prediction-and-cross-validation-in-modeling-incident-cases-of-hepatic-disorders-using-automated-medical-data/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparative-efficacy-of-nilotinib-and-dasatinib-in-newly-diagnosed-chronic-myeloid-leukemia--a-matching-adjusted-indirect-comparison-of-randomized-trials/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/safety-and-treatment-patterns-of-multikinase-inhibitors-in-patients-with-metastatic-renal-cell-carcinoma-at-a-tertiary-oncology-center-in-italy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-benefits-of-timely-intervention-with-zoledronic-acid-in-patients-with-metastatic-prostate-cancer-to-bones--a-retrospective-study-of-us-veterans/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/hospital-visits-and-costs-following-outpatient-treatment-of-cap-with-levofloxacin-or-moxifloxacin/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/private-sector-investment-and-employment-impacts-of-reassigning-spectrum-to-mobile-broadband-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/mortality-and-nonadherence-to-aeds/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/running-the-numbers/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-impacts-of-the-regional-greenhouse-gas-initiative-on-ten-northeast-and-mid-atlantic-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-impacts-of-the-regional-greenhouse-gas-initiative-on-ten-northeast-and-mid-atlantic-states--appendix/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-impacts-of-the-regional-greenhouse-gas-initiative-on-ten-northeast-and-mid-atlantic-states--methodological-note/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/early-retirement-and-income-loss-in-patients-with-early-and-advanced-parkinson-s-disease/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/integrated-telehealth-and-care-management-program-for-medicare-beneficiaries-with-chronic-disease-linked-to-savings/2020-11-09T15:05:31+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-impacts-of-the-regional-greenhouse-gas-initiative-on-ten-northeast-and-mid-atlantic-states--fact-sheet/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-evaluation-of-denosumab-compared-with-zoledronic-acid-in-hormone-refractory-prostate-cancer-patients-with-bone-metastases/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-applicability-of-the-epa-market-forces-study-to-the-scrap-metal-recycling-industry/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/evolving-brand-name-and-generic-drug-competition-may-warrant-a-revision-of-the-hatch-waxman-act/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/carbon-control-and-the-economy--economic-impacts-of-rggi-s-first-three-years/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/book-review--monopsony-in-law-and-economics/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/why-coal-plants-retire--power-market-fundamentals-as-of-2012/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/did-the-durban-meeting-succeed-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/labor-costs-and-the-rate-case/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/pay-as-bid-vs--uniform-pricing--discriminatory-auctions-promote-strategic-bidding-and-market-manipulation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/options-for-addressing-leakage-in-california-s-climate-policy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-hazard-rate-analysis-of-mirant-s-generating-plant-outages-in-california/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/california-s-cap-and-trade-decisions/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/next-steps-for-california-with-federal-cap-and-trade-policy-on-the-horizon/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/implementation-of-the-biosimilar-pathway--economic-and-policy-issues/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/recently-released-fda-guidance-and-biosimilar-development--implications-for-the-litigation-environment/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/assessing-the-effects-of-most-favored-nation-clauses/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-great-patent-purchase/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/expert-analysis-of-plan-losses-in-erisa-class-action-litigation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/some-economics-of-royalty-bundling/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-interdependence-of-electricity-and-natural-gas--current-factors-and-future-prospects/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-evolving-standards-for-class-certification-in-antitrust-cases/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/prioritizing-safety-versus-budget--fda-and-cms-adopt-different-stances/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-positive-outlook-for-cleaner-air-and-reliable-electric-service/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/persistence-and-compliance-of-deferoxamine-versus-deferasirox-in-medicaid-patients-with-sickle-cell-disease/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/concomitant-asthma-medication-use-in-patients-receiving-omalizumab--results-from-three-large-insurance-claims-databases/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economics-of-the-hematopoietic-growth-factors/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/lifetime-costs-to-medicare-of-providing-care-to-patients-with-chronic-lymphocytic-leukemia/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparison-of-skeletal-complications-and-treatment-patterns-associated-with-early-vs--delayed-zoledronic-acid-therapy-in-multiple-myeloma/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/health-related-quality-of-life-in-patients-with-advanced-renal-cell-carcinoma-receiving-pazopanib-or-placebo-in-a-randomised-phase-iii-trial/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/safety-and-treatment-patterns-of-angiogenesis-inhibitors-in-patients-with-metastatic-renal-cell-carcinoma--evidence-from-u-s--community-oncology-clinics/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/increased-risks-of-developing-anxiety-and-depression-in-young-patients-with-crohn-s-disease/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-of-post-traumatic-stress-disorder-vs-major-depressive-disorder-among-patients-covered-by-medicaid-or-private-insurance/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/interprofessional-education-about-decision-support-for-patients-across-cultures/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/direct-and-indirect-costs-of-patients-treated-with-extended-release-oxymorphone-hcl-or-controlled-release-oxycodone-hcl/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-role-of-tricyclic-antidepressants-in-the-treatment-of-fibromyalgia/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/direct-costs-and-survival-of-medicare-beneficiaries-with-early-and-advanced-parkinson-s-disease/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/utilization-and-cost-comparison-of-erythropoiesis-stimulating-agents-in-inpatient-and-outpatient-hospital-settings/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/clinical-and-economic-impact-of-vagus-nerve-stimulation-therapy-in-patients-with-drug-resistant-epilepsy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/risks-and-cost-burden-of-venous-thromboembolism-and-bleeding-for-patients-undergoing-total-hip-or-knee-replacement-in-a-managed-care-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/risks-of-developing-psychiatric-disorders-in-pediatric-patients-with-psoriasis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/reduced-mortality-in-cystic-fibrosis-patients-treated-with-tobramycin-inhalation-solution/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/clinical-and-economic-outcomes-of-multiple-versus-single-long-acting-inhalers-in-copd/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/excess-costs-associated-with-patients-with-chronic-thromboembolic-pulmonary-hypertension-in-a-u-s--privately-insured-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/tiotropium-therapy-versus-tiotropium-monotherapy-for-treating-severe-to-very-severe-copd/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/prevalence-of-pulmonary-arterial-hypertension-and-chronic-thromboembolic-pulmonary-hypertension-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/excess-costs-associated-with-patients-with-pulmonary-arterial-hypertension-in-a-u-s--privately-insured-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/therapy-persistence-and-adherence-in-patients-with-chronic-obstructive-pulmonary-disease--multiple-versus-single-long-acting-maintenance-inhalers/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/direct-and-indirect-costs-associated-with-dupuytren-s-contracture/2020-11-09T14:57:27+00:00weekly0.7http://qxclear.com/Insights/publishing/risk-and-economic-damages--theoretical-and-practical-issues/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-single-center-experience-with-low-dose-warfarin-in-patients-undergoing-total-hip-or-knee-replacement-surgery/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-metastatic-breast-cancer--a-u-s--managed-care-perspective/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/how-to-use-clinical-trial-data-in-court/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/climate-policy--a-breath-of-fresh-air/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/shut-up-and-stand-still--understanding-the-role-of-standstill-provisions-in-m-a-disputes/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/beyond-the-abstract---economic-evaluation-of-denosumab-compared-with-zoledronic-acid-in-hormone-refractory-prostate-cancer-patients-with-bone-metastases/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/reliability-and-emission-impacts-of-stationary-engine-backed-demand-response-in-regional-power-markets/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/promotional-reviews--an-empirical-investigation-of-online-review-manipulation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/can-options-for-cost-containment-raise-costs-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/implications-of-policy-interactions-for-california-s-climate-policy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/using-the-value-of-allowances-from-california-s-ghg-cap-and-trade-system/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/data-exclusivity-periods-and-next-generation-improvements-to-innovator-biologics--key-issues/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/tools-for-handling-mortgage-based-fca-claims/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/terrorism-and-the-electric-power-delivery-system/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/rising-rates-for-rent-a-bees/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/lost-in-the-clouds--the-impact-of-copyright-scope-on-investment-in-cloud-computing-ventures/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/doj-s-recent-workshop-on-most-favored-nation-clauses/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/personalized-medicine--trends-in-clinical-studies-based-on-national-registry-data/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/summary-of-quantifiable-benefits-and-costs-related-to-select-targeted-infrastructure-replacement-programs/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-direct-and-indirect-costs-among-u-s--privately-insured-employees-with-hypogonadism/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/duloxetine-use-in-chronic-low-back-pain--treatment-patterns-and-costs/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/effect-of-asthma-exacerbations-on-health-care-costs-among-asthmatic-patients-with-moderate-and-severe-persistent-asthma/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/physicians--decisions-to-prescribe-antidepressant-therapy-in-older-patients-with-depression-in-a-u-s--managed-care-plan/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/asthma-severity-categorization-using-a-claims-based-algorithm-or-pulmonary-function-testing/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/adherence-to-inhaled-corticosteroid-use-and-local-adverse-events-in-persistent-asthma/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/innovation-in-the-biopharmaceutical-pipeline--a-multidimensional-view/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/three-lingering-design-issues-affecting-market-performance-in-california-s-ghg-cap-and-trade-program/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/hypoglycaemia-and-accident-risk-in-people-with-type-2-diabetes-mellitus-treated-with-non-insulin-antidiabetes-drugs/2020-11-09T14:59:46+00:00weekly0.7http://qxclear.com/Insights/publishing/food-safety-concerns--impact-on-prices-and-producers/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-impact-of-the-regulatory-environment-on-it-entrepreneurship-in-the-u-s--and-eu/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/brief-of-antitrust-economists-as-amici-curiae-in-support-of-respondents/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/california-s-advanced-energy-economy--advanced-energy-business-leaders--perspectives-and-recommendations-on-california-s-energy-policies/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/is-it-worth-anything--using-surveys-in-intellectual-property-cases/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/caution-required-when-using-managerial-accounting-data-in-court/2020-10-26T18:50:17+00:00weekly0.7http://qxclear.com/Insights/publishing/the-role-of-regulators-and-grid-operators-in-meeting-natural-gas-and-electric-coordination-challenges/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/an-economic-perspective-on-building-labeling-policies/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/an-economic-model-of-parkinson-s-disease--implications-for-slowing-progression-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-impact-of-the-data-protection-regulation-in-the-eu/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/on-market-pricing-strategies/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/reflections-on-a-personal-milestone/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/planning-for-offshore-energy-development/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/planning-for-offshore-energy-development---summary-and-report/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/planning-for-offshore-energy-development---complete/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/development-and-validation-of-a-claims-based-prediction-model-for-copd-severity/2020-11-09T14:59:02+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-effectiveness-of-guanfacine-extended-release-as-an-adjunctive-therapy-to-a-stimulant-compared-with-stimulant-monotherapy-for-the-treatment-of-adhd/2020-11-09T15:12:37+00:00weekly0.7http://qxclear.com/Insights/publishing/use-the-right-model-for-auto-defect-suits/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/vertical-practices-and-the-exclusion-of-rivals-post-eaton/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/spectrum-auctions-around-the-world--an-assesment-of-international-experiences-with-auction-restrictions/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-hypothetical-negotiation-and-reasonable-royalty-damages--the-tail-wagging-the-dog/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/little-guidance-for-lower-courts-in-ftc-v--actavis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/assessment-of-the-impact-of-iso-ne-s-proposed-forward-capacity-market-performance-incentives/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/problems-with-hypothesizing-reasonable-royalty-negotiation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/monday-morning-quarterbacking-and-antitrust-damages/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/report-of-the-independent-advisory-panel-regarding-integration-of-renewable-energy-into-california-s-electric-system/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/beyond-ab-32--post-2020-climate-policy-for-california/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/what-attorneys-should-know-about-fda-s-medwatch-data/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/opportunities-for-improving-attainment-of-quality-measures-in-patients-with-type-2-diabetes-mellitus/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/recent-trends-in-brand-name-and-generic-drug-competition/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/project-vigilance--functional-feasibility-study-for-the-installation-of-ambri-energy-storage-batteries-at-joint-base-cape-cod/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-impacts-of-the-green-communities-act-on-the-massachusetts-economy--a-review-of-the-first-six-years-of-the-act-s-implementation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-impacts-of-the-green-communities-act-on-the-massachusetts-economy--a-review-of-the-first-six-years-of-the-act-s-implementation--faq/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/greenhouse-gas-emission-reductions-from-existing-power-plants--options-to-ensure-electric-system-reliability--report/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/greenhouse-gas-emission-reductions-from-existing-power-plants--options-to-ensure-electric-system-reliability--q-and-a/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/presentation-of-econometric-analyses/2020-07-29T16:42:57+00:00weekly0.7http://qxclear.com/Insights/publishing/applying-econometrics-to-address-class-certification/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/crediting-greenhouse-gas-emission-reductions-from-energy-efficiency-investments/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/epa-s-clean-power-plan---states--tools-for-reducing-costs-and--increasing-benefits-to-consumers/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/expert-analysis--using-simulation-to-assist-courts-in-assessing-the-prudence-of-retirement-plan-investment-decisions/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/big-data-can-yield-big-insights-on-promotional-practices/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/meta-analysis-of-the-efficacy-and-safety-of-bortezomib-re-treatment-in-patients-with-multiple-myeloma/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/assessment-of-vancouver-energy-socioeconomic-impacts--primary-economic-impacts/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-systematic-review-of-the-economic-and-humanistic-burden-of-illness-in-irritable-bowel-syndrome-and-chronic-constipation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comorbidities-in-patients-with-irritable-bowel-syndrome-with-constipation-or-chronic-idiopathic-constipation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/incremental-direct-and-indirect-costs-of-untreated-vasomotor-symptoms/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/early-evidence-suggests-gigabit-broadband-drives-gdp/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-fallacy-of-inferring-collusion-from-countercyclical-prices/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/random-selection-is-best-for-mdl-bellwether-trials/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/assessment-of-epa-s-clean-power-plan--evaluation-of-energy-efficiency-program-ramp-rates-and-savings-levels/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/gastrointestinal-comorbidities-associated-with-atrial-fibrillation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/prasugrel-vs--clopidogrel-in-acute-coronary-syndrome-patients-treated-with-prasugrel/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/hospital-length-of-stay-of-nonvalvular-atrial-fibrillation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/is-rivaroxaban-associated-with-lower-inpatient-costs-compared-to-warfarin-among-patients-with-non-valvular-atrial-fibrillation-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/weekly-risk-of-venous-thromboembolism-recurrence-in-patients-receiving-oral-anticoagulants/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-comparative-effectiveness-and-safety-of-rivaroxaban-and-warfarin-in-nonvalvular-atrial-fibrillation-patients/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/medicaid-spending-on-contraceptive-coverage-and-pregnancy-related-care/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-early-versus-late-systemic-lupus-erythematosus-diagnosis-on-clinical-and-economic-outcomes/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/hospital-length-of-stay--is-rivaroxaban-associated-with-shorter-inpatient-stay-compared-to-warfarin-among-patients-with-non-valvular-atrial-fibrillation-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/risk-factors-associated-with-myocardial-infarction-in-venous-thromboembolism-patients/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/all-cause-and-disease-related-health-care-costs-associated-with-recurrent-venous-thromboembolism/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-once-daily-versus-twice-daily-dosing-frequency-on-adherence-to-chronic-medications-among-patients-with-venous-thromboembolism/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/direct-and-indirect-cost-burden-associated-with-multiple-sclerosis-relapses--excess-costs-of-persons-with-ms-and-their-spouse-caregivers/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-potential-of-energy-efficiency--a-resource-potentially-unlocked-by-the-clean-power-plan/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/towards-understanding-the-role-of-price-in-residential-electricity-choices--evidence-from-a-natural-experiment/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-effect-of-patent-litigation-and-patent-assertion-entities-on-entrepreneurial-activity/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/electric-system-reliability-and-epa-s-clean-power-plan--tools-and-practices/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-growing-economic-burden-of-depression-in-the-u-s-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/electric-system-reliability-and-epa-s-clean-power-plan--the-case-of-pjm/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-outcomes-among-medicare-patients-receiving-bioengineered-cellular-technologies-for-treatment-of-diabetic-foot-ulcers/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-epidemiology-of-herpes-zoster-and-its-complications-in-medicare-cancer-patients/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/tax-shelters-or-efficient-tax-planning--a-theory-of-the-firm-perspective-on-the-economic-substance-doctrine/2020-10-26T19:28:25+00:00weekly0.7http://qxclear.com/Insights/publishing/nyiso-capacity-market--evaluation-of-options/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/forecasting-corporate-failure--understanding-statistical-and-theoretical-approaches-to-bankruptcy-prediction/2020-11-09T16:58:54+00:00weekly0.7http://qxclear.com/Insights/publishing/a-note-on-the-economics-of-pass-through-with-two-part-tariff-pricing/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/3-questions-to-ask-when-using-surveys-in-litigation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/retrospective-analysis-of-dose-titration-and-serum-testosterone-level-assessments-in-patients-treated-with-topical-testosterone/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/duloxetine-use-in-employees-with-low-back-pain--treatment-patterns-and-direct-and-indirect-costs/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/costs-associated-with-intravenous-cancer-therapy-administration-in-patients-with-metastatic-soft-tissue-sarcoma-in-a-us-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-prevalence-and-economic-impact-of-prescription-opioid-related-side-effects-among-patients-with-chronic-noncancer-pain/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-comparative-analysis-of-medicaid-long-term-care-policies-and-their-effects-on-elderly-dual-enrollees/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-burden-of-undiagnosed-opioid-abuse-among-commercially-insured-individuals/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/burden-of-diabetic-foot-ulcers-for-medicare-and-private-insurers/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/sources-of-prescription-opioids-among-diagnosed-opioid-abusers/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-diagnosed-opioid-abuse-among-commercially-insured-individuals/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/estimating-the-costs-of-opioid-abuse-and-dependence-from-an-employer-perspective--a-retrospective-analysis-using-administrative-claims-data/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/refractory-hodgkin-lymphoma-post-asct--median-overall-survival-meta-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/refractory-hodgkin-lymphoma-post-autologous-transplant--meta-analysis-versus-historical-data/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-direct-and-indirect-costs-of-uterine-fibroid-tumors--a-systematic-review-of-the-literature-between-2000-and-2013/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-epidemiology-and-targeted-therapies-for-relapsed-and-refractory-cd30--lymphomas/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/healthcare-utilization-and-costs-in-women-diagnosed-with-endometriosis-before-and-after-diagnosis--a-longitudinal-analysis-of-claims-databases/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-of-adverse-events-during-treatment-with-everolimus-plus-exemestane-or-single-agent-chemotherapy-in-patients-with-advanced-breast-cancer-in-western-europe/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/budget-impact-analysis-of-liposomal-amphotericin-b-and-amphotericin-b-lipid-complex-in-the-treatment-of-invasive-fungal-infections-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/identifying-patient-subgroups-who-benefit-most-from-a-treatment--using-administrative-claims-data-to-uncover-treatment-heterogeneity/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-and-economic-burden-of-metastatic-and-recurrent-locally-advanced-head-and-neck-cancer-patients/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/healthcare-costs-associated-with-bevacizumab-and-cetuximab-in-second-line-treatment-of-metastatic-colorectal-cancer/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/incremental-third-party-costs-associated-with-copd-exacerbations--a-retrospective-claims-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/an-assessment-of-the-economic-and-industry-reasonableness-of-sprint-s-offer-for-clearwire/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/new-ec-competition-policy-brief/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/exploring-key-european-issues-that-have-significant-ramifications-for-u-s--interests/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/evaluating-the-prospects-for-convergence-in-collective-redress-remedies-in-the-european-union/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-comparative-analysis-of-uk--and-eu--proposed-collective-action-regimes/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/societal-economic-benefits-associated-with-an-extended-release-opioid-with-abuse-deterrent-technology-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/outlet-types-and-the-canadian-consumer-price-index/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/measurement-biases-in-consumer-price-indexes/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/direct-and-indirect-healthcare-resource-utilization-and-costs-associated-with-ulcerative-colitis-in-a-privately-insured-employed-population-in-the-us/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-effectiveness-of-pasireotide-on-health-related-quality-of-life-in-patients-with-cushing-s-disease/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-health-related-quality-of-life-study-comparing-vitala-continence-control-device-versus-traditional-pouch-system-only-in-patients-with-end-colostomy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/pain-relief-and-tolerability-balance-of-immediate-release-tapentadol-or-oxycodone-treatment-for-patients-with-moderate-to-severe-osteoarthritis-or-low-back-pain/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/validating-migraine-specific-quality-of-life-questionnaire-v2-1-in-episodic-and-chronic-migraine/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-qualitative-study-on-feasibility-of-a-web-based-women-s-health-portal-and-information-system/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-novel-approach-to-estimate-the-minimally-important-difference-for-the-fatigue-impact-scale-in-multiple-sclerosis-patients/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/interpreting-premenstrual-symptoms-impact-survey-scores-using-outcomes-in-health-related-quality-of-life-and-sexual-drive-impact/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-effectiveness-analysis-of-treatments-for-premenstrual-dysphoric-disorder/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/interpreting-score-differences-in-the-insomnia-severity-index--using-health-related-outcomes-to-define-the-minimally-important-difference/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparability-of-the-asthma-control-test-telephone-interview-administration-format-with-self-administered-mail-out-mail-back-format/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/antipsychotic-medication-utilization-trends-among-texas-veterans--1997-2002/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/burden-of-premenstrual-dysphoric-disorder-on-health-related-quality-of-life/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/factors-related-to-antipsychotic-oversupply-among-central-texas-veterans/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/mapping-mos-sleep-scale-scores-to-sf-6d-utility-index/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/frequency-of-new-onset-diabetes-mellitus-and-use-of-antipsychotic-drugs-among-central-texas-veterans/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/provision-of-pharmacy-services-in-community-health-centers-and-migrant-health-centers/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/rights-issues-and-creeping-acquisitions-in-india/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/carbon-control-and-competitive-wholesale-electricity-markets--compliance-paths-for-efficient-market-outcomes/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/average-overcharge-models-and-determining-individual-harm-in-collective-actions/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/ohio-s-electricity-future--assessment-of-context-and-options/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/electric-system-reliability-and-epa-s-clean-power-plan--the-case-of-miso/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/positive-subjective-measures-in-abuse-liability-studies-and-real-world-nonmedical-use/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-and-outcomes-in-braf-v600e-mutant-melanoma-patients-with-brain-metastases-receiving-vemurafenib-in-the-real-world-setting/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/alk-rearrangement-testing-and-treatment-patterns-for-patients-with-alk-positive-non-small-cell-lung-cancer/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/psoriasis-and-risk-of-diabetes-associated-microvascular-and-macrovascular-complications/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparison-of-survival-and-hospitalization-rates-between-medicare-patients-with-advanced-nsclc-treated-with-bevacizumab-carboplatin-paclitaxel-and-carboplatin-paclitaxel--a-retrospective-cohort-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/investigation-of-adverse-event-related-costs-for-patients-with-metastatic-breast-cancer-in-a-real-world-setting/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-impact-of-moderate-to-severe-crohn-s-disease-on-employees--salary-growth/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-low-grade-adverse-events-on-health-related-quality-of-life-in-adult-patients-receiving-imatinib-or-nilotinib-for-newly-diagnosed-philadelphia-chromosome-positive-chronic-myelogenous-leukemia/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/distribution-and-drivers-of-costs-in-type-2-diabetes-mellitus-treated-with-oral-hypoglycemic-agents--a-retrospective-claims-data-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/risk-of-developing-colorectal-cancer-and-benign-colorectal-neoplasm-in-patients-with-chronic-constipation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/association-between-regular-molecular-monitoring-and-tyrosine-kinase-inhibitor-therapy-adherence-in-chronic-myelogenous-leukemia-in-the-chronic-phase/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-benefits-of-adequate-molecular-monitoring-in-patients-with-chronic-myelogenous-leukemia/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/association-between-molecular-monitoring-and-long-term-outcomes-in-chronic-myelogenous-leukemia-patients-treated-with-first-line-imatinib/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-longitudinal-analysis-of-costs-associated-with-change-in-disease-activity-in-systemic-lupus-erythematosus/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparison-of-the-long-term-risk-of-recurrence-and-other-clinical-outcomes-in-gist-patients-receiving-imatinib-as-adjuvant-therapy--a-retrospective-chart-extract-based-approach/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/outcomes-in-atrial-fibrillation-patients-on-combined-warfarin---antiarrhythmic-therapy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparative-effectiveness-of-second-line-targeted-therapies-for-metastatic-renal-cell-carcinoma--a-systematic-review-and-meta-analysis-of-real-world-observational-studies/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/everolimus-and-sunitinib-for-advanced-pancreatic-neuroendocrine-tumors--a-matching-adjusted-indirect-comparison/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-pulmonary-exacerbation-risk-score-among-cystic-fibrosis-patients-not-receiving-recommended-care/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparison-of-treatment-patterns-and-economic-outcomes-in-metastatic-breast-cancer-patients-initiated-on-trastuzumab-versus-lapatinib--a-retrospective-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/hyperactivity-disorder--a-retrospective-analysis-of-patients-initiated-on-lisdexamfetamine-vs-other-medications/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparison-of-therapy-augmentation-and-deviation-rates-from-the-recommended-once-daily-dosing-regimen-between-ldx-and-commonly-prescribed-long-acting-stimulants-for-the-treatment-of-adhd-in-youth-and/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/hyperactivity-disorder--a-retrospective-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/net-metering-in-the-commonwealth-of-massachusetts--a-framework-for-evaluation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-analysis-in-fiduciary-monitoring-disputes-following-the-supreme-court-s--tibble--ruling/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/costs-and-resource-utilization-associated-with-anemia-and-rash-in-chronic-hepatitis-c-patients-treated-with-direct-acting-antiviral-agents-in-the-united-states/2020-11-09T15:07:10+00:00weekly0.7http://qxclear.com/Insights/publishing/don-t-let-nuke-plants-go-too-fast/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-modified-approach-to-random-selection-of-bellwether-cases/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/nomenclature-and-traceability-debate-for-biosimilars--small-molecule-surrogates-lend-support-for-distinguishable-nonproprietary-names/2020-11-09T15:02:34+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-a-telehealth-and-care-management-program-for-patients-with-chronic-obstructive-pulmonary-disease/2020-11-09T15:04:36+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-adherence-and-persistence-associated-with-nebivolol-or-hydrochlorothiazide-as-add-on-treatment-for-hypertension/2020-11-09T15:00:20+00:00weekly0.7http://qxclear.com/Insights/publishing/effects-of-care-management-and-telehealth--a-longitudinal-analysis-using-medicare-data/2020-11-09T15:06:40+00:00weekly0.7http://qxclear.com/Insights/publishing/appraisal-arbitrage----is-there-a-delaware-advantage-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/rebuttal-it-s-not-an-inappropriate-reasonable-royalty-rule/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/assessing-commercial-success-at-the-u-s--patent-trial-and-appeal-board/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/an-analysis-of-investment-and-drawdown-strategies-over-a-long-retirement-horizon/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/is-backdating-executive-stock-options-always-costly-to-shareholders-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/power-system-reliability-in-new-england--meeting-electric-resource-needs-in-an-era-of-growing-dependence-on-natural-gas/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-redemption-option--discussion-and-valuation-considerations-from-the-abi-commission-s--proposed-chapter-11-reform/2020-11-09T16:59:40+00:00weekly0.7http://qxclear.com/Insights/publishing/the-global-economic-impacts-associated-with-virtual-and-augmented-reality/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/global-economic-impacts-associated-with-artificial-intelligence/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/antitrust-enforcement-in-two-sided-markets/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/when-retailing-and-las-vegas-meet--probabilistic-free-price-promotions/2020-02-18T20:25:38+00:00weekly0.7http://qxclear.com/Insights/publishing/ferc-revises-market-based-rate-procedures/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-paris-agreement-lays-a-good-foundation-for-climate-progress/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/assessing-liability-in-the-context-of-corporate-misconduct/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-schizophrenia-in-the-united-states-in-2013/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/4-considerations-for-residential-mass-appraisal-valuation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/can-the-life-sciences-industry-bank-on-biosimilars-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/correlation-or-cause--brand-name-drug-prescription-rates/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/donning-and-doffing-damages--tyson-takeaways-for-antitrust/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/machine-learning-algorithms-can-help-health-care-litigation/2020-04-07T18:27:49+00:00weekly0.7http://qxclear.com/Insights/publishing/response-to-rejoinder--clearing-up-the-confusion/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-myth-of--price-disconnects--in-us-pharma-markets/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/viewing-recent-opioid-regulations-in-context/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/use-and-abuse--the-myth-of-divided-antitrust-economics/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economics-of-pass-through-with-production-constraints/2020-08-06T19:46:36+00:00weekly0.7http://qxclear.com/Insights/publishing/the-value-of-der-to-d/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/rggi-and-co2-emissions-trading-under-the-clean-power-plan--options-for-trading-among-generating-unit/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/stock-prices-aren-t-enough-for--rule-of-reason--analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/pay-for-delay-and-stock-prices---smoking-gun-or-damp-squib/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-potential-for-litigation-in-new-era-of-biosimilars/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/following-recent-trends-in-affordable-care-act-insurance/2021-01-07T19:18:31+00:00weekly0.7http://qxclear.com/Insights/publishing/will-expanded-eeo-1-data-collection-yield-new-insights-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-u-s--coal-industry--challenging-transitions-in-the-21st-century/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/does-the-clean-power-plan-go-too-far--no-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/practical-uses-for-machine-learning-in-health-care-cases/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-evaluation-of-timely-versus-delayed-use-of-tumor-necrosis-factor-inhibitors-for-treatment-of-psoriatic-arthritis-in-the-us/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/burden-of-systemic-glucocorticoid-related-complications-in-severe-asthma/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/can-social-media-data-lead-to-earlier-detection-of-drug-related-adverse-events/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-common-adverse-events-associated-with-metastatic-colorectal-cancer-treatment-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-and-healthcare-costs-among-newly-diagnosed-patients-with-chronic-myeloid-leukemia-receiving-dasatinib-or-nilotinib-as-first-line-therapy-in-the-united-states/2020-05-21T15:52:40+00:00weekly0.7http://qxclear.com/Insights/publishing/systematic-literature-review-of-dpp-4-inhibitors-in-patients-with-type-2-diabetes-mellitus-and-renal-impairment/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-paliperidone-palmitate-versus-oral-atypical-antipsychotics-on-health-care-resource-use-and-costs-in-veterans-with-schizophrenia/2020-03-25T21:29:15+00:00weekly0.7http://qxclear.com/Insights/publishing/association-between-time-to-progression-and-subsequent-survival-inceritinib-treated-patients-with-advanced-alk-positive-non-small-cell-lung-cancer/2020-09-25T18:30:45+00:00weekly0.7http://qxclear.com/Insights/publishing/categorizing-natural-history-trajectories-of-ambulatory-function-measured-by-the-6-minute-walk-distance-in-patients-with-duchenne-muscular-dystrophy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/excess-costs-associated-with-possible-misdiagnosis-of-alzheimer-s-disease-among-patients-with-vascular-dementia-in-a-uk-cprd-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/ledipasvir-for-hepatitis-c-genotype-1-in-japanese-patients--an-indirect-comparison/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/delay-in-initiation-of-adjuvant-trastuzumab-therapy-leads-to-decreased-overall-survival-and-relapse-free-survival-in-patients-with-her2-positive-non-metastatic-breast-cancer/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-and-treatment-patterns-of-cycling-between-conventional-synthetic-disease-modifying-antirheumatic-drugs-among-biologic-treated-patients-with-rheumatoid-arthritis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-brain-metastasis-among-lung-cancer-patients-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-of-switching-to-a-non-tumor-necrosis-factor-inhibitor-versus-a-tumor-necrosis-factor-inhibitor-biologic-therapy-among-patients-with-rheumatoid-arthritis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-dosing-and-drug-costs-with-everolimus-or-axitinib-as-second-targeted-therapies-for-advanced-renal-cell-carcinoma--a-retrospective-chart-review-in-the-us/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/hyperactivity-disorder-treated-with-lisdexamfetamine-dimesylate-or-atomoxetine/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-rejection-principle-for-sequential-tests-of-multiple-hypotheses-controlling-familywise-error-rates/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/adherence-to-iron-chelation-therapy-and-associated-healthcare-resource-utilization-and-costs-in-medicaid-patients-with-sickle-cell-disease-and-thalassemia/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/daclatasvir---sofosbuvir-versus-standard-of-care-for-hepatitis-c-genotype-3--a-matching-adjusted-indirect-comparison/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/drug-drug-interaction-associated-with-mold-active-triazoles-among-hospitalized-patients/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/her2--metastatic-breast-cancer-receiving-everolimus-based-therapy-or-chemotherapy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/her2--metastatic-breast-cancer--a-retrospective-us-claims-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparative-efficacy-and-incremental-cost-per-responder-of-methotrexate-versus-apremilast-for-methotrexate-naive-patients-with-psoriasis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/network-meta-analysis-and-cost-per-responder-of-tumor-necrosis-factor-alpha-and-interleukin-inhibitors-in-the-treatment-of-active-ankylosing-spondylitis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/healthcare-resource-utilization-and-work-loss-in-dermatomyositis-and-polymyositis-patients-in-a-privately-insured-us-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/what-happens-after-a-single-surgical-intervention-for-hidradenitis-suppurativa--a-retrospective-claims-based-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/management-of-epidermal-growth-factor-receptor-inhibitor-associated-rash--a-systematic-review/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/daclatasvir-and-sofosbuvir-versus-sofosbuvir-and-ribavirin-in-patients-with-chronic-hepatitis-c-coinfected-with-hiv--a-matching-adjusted-indirect-comparison/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/her2--metastatic-breast-cancer-in-the-united-states--a-physician-survey/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/relationship-between-brain-volume-loss-and-cognitive-outcomes-among-patients-with-multiple-sclerosis--a-systematic-literature-review/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/an-evaluation-of-treatment-patterns-and-outcomes-in-elderly-patients-newly-diagnosed-with-acute-myeloid-leukemia--a-retrospective-analysis-of-electronic-medical-records-from-us-community-oncology-prac/2020-03-24T15:10:02+00:00weekly0.7http://qxclear.com/Insights/publishing/updated-trends-in-us-brand-name-and-generic-drug-competition/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/validation-of-a-new-risk-measure-for-chronic-obstructive-pulmonary-disease-exacerbation-using-health-insurance-claims-data/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparative-effectiveness-of-everolimus-and-axitinib-as-second-targeted-therapies-for-metastatic-renal-cell-carcinoma-in-the-us--a-retrospective-chart-review/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparison-of-medicaid-spending-in-schizoaffective-patients-treated-with-once-monthly-paliperidone-palmitate-or-oral-atypical-antipsychotics/2020-03-24T13:12:34+00:00weekly0.7http://qxclear.com/Insights/publishing/her2--metastatic-breast-cancer-receiving-everolimus-based-therapy-or-chemotherapy--a-retrospective-cla/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/development-and-validation-of-an-algorithm-for-identifying-urinary-retention-in-a-cohort-of-patients-with-epilepsy-in-a-large-us-administrative-claims-database/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-direct-and-indirect-costs-associated-with-endometriosis--a-systematic-literature-review/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/her2--mbc-patients-with-multiple-metastatic-sites/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/venous-thromboembolism-and-cardiovascular-disease-complications-in-menopausal-women-using-transdermal-versus-oral-estrogen-therapy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/human-epidermal-growth-factor-receptor-2-negative-metastatic-breast-cancer--a-retrospective-c/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/changes-in-practice-patterns-of-clopidogrel-in-combination-with-proton-pump-inhibitors-after-an-fda-safety-communication/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/matching-adjusted-indirect-comparisons-of-efficacy-of-bay-81-8973-vs-two-recombinant-factor-viii-for-the-prophylactic-treatment-of-severe-hemophilia-a/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/public-health-impact-of-complete-and-incomplete-rotavirus-vaccination-among-commercially-and-medicaid-insured-children-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/retrospective-analysis-of-the-impact-of-increasing-access-to-long-acting-reversible-contraceptives-in-a-commercially-insured-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/ml-compared-with-other-basal-insulin-therapies-in-patients-with-type-2-diabetes-mellitus--a-network-meta-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/survival-in-patients-with-non-metastatic-breast-cancer-treated-with-adjuvant-trastuzumab-in-clinical-practice/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/variation-in-care-for-patients-with-irritable-bowel-syndrome-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/reliable-analysis-is-key-to-addressing-ascertainability/2020-10-16T15:12:33+00:00weekly0.7http://qxclear.com/Insights/publishing/how-bad-data-analyses-can-sabotage-discrimination-cases/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/millstone-power-station---providing-support-for-achieving-connecticut-s-clean-energy-goals/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/challenges-for-empirical-research-on-rpm/2021-01-05T21:44:44+00:00weekly0.7http://qxclear.com/Insights/publishing/is-your-promotion-killing-your-most-faithful-customers-/2020-02-18T20:20:43+00:00weekly0.7http://qxclear.com/Insights/publishing/zero-as-a-special-price--the-true-value-of-free-products/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/can-benefit-based-conjoint-analysis-benefit-product-design-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-proposed-northern-pass-transmission-project--assessing-its-impacts-on-new-hampshire/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-comparison-of-residential-water-bills--cal-water-oroville-and-south-feather-water---power-agency/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-early-origins-of-birth-order-differences-in-children-s-outcomes-and-parental-behavior/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/racial-discrimination-in-the-labor-market--theory-and-empirics/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/evaluating-dose-ratio-of-subcutaneous-to-intravenous-immunoglobulin-therapy-among-patients-with-primary-immunodeficiency-disease-switching-to-20--subcutaneous-immunoglobulin-therapy/2020-03-25T21:28:05+00:00weekly0.7http://qxclear.com/Insights/publishing/study-to-establish-new-york-electricity-market-icap-demand-curve-parameters/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/murky-markets--a-review-of-ferc-s-determination-of-submarkets-in-wholesale-electric-power-mergers/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/asunaprevir-versus-ifn-based-regimens-in-genotype-1b-hepatitis-c-virus-infection/2020-09-25T18:32:00+00:00weekly0.7http://qxclear.com/Insights/publishing/comparative-efficacy-of-biological-treatments-for-moderate-to-severe-psoriasis--a-network-meta-analysis-adjusting-for-cross-trial-differences-in-reference-arm-response/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/new-technologies-and-obsolete-analyses--internet-search-and-the-analysis-of-market-definition/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-consequences-of-contested-government-takeovers-of-investor-owned-water-utilities/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/what-consumers-really-think-about-reference-price-labels/2020-02-18T20:23:01+00:00weekly0.7http://qxclear.com/Insights/publishing/ensuring-validity-and-admissibility-of-consumer-surveys/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/patterns-of-disease-monitoring-and-treatment-among-patients-with-tuberous-sclerosis-complex-related-angiomyolipomas/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/association-lifetimes-of-hydrophobic-amino-acid-pairs-measured-directly-from-molecular-dynamics-simulations/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/tracing-the-path-to-health-care-investigation-settlements/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/proliferation-and-apoptosis-of-smooth-muscle-cells-in-benign-prostate-hyperplasia/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/certain-and-progressive-methylation-of-histone-h4-at-lysine-20-during-the-cell-cycle/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-risk-score-for-fluconazole-failure-among-patients-with-candidemia/2020-03-06T21:06:27+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-effectiveness-analysis-of-isavuconazole-vs--voriconazole-as-first-line-treatment-for-invasive-aspergillosis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/domains-of-heterochromatin-protein-1-required-for-drosophila-melanogaster-heterochromatin-spreading/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-multiple-facets-of-histone-h4-lysine-20-methylation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/preferential-dimethylation-of-histone-h4-lysine-20-by-suv4-20/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/expert-analysis-of-class-certification-issues/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-analysis-of-nonpatent-intellectual-property-rights-and-damages-measures/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/federal-securities-acts-and-areas-of-expert-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/what-motivates-user-generated-content--small-monetary-rewards-backfire-again/2020-02-18T20:20:04+00:00weekly0.7http://qxclear.com/Insights/publishing/phase-ii-assessment-of-the-competitive-effects-associated-with-the-new-gtld-program/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/enforcement-of-anticollusion-laws-against-domestic-and-foreign-firms/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/rggi-and-emissions-allowance-trading--options-for-voluntary-cooperation-among-rggi-and-non-rggi-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-biopharmaceutical-pipeline--innovative-therapies-in-clinical-development/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/survey-and-real-world-data--a-winning-combination/2020-02-18T20:24:30+00:00weekly0.7http://qxclear.com/Insights/publishing/enhancing-the-resilience-of-the-nation-s-electricity-system/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/over-declaration-of-standard-essential-patents-and-determinants-of-essentiality/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/decision-making-in-a-world-of-comparative-effectiveness-research/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/introducing-decision-making-in-a-world-of-comparative-effectiveness-research/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/perspectives-of-comparative-effectiveness-research-from-the-world-of-decision-making/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/perspectives-on-the-use-of-comparative-effectiveness-research-by-life-sciences-executives--an-interview-with-a-senior-executive-at-an-international-life-science-company/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/policy-considerations--ex-us-payers-and-regulators/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/perspectives-on-the-common-drug-review-process-at-the-canadian-agency-for-drugs-and-technologies-in-health/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/evaluating-non-pharmaceutical-technologies-at-the-canadian-agency-for-drugs-and-technologies-in-health/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/legal-considerations-in-a-world-of-comparative-effectiveness-research/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/challenges-in-developing-and-assessing-comparative-effectiveness-evidence-for-medical-technology/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/indirect-comparisons--a-brief-history-and-a-practical-look-forward/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/perspectives-on-the-use-of-comparative-effectiveness-research-by-life-sciences-executives--an-interview-with-mike-bonney/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/managing-multiple-expert-witnesses--best-practices-and-pitfalls/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-new-standard-for-suspicious-order-monitoring/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-effectiveness-analysis-of-ocrelizumab-versus-subcutaneous-interferon-beta-1a-for-the-treatment-of-relapsing-multiple-sclerosis/2020-10-16T16:34:28+00:00weekly0.7http://qxclear.com/Insights/publishing/insights-on-provider-consolidation-and-narrow-networks/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/marijuana-legalization-implications-for-massachusetts/2021-01-06T18:50:31+00:00weekly0.7http://qxclear.com/Insights/publishing/consider-value-vs--budget-impact-in-mass--drug-prices/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/health-related-quality-of-life-and-work-productivity-associated-with-hiscr-and-nrs30-response-among-patients-with-moderate-to-severe-hidradenitis-suppurativa/2021-01-07T14:54:18+00:00weekly0.7http://qxclear.com/Insights/publishing/natural-gas-pipeline-certification--policy-considerations-for-a-changing-industry/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/united-states--economics/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/capacity-resource-performance-in-nyiso-markets--an-assessment-of-wholesale-market-options/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/apolipoprotein-c-iii-and-high-density-lipoprotein-subspecies-defined-by-apolipoprotein-c-iii-in-relation-to-diabetes-risk/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-and-early-outcomes-of-alk-positive-non-small-cell-lung-cancer-patients-receiving-ceritinib--a-chart-review-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/monitoring-for-and-characterizing-crizotinib-progression--a-chart-review-of-alk-positive-non-small-cell-lung-cancer-patients/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-outcomes-of-acute-ischemic-stroke-treatment-with-intravenous-recombinant-tissue-plasminogen-activator/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/readmission-risk-in-chronic-obstructive-pulmonary-disease-patients--comparative-study-of-nebulized-beta2-agonists/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/utility-values-associated-with-advanced-or-metastatic-non-small-cell-lung-cancer--data-needs-for-economic-modeling/2020-07-02T14:14:24+00:00weekly0.7http://qxclear.com/Insights/publishing/health-services-utilization-among-fee-for-service-medicare-and-medicaid-patients-under-age-65-with-behavioral-health-illness-at-an-urban-safety-net-hospital/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/achievement-of-glycated-hemoglobin-goals-in-the-us-remains-unchanged-through-2014/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-treatment-patterns-among-patients-with-advanced-gastric-cancer-in-south-korea/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-bipolar-i-disorder-in-the-united-states-in-2015/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/importance-of-balancing-follow-up-time-and-impact-of-oral-anticoagulant-users--selection-when-evaluating-medication-adherence-in-atrial-fibrillation-patients-treated-with-rivaroxaban-and-apixaban/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/maintenance-of-weight-loss-or-stability-in-subjects-with-obesity--a-retrospective-longitudinal-analysis-of-a-real-world-population/2020-03-25T21:39:50+00:00weekly0.7http://qxclear.com/Insights/publishing/functional-limitations-and-health-care-resource-utilization-for-individuals-with-cognitive-impairment-without-dementia--findings-from-a-united-states-population-based-survey/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparative-efficacy-of-long-acting-beta2-agonists-as-monotherapy-for-chronic-obstructive-pulmonary-disease--a-network-meta-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/age-and-outcomes-of-primary-prevention-implantable-cardioverter-defibrillators-in-patients-with-nonischemic-systolic-heart-failure/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/health-care-resource-utilization-before-and-after-perampanel-initiation-among-patients-with-epilepsy-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/access-to-cancer-specialist-care-and-treatment-in-patients-with-advanced-stage-lung-cancer/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/poor-early-response-to-methotrexate-portends-inadequate-long-term-outcomes-in-patients-with-moderate-to-severe-psoriasis--evidence-from-2-phase-3-clinical-trials/2020-09-25T18:25:09+00:00weekly0.7http://qxclear.com/Insights/publishing/inpatient-admissions-and-costs-associated-with-persistent-use-of-dalfampridine-extended-release-in-multiple-sclerosis--a-claims-database-analysis/2020-11-09T15:20:39+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-treatment-patterns-in-advanced-pancreatic-neuroendocrine-tumors-in-the-era-of-targeted-therapy--perspectives-from-an-academic-tertiary-center-and-community-oncology-practices/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/benefit-risk-trade-offs-for-treatment-decisions-in-moderate-to-severe-rheumatoid-arthritis--focus-on-the-patient-perspective/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/improvement-of-carcinoid-syndrome-symptoms-following-treatment-with-above-standard-dose-of-octreotide-lar/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/number-needed-to-treat-and-costs-per-responder-among-biologic-treatments-for-moderate-to-severe-plaque-psoriasis-in-japan/2020-09-25T18:27:05+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-treatment-patterns-and-effectiveness-among-patients-with-metastatic-colorectal-cancer-treated-with-ziv-aflibercept-in-community-oncology-practices-in-the-usa/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/overall-survival-in-patients-with-glioblastoma-before-and-after-bevacizumab-approval/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/baseline-characteristics-and-treatment-patterns-of-patients-with-schizophrenia-initiated-on-once-every-three-months-paliperidone-palmitate-in-a-real-world-setting/2020-03-24T13:32:25+00:00weekly0.7http://qxclear.com/Insights/publishing/out-of-pocket-medical-costs-and-third-party-healthcare-costs-for-children-with-down-syndrome/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/risk-for-venous-thromboembolism-recurrence-among-rivaroxaban-treated-patients-who-continued-versus-discontinued-therapy--analyses-among-patients-with-vte/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-opioid-abuse--updated-findings/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/same-day-hiv-testing-with-initiation-of-antiretroviral-therapy-versus-standard-care-for-persons-living-with-hiv--a-randomized-unblinded-trial/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/public-health-impact-of-rotarix-vaccination-among-commercially-insured-children-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/health-care-resource-utilization-and-costs-in-patients-with-chronic-myeloid-leukemia-with-better-adherence-to-tyrosine-kinase-inhibitors-and-increased-molecular-monitoring-frequency/2020-05-21T15:42:52+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-paliperidone-palmitate-versus-oral-atypical-antipsychotics-on-health-care-resource-use-and-costs-in-veterans-with-schizophrenia-and-comorbid-substance-abuse/2020-03-25T21:44:15+00:00weekly0.7http://qxclear.com/Insights/publishing/attributes-of-nuclear-imaging-centers-impacting-physician-referrals-for-single-photon-emission-computed-tomography-myocardial-perfusion-imaging-tests/2020-09-25T18:29:43+00:00weekly0.7http://qxclear.com/Insights/publishing/her2--metastatic-breast-cancer/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/nilotinib-versus-dasatinib-as-second-line-therapy-in-patients-with-philadelphia-chromosome-positive-chronic-myeloid-leukemia-in-chronic-phase-who-are-resistant-or-intolerant-to-imatinib--a-cost-effect/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/characteristics-and-outcomes-of-alk--non-small-cell-lung-cancer-patients-in-korea/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/number-needed-to-treat-and-associated-incremental-costs-of-treatment-with-enzalutamide-versus-abiraterone-acetate-plus-prednisone-in-chemotherapy-naive-patients-with-metastatic-castration-resistant-pr/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-following-allogeneic-hematopoietic-stem-cell-transplant-in-patients-with-diffuse-large-b-cell-lymphoma/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-symptomatic-skeletal-events-on-health-care-resource-utilization-and-quality-of-life-among-patients-with-castration-resistant-prostate-cancer-and-bone-metastases/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/burden-and-treatment-patterns-of-advanced-basal-cell-carcinoma-among-commercially-insured-patients-in-a-united-states-database-from-2010-to-2014/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-costs-of-ischemic-stroke-by-discharge-status/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/outcomes-based-contracting-experience--research-findings-from-u-s--and-european-stakeholders/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/stroke-risk-reduction-outweighed-bleeding-risk-increase-from-vitamin-k-antagonist-treatment-among-nonvalvular-atrial-fibrillation-patients-with-high-stroke-risk-and-low-bleeding-risk/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/overall-survival-with-ponatinib-versus-allogeneic-stem-cell-transplantation-in-philadelphia-chromosome-positive-leukemias-with-the-t315i-mutation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/patient-characteristics-and-overall-survival-in-patients-with-post-docetaxel-metastatic-castration-resistant-prostate-cancer-in-the-community-setting/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-characteristics-and-outcomes-of-patients-wth-metastatic-castration-resistant-prostate-cancer-receiving-chemotherapy-versus-androgen-receptor-targeted-therapy-after-failure-of-first-line-and/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-survival-outcomes-and-prognostic-factors-among-patients-receiving-first-targeted-therapy-for-advanced-renal-cell-carcinoma--a-seer-medicare-database-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/patterns-of-care-among-patients-receiving-sequential-targeted-therapies-for-advanced-renal-cell-carcinoma--a-retrospective-chart-review-in-the-usa/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/basal-insulin-initiation-use-and-experience-among-people-with-type-2-diabetes-mellitus-with-different-patterns-of-persistence--results-from-a-multi-national-survey/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-persistence-and-hospitalization-rates-among-patients-with-schizophrenia--a-quasi-experiment-to-evaluate-a-patient-information-program/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/duration-of-treatment-in-prostate-cancer-patients-treated-with-abiraterone-acetate-or-enzalutamide/2020-03-24T14:08:17+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-in-medicaid-patients-with-schizophrenia-initiated-on-a-first--or-second-generation-long-acting-injectable-versus-oral-antipsychotic/2020-03-24T13:16:45+00:00weekly0.7http://qxclear.com/Insights/publishing/assessment-of-treatment-patterns-and-healthcare-costs-associated-with-probable-lennox-gastaut-syndrome/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-of-sarcoidosis-in-a-commercially-insured-population-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/high-cost-sarcoidosis-patients-in-the-united-states--patient-characteristics-and-patterns-of-health-care-resource-utilization/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-burden-of-hepatorenal-syndrome-among-commercially-insured-and-medicare-patients-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/long-term-systemic-corticosteroid-exposure--a-systematic-literature-review/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/diagnostic-yield-of-active-case-finding-for-tuberculosis-and-hiv-at-the-household-level-in-slums-in-haiti/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/opioid-abuse--a-detailed-examination-of-cost-drivers-over-a-24-month-follow-up-period--journal-of-managed-care-and-specialty-pharmacy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/drivers-of-excess-costs-of-opioid-abuse-among-a-commercially-insured-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/retreatment-rates-among-endometriosis-patients-undergoing-hysterectomy-or-laparoscopy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparative-effectiveness-of-adalimumab-versus-secukinumab-for-the-treatment-of-psoriatic-arthritis--a-matching-adjusted-indirect-comparison/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/can-matching-adjusted-indirect-comparison-methods-mitigate-placebo-response-differences-among-patient-populations-in-adjunctive-trials-of-brivaracetam-and-levetiracetam-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/clinical-and-economic-outcomes-in-elderly-advanced-renal-cell-carcinoma-patients-starting-pazopanib-or-sunitinib-treatment--a-retrospective-medicare-claims-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-renal-function-on-ischemic-stroke-and-major-bleeding-rates-in-nonvalvular-atrial-fibrillation-patients-treated-with-warfarin-or-rivaroxaban--a-retrospective-cohort-study-using-real-world-evi/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/clinical-outcomes-associated-with-switching-or-discontinuation-from-anti-tnf-inhibitors-for-nonmedical-reasons/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cardiovascular-event-risk-assessment-in-psoriasis-patients-treated-with-tumor-necrosis-factor-alpha-inhibitors-versus-methotrexate/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/quality-measure-and-weight-loss-assessment-in-patients-with-type-2-diabetes-mellitus-treated-with-canagliflozin-or-dipeptidyl-peptidase-4-inhibitors/2020-03-24T14:05:08+00:00weekly0.7http://qxclear.com/Insights/publishing/relationship-between-patient-copayments-in-medicare-part-d-and-vaccination-claim-status-for-herpes-zoster-and-tetanus-diphtheria-acellular-pertussis/2020-03-25T21:33:00+00:00weekly0.7http://qxclear.com/Insights/publishing/effectiveness-and-healthcare-costs-among-stabilised-rheumatoid-arthritis-patients-with-dose-reduction-of-adalimumab-or-etanercept-in-real-world/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/her2--advanced-breast-cancer-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/hyperactivity-disorder-in-a-commercially-insured-population-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/hyperactivity-disorder-in-the-uk/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/introduction-to-lost-profits/2020-10-26T19:12:12+00:00weekly0.7http://qxclear.com/Insights/publishing/proving-loss-causation/2020-10-26T19:26:07+00:00weekly0.7http://qxclear.com/Insights/publishing/analysis-of-cost-behavior/2020-10-26T18:49:18+00:00weekly0.7http://qxclear.com/Insights/publishing/using-net-cash-flow-versus-accrual-net-income/2020-10-26T19:29:55+00:00weekly0.7http://qxclear.com/Insights/publishing/the-ability-to-achieve-lost-sales-as-a-consideration-in-damages-analyses/2020-10-26T19:29:22+00:00weekly0.7http://qxclear.com/Insights/publishing/consumer-choice-and-autonomy-in-the-age-of-artificial-intelligence-and-big-data/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/fiscal-state-aid--are-us-companies-being-unfairly-targeted-/2020-10-26T19:10:03+00:00weekly0.7http://qxclear.com/Insights/publishing/prejudice-and-racial-matches-in-employment/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/how-to-interpret-a-contract--ask-those-who-d-sign-it/2020-02-18T20:25:05+00:00weekly0.7http://qxclear.com/Insights/publishing/avoiding-bias--ensuring-validity-and-admissibility-of-survey-evidence-in-litigations/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/consumer-surveys-in-trademark-infringement-litigation--fiji-vs--viti-case-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/recent-developments-in-litigation-and-regulation-related-to-no-hire-and-employee-non-compete-agreements--implications-for-franchise-systems/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-department-of-justice-and-federal-trade-commission-guidance-for-human-resources-professionals-and-recent-comments-by-enforcement-officials-related-to-no-poaching-agreements/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/more-blurred-lines--on-downstream-infringement-and-the-disgorgement-of-profits/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/are-workers-willing-to-pay-to-join-a-better-team-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/competition-drives-rapid-growth-in-california-communications-market/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/proactive-pay-equity-studies-can-shield-mass--employers/2021-01-06T18:49:14+00:00weekly0.7http://qxclear.com/Insights/publishing/music-consumption-and-marketing-science--does-spotify-change-users--music-consumption-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-primer-on-bargaining--how-mergers-may-affect-negotiated-prices/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/claims-based-risk-model-for-first-severe-copd-exacerbation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/spontaneous-urticaria-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/patient-characteristics-and-outcomes-associated-with-receiving-an-earlier-versus-later-diagnosis-of-probable-alzheimer-s-disease/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-analysis-of-braf-gene-mutation-testing-in-real-world-practice-using-claims-data/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/implications-of-stroke-and-bleeding-risk-scores-and-comorbidities-on-episode-based-bundled-payments-for-patients-with-nonvalvular-atrial-fibrillation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-prevalence-of-hyperkalemia-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-utilization-of-molecular-diagnostic-testing-and-matched-drug-therapies-in-the-treatment-of-metastatic-cancers/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/direct-and-indirect-cost-burden-and-change-of-employment-status-in-treatment-resistant-depression--a-matched-cohort-study-using-a-us-commercial-claims-database/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-of-patients-with-inadequate-response-to-targeted-immunomodulators-for-rheumatoid-arthritis/2020-11-09T15:01:29+00:00weekly0.7http://qxclear.com/Insights/publishing/increased-prevalence-of-cancer-in-adult-patients-with-psoriasis-in-the-united-states--a-claims-based-analysis/2020-05-21T16:08:27+00:00weekly0.7http://qxclear.com/Insights/publishing/assessment-of-costs-associated-with-adverse-events-in-patients-with-cancer/2020-05-21T16:05:55+00:00weekly0.7http://qxclear.com/Insights/publishing/prevalence-of-psoriasis-in-children-and-adolescents-in-the-united-states--a-claims-based-analysis/2020-03-24T13:48:23+00:00weekly0.7http://qxclear.com/Insights/publishing/her2--metastatic-breast-cancer-in-us-community-oncology-practices--an-observational-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-comparison-of-continued-anticoagulation-with-rivaroxaban-versus-placebo-based-on-the-1-year-einstein-extension-trial-efficacy-and-safety-results/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/one-year-effect-of-the-medicare-annual-wellness-visit-on-detection-of-cognitive-impairment--a-cohort-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/hba1c-control-and-cost-effectiveness-in-patients-with-type-2-diabetes-mellitus-initiated-on-canagliflozin-or-a-glucagon-like-peptide-1-receptor-agonist-in-a-real-world-setting/2020-03-24T13:34:53+00:00weekly0.7http://qxclear.com/Insights/publishing/quality-goal-attainment-and-maintenance-in-patients-with-type-ii-diabetes-mellitus-initiated-on-canagliflozin-or-a-glucagon-like-peptide-1-receptor-agonist-in-an-actual-practice-setting/2020-03-24T13:13:50+00:00weekly0.7http://qxclear.com/Insights/publishing/insurance-switching-and-mismatch-between-the-costs-and-benefits-of-new-technologies/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-effectiveness-of-ceritinib-in-previously-untreated-anaplastic-lymphoma-kinase-positive-metastatic-non-small-cell-lung-cancer-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-and-medicaid-spending-in-comorbid-schizophrenia-populations--once-monthly-paliperidone-palmitate-versus-oral-atypical-antipsychotics/2020-03-24T13:38:50+00:00weekly0.7http://qxclear.com/Insights/publishing/epidemiologic-and-clinical-characteristics-of-nontransfusion-dependent-thalassemia-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparison-of-adalimumab-and-etanercept-for-the-treatment-of-moderate-to-severe-psoriasis--an-indirect-comparison-using-individual-patient-data-from-randomized-trials/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-of-treatment-failure-in-chronic-lymphocytic-leukemia-patients/2020-03-24T13:33:49+00:00weekly0.7http://qxclear.com/Insights/publishing/adherence-iron-chelation-therapy-patients-switched-deferasirox-dispersible-tablets-to-deferasirox-film-coated/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/procalcitonin-guidance-in-patients-with-lower-respiratory-tract-infections--a-systematic-review-and-meta-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/effectiveness-and-safety-of-anticoagulants-for-the-treatment-of-venous-thromboembolism-in-patients-with-cancer/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/severe-adverse-events-impact-overall-survival-and-costs-in-elderly-patients-with-advanced-non-small-cell-lung-cancer-on-second-line-therapy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/her2--metastatic-breast-cancer--a-network-meta-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-persistence-with-fingolimod-for-the-treatment-of-multiple-sclerosis--a-systematic-review-and-meta-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/number-needed-to-treat-and-costs-per-responder-among-biologic-treatments-for-moderate-to-severe-psoriasis--a-network-meta-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/her2--metastatic-breast-cancer-among-adult-premenopausal-women/2020-05-21T16:01:26+00:00weekly0.7http://qxclear.com/Insights/publishing/the-cost-of-hyperkalemia-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/healthcare-resource-use-and-cost-associated-with-varying-dosages-of-extended-corticosteroid-exposure-in-a-us-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/quantitative-characterization-of-the-relationship-between-levels-of-extended-corticosteroid-use-and-related-adverse-events-in-a-us-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/efficacy-of-ponatinib-versus-earlier-generation-tyrosine-kinase-inhibitors-for-front-line-treatment-of-newly-diagnosed-philadelphia-positive-acute-lymphoblastic-leukemia/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/drivers-of-treatment-patterns-in-patients-with-chronic-lymphocytic-leukemia-stopping-ibrutinib-or-idelalisib-therapies/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/number-needed-to-treat-and-costs-per-responder-among-biologic-treatments-for-moderate-to-severe-psoriasis/2020-09-25T18:19:02+00:00weekly0.7http://qxclear.com/Insights/publishing/role-of-cost-sharing-subsidies-on-the-initiation-of-and-adherence-to-tyrosine-kinase-inhibitor-therapy-by-medicare-beneficiaries-with-chronic-myeloid-leukemia/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/systematic-literature-review-and-meta-analysis-of-tumor-necrosis-factor-alpha-experienced-rheumatoid-arthritis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/retention-in-care-among-patients-with-early-hiv-disease-in-haiti/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/understanding-the-gap-between-efficacy-in-randomized-controlled-trials-and-effectiveness-in-real-world-use-of-glp-1-ra-and-dpp-4-therapies-in-patients-with-type-2-diabetes/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-in-patients-with-advanced-gastric-cancer-in-taiwan/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparing-the-cost-of-treatment-with-octreotide-long-acting-release-versus-lanreotide-in-patients-with-metastatic-gastrointestinal-neuroendocrine-tumors/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/efficacy-and-safety-of-procalcitonin-guidance-in-patients-with-suspected-or-confirmed-sepsis--a-systematic-review-and-meta-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/insurer-and-provider-market-share/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/keeping-covenants--getting-debt-ratios-right/2020-10-26T19:12:44+00:00weekly0.7http://qxclear.com/Insights/publishing/are-payers-ready-to-address-the-financial-challenges-associated-with-gene-therapy-/2020-10-27T14:33:57+00:00weekly0.7http://qxclear.com/Insights/publishing/vehicle-fuel-economy-and-air-pollution-standards--a-literature-review-of-the-rebound-effect/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/an-expanding-carbon-cap-and-trade-regime--a-decade-of-experience-with-rggi-charts-a-path-forward/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-tyranny-of-market-shares--incorporating-survey-based-evidence-into-merger-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/we-need-to-improve-medicare-s-annual-wellness-visit-to-better-detect-early-dementia/2021-01-07T18:55:23+00:00weekly0.7http://qxclear.com/Insights/publishing/b-vaccination-series-completion-among-us-adults--a-claims-based-analysis/2021-01-06T22:28:02+00:00weekly0.7http://qxclear.com/practices/health-care/health-care-policy/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/health-care/controlled-substance-monitoring-and--analytics/2020-06-08T18:43:13+00:00weekly0.7http://qxclear.com/practices/health-care/market-access-and--commercial-strategy/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/health-care/modeling-and--analytics/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/insurance/claims-handling-and--payment/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/insurance/pricing-coverage-and--management-issues/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/insurance/sales-practices-and--product-performance/2020-11-02T22:03:53+00:00weekly0.7http://qxclear.com/practices/intellectual-property/ip-litigation/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/intellectual-property/ip-strategy/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/labor-and--employment/class-certification/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/labor-and--employment/discrimination-and--pay-equity/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/labor-and--employment/labor-market-antitrust/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/labor-and--employment/surveys-experiments-and--other-primary-data-collection-in-labor-and--employment-litigation/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/labor-and--employment/wage-and--hour-litigation/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/labor-and--employment/worker-misclassification/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/media-entertainment-and--communications/copyright-disputes/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/media-entertainment-and--communications/wireless-communications-and--spectrum-valuation/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/media-entertainment-and--communications/cable-and--satellite-distribution/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/health-care/litigation-services/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/epidemiology-and--biostatistics/biostatistical-analysis/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/epidemiology-and--biostatistics/epidemiology-capabilities-and--services/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/health-care/health-economics-and--outcomes-research-heor/2020-09-04T14:20:01+00:00weekly0.7http://qxclear.com/practices/erisa/company-stock-issues/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/erisa/defined-benefit-plans/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/erisa/erisa-class-actions/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/erisa/excessive-fees-issues/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/erisa/process-of-monitoring-and-selecting-investments/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/government-and--corporate-investigations/antitrust-investigations/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/government-and--corporate-investigations/health-care-investigations/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/government-and--corporate-investigations/securities-investigations/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/government-and--corporate-investigations/tax-and--other-types-of-investigations/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/commercial-disputes/mass-torts/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/commercial-disputes/breach-of-contract/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/commercial-disputes/false-advertising/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/commercial-disputes/professional-malpractice/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/damages/specialized-expertise/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/damages/industry-experience/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/damages/causes-of-actions/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/energy-environment/energy-and--environment-litigation/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/energy-environment/energy-environmental-climate-policy/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/energy-environment/infrastructure-valuation-investment-and--siting/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/energy-environment/utility-ratemaking-and--regulation/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/energy-environment/power-system-market-design-and--analysis/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/energy-environment/mergers-and--industry-structure/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/energy-environment/resource-planning-and--management/2020-06-08T18:44:04+00:00weekly0.7http://qxclear.com/Insights/ag-feature/a-distinctive-business-model/2020-02-06T22:46:01+00:00weekly0.7http://qxclear.com/Insights/ag-feature/modernization-opportunities-in-new-epa-regulations/2018-11-01T15:16:54+00:00weekly0.7http://qxclear.com/Insights/ag-feature/sizing-up-the-competition--antitrust-enforcement-and-the-bazaarvoice-ruling/2018-11-01T15:16:54+00:00weekly0.7http://qxclear.com/Insights/ag-feature/merger-arbitrage-spread---still-shrinking-/2018-11-01T15:16:54+00:00weekly0.7http://qxclear.com/Insights/ag-feature/the-right-expert-essential-to-bear-stearns-acquittal/2019-03-11T00:07:48+00:00weekly0.7http://qxclear.com/Insights/ag-feature/academic-perspectives-on-investor-activism/2019-07-23T17:27:29+00:00weekly0.7http://qxclear.com/Insights/ag-feature/high-frequency-trading-investigations/2018-11-08T22:04:55+00:00weekly0.7http://qxclear.com/Insights/ag-feature/wolf-pack-activism--a-deeper-look/2018-11-01T15:16:53+00:00weekly0.7http://qxclear.com/Insights/ag-feature/analysis-group-insights-featured-in-law360/2018-11-01T15:16:51+00:00weekly0.7http://qxclear.com/Insights/ag-feature/analysis-group-forum/2020-03-02T17:49:56+00:00weekly0.7http://qxclear.com/practices/transaction-and--governance-litigation/appraisal/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/transaction-and--governance-litigation/hostile-bids-and--activism/2020-07-17T14:55:12+00:00weekly0.7http://qxclear.com/practices/transaction-and--governance-litigation/governance-and--contract-disputes/2020-07-16T21:17:20+00:00weekly0.7http://qxclear.com/practices/transaction-and--governance-litigation/post-merger-disputes/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/securities-financial-products-and--institutions/investment-suitability/2020-12-04T16:12:38+00:00weekly0.7http://qxclear.com/practices/securities-financial-products-and--institutions/market-microstructure/2021-01-15T14:56:16+00:00weekly0.7http://qxclear.com/practices/securities-financial-products-and--institutions/mutual-funds-and--hedge-funds/2021-01-15T16:16:15+00:00weekly0.7http://qxclear.com/practices/securities-financial-products-and--institutions/securities-fraud/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/securities-financial-products-and--institutions/structured-finance-and--derivatives/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/strategy-policy-and--analytics/modeling-and--decision-tools/2020-07-20T17:21:58+00:00weekly0.7http://qxclear.com/practices/strategy-policy-and--analytics/public-policy-and--economic-impact-analysis/2020-11-05T21:42:21+00:00weekly0.7http://qxclear.com/practices/strategy-policy-and--analytics/analytics/2020-10-15T20:04:01+00:00weekly0.7http://qxclear.com/practices/surveys-and--experimental-studies/application-and--uses/2020-07-17T16:42:27+00:00weekly0.7http://qxclear.com/practices/surveys-and--experimental-studies/methods/2020-07-17T18:17:17+00:00weekly0.7http://qxclear.com/practices/accounting/accounting-liability-issues/2020-10-26T18:59:27+00:00weekly0.7http://qxclear.com/practices/accounting/damages-and-materiality-analyses/2020-10-26T18:59:38+00:00weekly0.7http://qxclear.com/practices/technology/hardware/2020-12-28T15:34:39+00:00weekly0.7http://qxclear.com/practices/technology/policy-and--strategy/2020-12-28T15:45:10+00:00weekly0.7http://qxclear.com/practices/technology/litigation/2020-12-28T15:50:50+00:00weekly0.7http://qxclear.com/practices/technology/software/2020-12-28T17:49:17+00:00weekly0.7http://qxclear.com/practices/technology/coding-analytics-digital-forensics/2020-12-28T17:50:05+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/jeffrey-kinrich---analysis-group-expert---co-edits-comprehensive-new-book-on-lost-profits-damages/2020-10-26T19:34:28+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-recognized-as-a-leading-global-economic-consultancy-by-global-competition-review/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-welcomes-new-affiliates-and-consultants-and-announces-recent-promotions/2020-10-20T15:23:33+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/new-data-from-analysis-group-show-limiting-carbon-emissions-from-power-plants-continues-to-boost-the-economy-and-create-jobs/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-to-present-health-economics-and-outcomes-research-at--ispor-annual-meeting/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-provides-support-in-blocked-marine-company-merger/2020-08-06T19:47:32+00:00weekly0.7http://qxclear.com/news-and-events/events/vice-president-peter-schwechheimer-to-present-on-patent-remedies-in-the-aftermath-of-recent-federal-circuit-decisions/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-anita-chawla-to-speak-at-uc-san-diego-on-early-commercial-strategy-and-reimbursement-issues-in-health-care-innovation/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-sponsors-the-american-society-for-pharmacy-laws-28th-annual-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-sponsors-3rd-annual-promis-health-organization-pho-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-sponsors-the-new-york-state-bar-association-antitrust-law-section-annual-dinner---2018/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar---analysis-group-to-host-discussion-on-icann-nomcom-organizational-review-assessment-report/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar---vice-president-na-dawson-to-discuss-proving-damages-in-lost-profit-litigation/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar---principal-robert-vigil-to-discuss-intellectual-property-valuation/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar---managing-principal-john-jarosz-to-discuss-apportionment-in-patent-damages/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/vice-president-noam-kirson-moderates-panel-on-finding-the-right-partners-at-the-right-time/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-affiliate-catherine-tucker-to-participate-in-panel-on-blockchain-and-antitrust-compliance/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar---managing-principal-aaron-yeater-to-discuss-ip-licensing-and-antitrust-law/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-vice-president-todd-schatzki-to-present-at-uscanada-cross-border-energy-summit/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-managing-principals-mei-sheng-duh-and-michael-holland-join-panel-on-risks-and-rewards-of-accelerated-fda-pathways/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/teleconference---vice-president-markus-von-wartburg-to-moderate-panel-on-artificial-intelligence-and-collusion/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar---managing-principal-justin-mclean-to-discuss-the-lost-profits-and-damages-calculations/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar---analysis-group-senior-advisor-genia-long-to-present-on-costs-benefits-and-savings-of-new-drug-treatments/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/vice-president-andrea-okie-co-chairs-conference-on-electric-transmission-in-the-northeast/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/principal-paul-hibbard-joins-panel-discussion-on-the-expansion-of-the-regional-greenhouse-gas-initiative-rggi/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/vice-president-eric-korman-to-moderate-discussion-on-mand-a-in-the-electricity-market/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/teleconference--managing-principal-aaron-yeater-to-moderate-discussion-on-competition-in-employment-practices/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-principal-samuel-weglein-to-co-chair-and-principal-antoine-chapsal-to-speak-at-gcr-live-3rd-annual-cartels/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-peter-hess-to-discuss-recent-trends-and-developments-in-intellectual-property-valuation/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/conference-on-medical-big-data-and-health-technology-assessment-research-in-china-organized-by-analysis-group-tsinghua-university-and-fudan-university/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-sponsors-2018-competition-law-spring-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar---principal-samuel-weglein-to-discuss-antitrust-issues-in-health-care-and--pharma/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/amcp-annual-meeting-to-feature-new-health-economics-and-outcomes-research-from-analysis-groups-health-care-practice/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-manager-juliette-caminade-to-chair-evolving-antitrust-issues-in-healthcare-session-at-the-iioc/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--managing-principal-john-jarosz-to-discuss-reasonable-royalty-damages-in-patent-litigation/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-sponsors-annual-gala-recognizing-women-in-energy-and-environment/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-managing-principal-dov-rothman-to-join-panel-on-vertical-arrangements-in-health-care/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-managing-principal-aaron-yeater-to-speak-at-gcr-live-2nd-annual-ip-and--antitrust-california/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/principal-paul-hibbard-to-join-roundtable-discussion-on-carbon-pricing-developments/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-sponsors-2018-canadian-economics-association-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-health-care-consultants-present-at-2018-ispor-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-mihran-yenikomshian-to-discuss-statistical-sampling-and-extrapolation-in-fca-litigation/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-richard-mortimer-to-discuss-the-bpcia-litigation-landscape/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-mark-howrey-to-discuss-trends-in-securities-and-shareholder-litigation/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-principal-antoine-chapsal-to-join-panel-at-new-frontiers-of-antitrust-conference-in-paris/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--rebecca-kirk-fair-to-participate-in-panel-discussion-on-the-competitive-landscape-for-online-retail/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-health-care-consultants-to-present-at-2018-ashecon/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-peter-simon-to-participate-in-panel-discussion-on-the-use-of-statistical-sampling-in-employment-class-actions/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--principal-robert-vigil-to-discuss-calculating-intellectual-property-damages/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-jee-yeon-lehmann-to-participate-in-panel-discussion-on-employee-anti-poaching-agreements/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-stephen-fink-to-participate-in-panel-discussion-on-the-2018-pay-for-delay-antitrust-landscape/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-laura-o-laughlin-to-discuss-effective-trademark-survey-evidence/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--principal-almudena-arcelus-to-participate-in-panel-discussion-on-the-legal-and-economic-considerations-in-antitrust-damages/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/news/ceo-martha-samuelson-discusses-leadership-approach-in-new-york-times/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/ceo-martha-samuelson-interviewed-in-new-book-on-leadership-culture-and-innovation/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/academic-affiliate-catherine-tucker-receives-american-marketing-association-award-for-online-advertising-article/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/vice-president-aaron-yeaters-monday-morning-quarterbacking-article-nominated-for-2015-antitrust-writing-award/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/experts-from-analysis-group-and-sidley-austin-explain-considerations-for-the-use-of-statistical-sampling-in-false-claims-litigation/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-experts-author-aba-newsletter-article-examining-the-benefits--and-potential-pitfalls--of-using-consumer-surveys-in-litigation/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/jeffrey-kinrich---analysis-group-expert---co-edits-comprehensive-new-book-on-lost-profits-damages/2020-10-26T19:34:01+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-manager-douglas-frank-co-authors-article-examining-consumer-choice-in-the-age-of-ai-and-big-data/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-authors-nominated-for-2018-concurrences-antitrust-writing-awards/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/new-analysis-group-article-discusses-alternative-views-of-the-hypothetical-monopolist-test-in-health-care-mergers/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-publishes-assessment-report-on-the-icann-nominating-committee/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-client-noven-pharmaceuticals-prevails-on-commercial-success-in-patent-infringement-suit/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-authors-publish-article-examining-state-aid-investigations-by-the-european-commission/2020-10-26T19:33:26+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-senior-advisor-susan-tierney-invited-to-join-national-academy-of-sciences-committee-on-climate-change/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-recognized-as-a-leading-global-economic-consultancy-by-global-competition-review/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-client-prevails-in-chapter-11-proceeding/2020-11-09T17:17:36+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-expert-publishes-study-on-racial-discrimination-in-the-us-labor-market/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-principal-david-sosa-argues-against-government-takeover-of-california-regional-water-system-in-op-ed/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/in-law360-article-analysis-group-coauthors-advocate-for-using-surveys-in-contract-disputes/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-team-works-with-professor-edward-snyder-in-landmark-cartel-ruling/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-models-cost-effectiveness-of-car-t-therapy/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/article-by-analysis-group-president-pierre-cremieux-and-affiliate-edward-snyder-voted-a-finalist-in-concurrences-2018-antitrust-writing-awards/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-welcomes-new-affiliates-and-consultants-and-announces-recent-promotions/2020-10-20T15:24:41+00:00weekly0.7http://qxclear.com/news-and-events/news/six-analysis-group-consultants-contribute-to-new-handbook-on-marketing-analytics/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-consultants-author-aba-newsletter-articles-on-the-implications-of-no-hire-non-compete-and-no-poaching-agreements-for-franchises/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/amcps-managed-care-and--specialty-pharmacy-annual-meeting-to-feature-new-outcomes-research-from-analysis-group/2020-11-09T15:25:18+00:00weekly0.7http://qxclear.com/news-and-events/news/latest-study-from-analysis-group-confirms-that-rggi-program-continues-to-boost-the-economy-and-create-jobs/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-vice-president-peter-rybolt-authors-article-on-blurred-lines-downstream-infringement/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-consultants-coauthor-article-on-conducting-proactive-pay-equity-studies/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-listed-among-30-largest-private-companies-in-massachusetts-for-fourth-straight-year/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/music-consumption-and-marketing-science--does-spotify-change-users-music-consumption-/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/recent-analysis-group-article-examines-the-effect-of-mergers-on-negotiated-prices/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-client-prevails-in-class-certification-ruling/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-works-with-foundation-medicine-to-obtain-national-coverage-determination-for-groundbreaking-comprehensive-genomic-profiling-assay-for-all-solid-tumors/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-affiliate-roger-ware-receives-canadian-bar-association-award-for-paper-on-loyalty-discount-programs/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-co-hosts-beijing-forum-on-medical-big-data-and-health-technology-assessment-research/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-expert-report-successfully-considered-in-sec-prosecution-of-securities-fraud/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-to-present-health-economics-and-outcomes-research-at-ispor-annual-meeting/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-managing-principal-d.-lee-heavner-contributes-to-aba-business-law-compilation/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/vice-president-noam-kirson-presents-on-insurance-switching-and-coverage-challenges-for-innovative-therapies/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-managing-principal-rebecca-kirk-fair-examines-damages-model-considerations-from-recent-false-advertising-class-certification-rulings/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-senior-advisor-susan-tierney-analyzes-strategies-for-saving-coal-and-nuclear-power-plants/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-senior-advisor-susan-tierney-discusses-fracking-and-rggi-at-the-energy-policy-institute-at-the-university-of-chicago/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-report-cited-in-debate-over-proposed-food-pricing-law-in-france/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/new-fasb-guidelines-impact-on-covenant-ratios-explored-in-analysis-group-article/2020-10-26T19:32:51+00:00weekly0.7http://qxclear.com/news-and-events/news/six-analysis-group-consultants-named-as-top-expert-witnesses-in-the-iam-patent-1000/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/findings-on-biosimilar-nonmedical-switching-costs-presented-at-european-congress-of-rheumatology/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/alternate-payment-strategies-for-gene-therapy-explored-by-analysis-group-experts-in-health-affairs/2020-10-27T14:35:45+00:00weekly0.7http://qxclear.com/news-and-events/news/white-paper-on-vehicle-efficiency-standards-released-by-analysis-group-energy-experts/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/with-testimony-from-analysis-group-expert-delaware-prevails-in-lawsuit-over-regional-greenhouse-gas-initiative-rggi/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-testimony-cited-in-successful-settlement-in-california-water-case/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-principal-david-sosa-comments-on-california-net-neutrality-bill-in-op-ed/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/an-antitrust-analysis-of-professional-licensing-explored-in-article-by-analysis-group-experts/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/royalty-damages-estimated-including-online-survey-for-technology-client-in-patent-infringement-case/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/a-decade-of-states-cap-and-trade-experience-detailed-in-new-article-by-analysis-group-experts/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/using-surveys-in-merger-reviews-to-define-competition-more-accurately/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-consultants-comment-on-medicare-annual-wellness-visit-in-op-ed/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-collaborates-on-research-to-determine-hepatitis-vaccination-practices/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-affiliate-jean-pierre-landau-publishes-op-ed-on-monetary-funds-in-the-eurozone/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/microsoft-private-litigations/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/vitamins-antitrust-litigation/2020-09-08T17:56:44+00:00weekly0.7http://qxclear.com/Insights/cases/us-doj-v--mastercard-international-and-visa/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/brand-name-prescription-drug-litigation/2020-09-08T17:51:44+00:00weekly0.7http://qxclear.com/Insights/cases/virgin-atlantic-v--british-airways/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/carnival-corporation-merger/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/class-action-v--allstate-insurance/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/colgate-v--procter---gamble-company/2020-06-01T15:44:33+00:00weekly0.7http://qxclear.com/Insights/cases/united-states-ex-rel--jordan-v--northrop-grumman-corporation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/procter---gamble-co--v--haugen/2020-09-08T18:19:38+00:00weekly0.7http://qxclear.com/Insights/cases/evergreen-international-airlines-v--asiana-airlines/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/ferc-market-based-rate-applications-for-renewable-energy-power-plants/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/distribution-system-reliability--estimation-using-sampling-and-statistical-analysis/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/option-valuation-of-peaking-capacity/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/industry-restructuring-evaluation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/modeling-of-bidding-behavior-in-competitive-electricity-markets/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/analysis-of-strategic-bidding-and-withholding/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/wholesale-market-design-analysis/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/market-modeling--electricity-pricing-analyses/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/pricing-and-retail-contract-analysis/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/valuation-of-a-new-hydroelectric-plant/2020-11-03T15:12:49+00:00weekly0.7http://qxclear.com/Insights/cases/market-monitoring-and-mitigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/environmental-economics-and-policy-for-the-electric-and-gas-industries/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/independent-market-monitoring/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/contract-and-regulatory-disputes/2020-11-09T16:42:35+00:00weekly0.7http://qxclear.com/Insights/cases/damages-analysis-regarding-price-risk-management-strategy/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/energy-facility-siting/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/developing-a-technical-computing-framework/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/energizing-a-portfolio-for-the-deregulated-marketplace/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/bmi-royalty-rates-analysis/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/united-haulers-association-v--oneida-herkimer-solid-waste-management-authority/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/economic-and-environmental-impacts-of-energy-infrastructure/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/negotiations-regarding-insurance-coverage-of-environmental-liabilities/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/pfizer-asbestos-settlement/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/3250-wilshire-blvd--building-v--metropolitan-life-insurance-company/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/sheldon-h--solow-v--w--r--grace---company/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/florida-state-board-of-administration-v--alliance-capital-management/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/richard-duhaime-v--john-hancock-mutual-life-insurance-company/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/csr-v--lloyd-s-underwriters/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/mortgage-insurance-industry-respa-cases/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/class-action-v--ohio-national-life-insurance-company/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/winstar-damages-litigation/2020-04-06T13:03:34+00:00weekly0.7http://qxclear.com/Insights/cases/sumitomo-corporation-v--major-investment-banks/2020-04-06T13:06:42+00:00weekly0.7http://qxclear.com/Insights/cases/corporate-partners-v--coopers---lybrand/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/reinsurance-arbitrations/2020-04-06T13:06:02+00:00weekly0.7http://qxclear.com/Insights/cases/orange-county-bankruptcy/2020-11-09T16:40:07+00:00weekly0.7http://qxclear.com/Insights/cases/risk-characteristics-of-swaps/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/developing-a-comprehensive-product-strategy/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/developing-a-growth-strategy-under-constraints/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/achieving-commercial-results-in-managed-markets/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/emc-corp--v--karwowska/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/boston-symphony-orchestra-compensation-analysis/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/analysis-of-nursing-home-compensation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-clarent-corporation-securities-litigation/2020-10-26T20:56:58+00:00weekly0.7http://qxclear.com/Insights/cases/california-amplifier-10b-5-litigation/2020-06-01T15:26:55+00:00weekly0.7http://qxclear.com/Insights/cases/parnes-v--bally-entertainment-corp-/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/emeritus-corporation-v--arv-assisted-living/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/westside-cellular-v--new-par/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/telecom-excise-tax-challenges/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/digital-television-receiver-requirement/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/assessing-new-product-development/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/achieving-higher-levels-of-customer-satisfaction/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/private-aerospace-manufacturer/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/alkus-v--ods-technologies/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-lmusa-bankruptcy/2020-11-09T16:46:25+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-class-action-lawsuits/2020-11-03T14:58:45+00:00weekly0.7http://qxclear.com/Insights/cases/optimizing-a-go-to-market-capability/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/brokerage-company-class-action/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/aerospace-workers-class-action/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/overtime-pay-dispute/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/media-information-business--growth-strategy/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/assessing-advertising-effectiveness/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/commercializing-new-technologies/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/expanding-an-r-d-portfolio/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/health-care-economics-and-reimbursement-strategy/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/identifying-drivers-of-growth/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/modeling-the-economics-of-growth-opportunities/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/maintaining-competitive-advantage-in-the-face-of-rapid-commoditization/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/rapid-response-to-shifting-industry-structure/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/value-of-pharmaceuticals-to-society/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/understanding-the-challenges-of-alternative-energy-structures/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/moving-from-follower-to-market-leader/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/retail-banking-customer-satisfaction/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/retail-banking-performance-metrics/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/segmentation-and-contracting-strategy/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/venture-capital-firm-v--home-furnishings-company/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/mci-worldcom-bankruptcy/2020-11-09T16:49:30+00:00weekly0.7http://qxclear.com/Insights/cases/globalizing-product-development/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-lorazepam---clorazepate-antitrust-litigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/economic-impact-of-public-sewer-investments/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/lapd-racial-profiling-analysis/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/stranded-cost-measurement/2020-11-03T15:08:05+00:00weekly0.7http://qxclear.com/Insights/cases/us-unwired-acquisition/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/regents-of-the-university-of-california-v--monsanto-company/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/securities-and-exchange-commission-v--henry-yuen/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/steadfast-insurance-company-v--purdue-frederick-company/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/us-department-of-justice-v--tenet-healthcare-corporation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/energy-infrastructure-development/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/auction-design-for-wholesale-power-procurement/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/cost-benefit-analysis-of-wholesale-competition/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/baker-v--american-century-investment-management/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/putnam-investment-management/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/nyse-merger/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/proyectos-y-construcciones-procisa-v--continental-tire-of-north-america/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/archipelago-merger-litigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/new-world-tmt-v--prediwave/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/microsoft-iowa-settlement/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/bouygues-telecom-v--tekelec/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/mutual-fund-excessive-fee-case/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/lost-earnings-analysis-in-wrongful-termination-case/2020-06-01T15:42:21+00:00weekly0.7http://qxclear.com/Insights/cases/economic-loss-analyses-in-wrongful-death-case/2020-06-01T15:43:03+00:00weekly0.7http://qxclear.com/Insights/cases/using-cps-data-to-compare-wages-by-race/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/sargon-enterprises-v--university-of-southern-california/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/first-marblehead-corporation-v--gregory-house/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/energy-policy-act-section-1813-comments--report-of-the-ute-indian-tribe-of-the-uintah-and-ouray-reservation-for-submission-to-the-us-departments-of-energy-and-interior/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/vitascan-v--ge-healthcare/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/general-american-liquidation-litigation/2020-11-09T16:43:52+00:00weekly0.7http://qxclear.com/Insights/cases/coachella-valley-housing-coalition-v--city-of-moreno-valley/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/robins-v--roland/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/subprime-automobile-loan-portfolio-analysis/2020-11-09T16:57:22+00:00weekly0.7http://qxclear.com/Insights/cases/computer-hard-drive-manufacturer-v--commissioner-of-internal-revenue/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/managing-risk-under-new-climate-legislation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/black---decker-corp--v--united-states/2020-10-26T20:01:56+00:00weekly0.7http://qxclear.com/Insights/cases/damages-calculation-in-dispute-involving-tax-sharing-agreement/2020-10-26T20:04:54+00:00weekly0.7http://qxclear.com/Insights/cases/dunkin-donuts-v--michael-panagakos/2020-04-06T13:05:07+00:00weekly0.7http://qxclear.com/Insights/cases/flat-top-insurance-agency-v--us-dept--of-justice-taxation-division/2020-10-26T20:07:02+00:00weekly0.7http://qxclear.com/Insights/cases/otto-candies-v--us-dept--of-justice-taxation-division/2020-10-26T20:15:07+00:00weekly0.7http://qxclear.com/Insights/cases/rogers-v--united-states/2020-10-26T20:21:26+00:00weekly0.7http://qxclear.com/Insights/cases/semiconductor-company-v--commissioner-of-internal-revenue/2020-10-26T20:21:59+00:00weekly0.7http://qxclear.com/Insights/cases/evaluation-of-transfer-pricing-of-intercompany-services-of-a-global-oil-and-gas-company/2020-10-26T20:06:00+00:00weekly0.7http://qxclear.com/Insights/cases/global-transfer-pricing-planning-for-an-automotive-parts-supplier/2020-10-26T20:11:01+00:00weekly0.7http://qxclear.com/Insights/cases/transfer-pricing-for-a-software-company/2020-10-26T20:25:25+00:00weekly0.7http://qxclear.com/Insights/cases/valuing-financial-guarantees/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/allegations-of-bid-rigging-by-major-insurers/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/peoplesoft-v--oracle/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-calpine-reorganization/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/reducing-a-heavy-carbon-footprint/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/assessing-market-impact-of-greenhouse-gas-legislation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/interactivecorp-/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/slaughter-v--kohl/2020-04-06T13:06:20+00:00weekly0.7http://qxclear.com/Insights/cases/jones-v--harris-associates/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/awg-leasing-trust-v--united-states-of-america/2020-10-26T20:00:47+00:00weekly0.7http://qxclear.com/Insights/cases/nanovation-technologies-v--bearingpoint/2020-11-09T16:51:54+00:00weekly0.7http://qxclear.com/Insights/cases/carlyle-realty-partners-v--vweb-corporation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-managed-care-litigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/compilation-and-analysis-of-plaintiff-medical-records/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/extrapolating-from-proposed-payout-matrices-to-assess-overall-exposure/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/identification-of-the-timing-of-adverse-events-relative-to-drug-use/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/economic-assistance-in-connection-with-class-certification/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/assessment-of-excess-risk-for-causation-analysis/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/smithkline-v--revenue-canada/2020-10-26T20:22:37+00:00weekly0.7http://qxclear.com/Insights/cases/biotechnology-stock-drop-matter/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/development-of-a-framework-for-litigation-decision-making/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/cost-comparison-of-painful-conditions/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/analysis-of-roi-for-bariatric-surgery/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/quantifying-the-economic-burden-of-depression/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/economic-burden-of-opioid-abuse/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/effects-of-depression-relative-to-other-health-problems/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/costs-associated-with-adhd-patients-and-families/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/comparison-of-escitalopram-and-citalopram/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/epidemiology-studies-on-spinal-cord-injury/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/epidemiology-studies-on-rare-childhood-cancers/2020-09-08T17:54:41+00:00weekly0.7http://qxclear.com/Insights/cases/documenting-the-need-for-care-management-in-elderly-hypertensive-patients/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/studies-to-assess-incidence-of-renal-injury-in-cancer-patients-using-bisphosphonates/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/study-of-safety-and-efficacy-of-vegf-inhibitors-in-actual-use/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/studies-of-adverse-events/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/impact-of-aromatase-inhibitors-on-bone-loss-in-breast-cancer-patients/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/establishing-a-health-outcomes-organization/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/developing-a-new-drug-value-profile-to-inform-clinical-trials/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/determining-product-value-proposition/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/using-sensitivity-analysis-to-drive-pricing-strategy/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/priority-customer-segmentation-strategy/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/refining-contracting-strategies-in-the-face-of-competition/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/cardiovascular-acquisition-analysis/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/investment-and-acquisition-strategy/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/identifying-and-benchmarking-acquisition-targets/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/payer-billing-disputes/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/united-states-v--schiff/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-williams-securities-litigation/2020-06-01T15:43:50+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-bear-stearns-litigation/2020-11-09T16:44:52+00:00weekly0.7http://qxclear.com/Insights/cases/major-music-publisher-profitability-analysis/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/warner-brothers-television-international-distribution-v--golden-channels---co-/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/equity-broadcasting-corporation-v--pax-tv/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/economic-report-on-california-proposition-71/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/evaluating-opportunities-to-expand-oncology-franchise/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/go-to-market-strategy-for-a-solar-cell-start-up/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/financial-analysis-of-infrastructure-investments/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/scenario-analysis-of-product-and-franchise-performance/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/strategy-and-analysis-of-investment-options-for-global-pharmaceutical-company/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/financial-risk-management-for-a-chemical-company/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/cap-and-trade-system-design/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/assessment-of-alternative-climate-policies/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/erisa-class-action/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/calpine-corporation-bankruptcy-settlement/2020-11-09T16:42:15+00:00weekly0.7http://qxclear.com/Insights/cases/son-of-boss-matters/2020-10-26T20:23:12+00:00weekly0.7http://qxclear.com/Insights/cases/rohm-and-haas-co--v--the-dow-chemical-co-/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/restructuring-of-american-airlines/2020-11-09T16:52:45+00:00weekly0.7http://qxclear.com/Insights/cases/structuring-a-successful-turnaround/2020-11-09T16:56:56+00:00weekly0.7http://qxclear.com/Insights/cases/official-committee-of-asbestos-claimants-v--g-i-holdings/2020-11-09T16:52:11+00:00weekly0.7http://qxclear.com/Insights/cases/global-crossing-bankruptcy-bondholder-suit/2020-11-09T16:44:25+00:00weekly0.7http://qxclear.com/Insights/cases/shopping-center-management-fee-litigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-parmalat-securities-litigation/2020-11-09T16:46:56+00:00weekly0.7http://qxclear.com/Insights/cases/at-t-v--united-states-of-america/2020-10-26T19:59:18+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-oracle-securities-litigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/united-states-v--cioffi/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/lawrence-e--jaffe-pension-plan-v--household-international-inc-/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-american-funds-fee-litigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/microsoft-california-class-action/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/walmart-et-al--v--visa-and-mastercard/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/analysis-of-property-values-amid-allegations-of-contamination/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/an-economic-perspective-on-complex-climate-legislation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/mastercard-antitrust-litigations/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/innovating-to-reduce-emissions-and-energy-use/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/sofamor-danek-group-v--spine-tech/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/mylan-pharmaceuticals-v--procter---gamble-co-/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/kwaak-et-al-v--pfizer-inc-/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/cleaning-appliance-manufacturer-false-superiority-claims/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/false-superiority-claims-in-personal-hygiene-products-case/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/price-comparison-claims-made-by-big-box-retailer/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/mtbe-water-contamination-litigations/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/confidential-wetlands-contamination-case/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/confidential-case-involving-a-major-oil-company/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/cost-benefit-analysis-on-behalf-of-brayton-point-station/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/central-basin-municipal-water-district-v--metropolitan-water-district-of-southern-california/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/analysis-of-agricultural-industries-in-antitrust-litigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/identifying-high-impact-disruptive-technologies/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/new-product-development-strategy-for-international-joint-venture/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/kia-safety-class-actions/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/developing-an-alternative-propulsion-roadmap/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/business-impact-of-ghg-emissions-limits/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/air-canada-v--toronto-port-authority-and-porter-airlines/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/allegations-of-price-fixing-by-lcd-manufacturers/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/evan-weiner-et-al--v--snapple-beverage-corporation/2020-06-01T13:54:43+00:00weekly0.7http://qxclear.com/Insights/cases/pharmaceutical-off-label-promotion---kickbacks-settlements/2020-09-08T18:15:43+00:00weekly0.7http://qxclear.com/Insights/cases/pre-merger-investigation-of-medtronic-acquisition/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/otsuka-pharmaceuticals-abilify-litigations/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/revenue-decoupling-and-other-ratemaking-approaches-for-utility-energy-efficiency/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/transmission-policy/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/establishing-utility-revenue-requirements/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/assessing-california-electricity-markets/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/music-licensing-royalty-rate-analyses/2020-03-09T13:39:21+00:00weekly0.7http://qxclear.com/Insights/cases/personal-audio-llc-v--apple-inc-/2020-06-01T15:26:15+00:00weekly0.7http://qxclear.com/Insights/cases/e-i--du-pont-de-nemours---co--v--kolon-industries-inc-/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-countrywide-financial-corp--mortgage-marketing-and-sales-practices-litigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/nevada-power-rate-proceeding/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/assessing-competitiveness-of-retail-electricity-market-in-pennsylvania/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/consumer-benefits-of-competition-in-the-telecommunications-industry/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/analysis-of-at-t-marketing-practices/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/assessing-health-care-patent-infringement-claims/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/assessing-adverse-events/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/confidential-ongoing-pharmaceutical-mass-tort-matter/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-onstar-contract-litigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/procter---gamble-company-v--united-states/2020-10-26T20:18:14+00:00weekly0.7http://qxclear.com/Insights/cases/confidential-securities-lending-litigations/2020-03-09T15:32:40+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-google-adwords-litigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/assessing-potential-drug-safety-issues-for-a-major-pharmaceutical-company/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-certain-ground-fault-circuit-interrupters-and-products-containing-same/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/analyzing-causation-and-damages-in-data-breach-litigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/rabin-v--mony-life-insurance-company/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/analysis-of-government-instrumentality-factors-in-fcpa-prosecution/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/at-t-telecommunications-dispute-over-u-verse-equipment/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/confidential-erisa-litigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-marsh-erisa-litigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/the-board-of-trustees-of-the-southern-california-ibew-neca-defined-contribution-plan-et-al--v--the-bank-of-new-york-mellon-corporation-et-al-/2020-06-01T15:29:32+00:00weekly0.7http://qxclear.com/Insights/cases/multiple-antitrust-litigations-on-behalf-of-large-semiconductor-manufacturer/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-reorganization-plan-for-spectrum-brands/2020-11-09T16:47:21+00:00weekly0.7http://qxclear.com/Insights/cases/morpho-detection-inc--v--smiths-detection-inc-/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/market-research-in-support-of-pricing-strategies/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/pharmaceutical-product-development-and-launch/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/false-advertising-claims-in-consumer-beverages-market/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/netscape-v--microsoft/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/patent-infringement-matter-related-to-consumer-electronics/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/trademark-infringement-related-to-luxury-goods/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/alta-bates-and-summit-medical-centers-merger-antitrust-suit/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/analyzing-design-issues-in-a-product-safety-matter/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/patent-valuation-and-food-industry-r-d/2020-10-26T20:17:48+00:00weekly0.7http://qxclear.com/Insights/cases/chemtech-royalty-associates-l-p--v--united-states-of-america/2020-10-26T20:04:24+00:00weekly0.7http://qxclear.com/Insights/cases/rincon-ev-realty-llc-et-al--v--cp-iii-rincon-towers-inc-/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/analyzing-safety-preparedness-in-high-risk-work-environments/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/justice-department-investigation-into-health-care-fraud/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/erisa-class-action-against-provider-of-retirement-plan-services-to-small--and-mid-sized-plans/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/erisa-class-action-litigations-involving-plans-that-held-investment-options-affiliated-with-the-plan-sponsor/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/consultants-study-ceo-perspectives-and-recommendations-on-california-s-advanced-energy-policies/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/conducting-a-review-of-the-regional-greenhouse-gas-initiative-s-impact-on-consumer-electricity-bills/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/effingo-wireless-inc--v--motorola-mobility-llc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/washington-state-hospital-association-medicaid-supplemental-payments-matter/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/batsheva-ackerman-et-al--v--the-coca-cola-company-and-energy-brands-inc-/2020-06-01T15:40:57+00:00weekly0.7http://qxclear.com/Insights/cases/eplus-inc--v--lawson-software-inc-/2020-06-01T15:16:25+00:00weekly0.7http://qxclear.com/Insights/cases/sean-turnbow-et-al--v--life-partners-inc--et-al-/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/analyzing-the-performance-of-iso-ne-power-generation-resources/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-depth-new-analyses-on-the-use-of-renewable-energy-for-power-system-operations/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/newire-inc--v--southwire-company/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/saint-alphonsus-medical-center---nampa-et-al--v--st--luke-s-health-system-ltd-/2020-07-08T14:52:20+00:00weekly0.7http://qxclear.com/Insights/cases/sunset-drive-corporation-v--city-of-redlands/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/casino-developments/2020-06-09T12:40:36+00:00weekly0.7http://qxclear.com/Insights/cases/economic-and-fiscal-impacts-of-clean-fuels-project-alternative-in-kern-county/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/ferc-market-based-rate-authorization-and-market-power-analyses-in-wholesale-electric-markets/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/toyota-industries-and-cascade-corporation-transaction/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/nxp-b-v--v--blackberry-limited-and-blackberry-corporation/2020-06-01T15:41:37+00:00weekly0.7http://qxclear.com/Insights/cases/levi-jones-et-al--v--conagra-foods-inc-/2020-06-01T15:37:56+00:00weekly0.7http://qxclear.com/Insights/cases/corvex-management-et-al--v--commonwealth-reit-et-al-/2020-10-20T15:21:30+00:00weekly0.7http://qxclear.com/Insights/cases/demand-study-regarding-a-potential-combination-drug-for-a-major-pharmaceutical-company/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/blue-cross-blue-shield-of-minnesota-et-al-v--wells-fargo-bank-n-a-/2020-03-09T15:41:25+00:00weekly0.7http://qxclear.com/Insights/cases/sec-investigation-into-accounting-and-disclosure-practices/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/assessing-transmission-for-renewables-projects/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/class-action-v--horace-mann-life-insurance-et-al-/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/comcast-ip-holdings-i-llc-v--sprint-communications-co--lp-et-al-/2020-05-28T11:59:41+00:00weekly0.7http://qxclear.com/Insights/cases/pricing-and-positioning-of-complex-consumer-products/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/center-partners-ltd--et-al--v--urban-shopping-centers-lp--et-al-/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/mobile-telecommunications-technologies-llc-v--samsung-telecommunications-america-llc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/sec-v--mark-a--jackson-and-james-j--ruehlen/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/colgate-softsoap-false-advertising-consumer-class-action/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/product-liability-class-action--treated-wood-products/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/developing-a-go-to-market-strategy/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/postova-banka-as-and-istrokapital-se-v--the-hellenic-republic/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/wfc-holdings-corporation-v--united-states-of-america/2020-10-26T20:26:44+00:00weekly0.7http://qxclear.com/Insights/cases/tax-investigation-analysis/2020-10-26T20:24:47+00:00weekly0.7http://qxclear.com/Insights/cases/assessment-of-alleged-postal-fraud/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/analysis-of-investment-performance/2020-10-16T15:55:32+00:00weekly0.7http://qxclear.com/Insights/cases/earn-out-dispute-in-acquisition-of-engineering-and-project-management-firm/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/fox-broadcasting-company-et-al-v--dish-network-llc-et-al/2020-10-16T15:45:26+00:00weekly0.7http://qxclear.com/Insights/cases/evaluating-the-economic-impact-of-early-diagnosis-of-alzheimer-s-disease/2021-01-07T18:54:46+00:00weekly0.7http://qxclear.com/Insights/cases/assessing-economic-benefits-of-diabetic-foot-ulcer-treatment/2021-01-07T18:53:34+00:00weekly0.7http://qxclear.com/Insights/cases/miriam-haskins-at-al--v--first-american-title-insurance-company/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/st--clair-intellectual-property-consultants-inc--v--toshiba-corp--et-al-/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/e-retailer-false-advertising-matter/2020-02-18T20:28:08+00:00weekly0.7http://qxclear.com/Insights/cases/crtc-review-of-wholesale-wireline-services-and-associated-policies/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/bayer-healthcare-pharmaceuticals-inc--v--glenmark-pharmaceuticals-ltd-/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/economic-impact-analysis-of-direct-lender-ondeck/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/at-t-acquisition-of-directv----survey-of-consumer-preferences/2020-02-18T20:26:16+00:00weekly0.7http://qxclear.com/Insights/cases/assessing-potential-impacts-of-california-climate-policies/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/report-on-the-economic-effects-of-mandatory-energy-labeling-for-buildings/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/evaluating-the-epa-s-clean-air-transport-rule/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/contentguard-holdings-inc--v--google-inc-/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/analysis-in-nfl-players-association-deflategate-matter/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/bittitan-inc-v-skykick-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/phigenix-v--immunogen/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/wisconsin-alumni-research-foundation-v--apple/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/medtronic-minimed-v-nova-biomedical/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/nes-financial-corp--v--jpmorgan-chase-bank/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/romag-fasteners-inc--v--fossil-inc--et-al-/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/class-action-sales-practices-litigation-surrounding-vanishing-premium-sales/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/confidential-regulatory-matter-involving-alleged-failure-to-annuitize-variable-annuities/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/wellbutrin-xl-antitrust-litigation/2020-10-16T15:26:42+00:00weekly0.7http://qxclear.com/Insights/cases/controlled-substance-suspicious-order-monitoring-modeling/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/controlled-substance-monitoring-and-effective-controls-against-diversion--investigations-and-settlements/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/tribunal-de-commerce-francophone-de-bruxelles---patrinvest-v--sa-ageas/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/bmg-rights-management-et-al-v-cox-communications/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/federal-deposit-insurance-corporation-as-receiver-for-vantus-bank-v--officers-and-directors-of-vantus-bank/2020-03-06T16:14:51+00:00weekly0.7http://qxclear.com/Insights/cases/solyndra-antitrust-litigation/2020-11-09T16:53:17+00:00weekly0.7http://qxclear.com/Insights/cases/philip-morris-v--uruguay/2020-03-09T15:27:29+00:00weekly0.7http://qxclear.com/Insights/cases/petition-to-the-governor-in-council-concerning-telecom-regulatory-policy-crtc-2015-326/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/daiichi-sankyo-and-ranbaxy-laboratories-damages-arbitration/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/tax-dispute-concerning-charitable-easements/2021-01-05T21:45:12+00:00weekly0.7http://qxclear.com/Insights/cases/innopharma-licensing-inc--et-al--v--senju-pharmaceutical-co--ltd--et-al-/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/fresenius-kabi-usa-llc-v-fera-pharmaceuticals-llc-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/economic-impact-of-rwandan-hospital-on-its-community-is-examined-pro-bono-by-analysis-group-at-request-of-pih/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/analysis-group-pro-bono-team-assists-harvard-medical-school-in-tb-genome-machine-learning-project/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/analysis-group-team-works-pro-bono-with-gheskio-to-study-characteristics-of-sexual-assault-in-haiti/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/analysis-group-team-provides-pro-bono-assistance-to--major-homeless-shelter-initiative-in-massachusetts/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/dang-v-san-francisco-forty-niners-ltd-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/sec-v-stifel-nicolaus-co-inc-and-david-w-noack/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/city-of-claremont-v--golden-state-water-company/2020-02-24T16:20:51+00:00weekly0.7http://qxclear.com/Insights/cases/us-et-al--v--anthem-inc--et-al/2020-03-09T13:43:06+00:00weekly0.7http://qxclear.com/Insights/cases/kenneth-hobbs-v-brother-international-corporation-et-al/2020-06-01T15:53:21+00:00weekly0.7http://qxclear.com/Insights/cases/lapd-pedestrian-and-motor-vehicle-stop-data-analyses/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-fedex-ground-package-system-inc-employment-practices-litigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/drivers-v-united-parcel-services-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/high-tech-employee-class-action-involving-alleged-no-poaching-agreements/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/pat-cason-merenda-et-al-v-detroit-medical-center-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/analysis-group-pro-bono-team-assists-suffolk-law-school-in-examining-gender-identity-discrimination-in-the-metro-boston-rental-housing-market/2020-07-01T16:53:04+00:00weekly0.7http://qxclear.com/Insights/cases/denimafia-inc-v-new-balance-athletic-shoe-inc-et-al-and-new-balance-athletic-shoe-inc-v-denimafia-inc/2020-02-18T20:30:04+00:00weekly0.7http://qxclear.com/Insights/cases/basis-pac-rim-opportunity-fund-index-master-et-al-vs-tcw-asset-management-company/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/overall-survival-with-ponatinib-versus-allogeneic-stem-cell-transplantation-in-philadelphia-chromosome-positive-leukemias-with-the-t315i-mutation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-appraisal-of-petsmart-inc-2017-bl-177567-del-ch-no-10782/2020-10-16T16:14:16+00:00weekly0.7http://qxclear.com/Insights/cases/adidas-america-inc-et-al-v-skechers-usa-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-appraisal-of-sws-group-inc-ca-no-10554-vcg/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/wex-inc-acquisition-of-electronic-funds-source-llc/2021-01-06T22:01:13+00:00weekly0.7http://qxclear.com/Insights/cases/cintas-corporation-acquisition-of-gk-services/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/united-states-of-america-et-al-ex-rel-brown-v-celgene-corp/2020-09-08T18:30:00+00:00weekly0.7http://qxclear.com/Insights/cases/in-the-matter-of-william-tirrell-before-the-us-securities-and-exchange-commission/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/cftc-v--hunter-and-ferc-v--hunter/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/central-vermont-public-service-corporation-and-green-mountain-power-corporation-v--entergy-nuclear-vermont-yankee/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/market-analysis-in-a-contractual-dispute/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/analysis-of-economic-feasibility-of-proposed-coal-plant/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/bankruptcy-filing-in-the-offshore-drilling-industry/2020-11-09T16:39:27+00:00weekly0.7http://qxclear.com/Insights/cases/economic-analysis-in-a-water-rights-dispute/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/shareholder-derivative-suit-following-an-operational-incident/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-the-matter-of-lynn-tilton-et-al-before-the-us-securities-and-exchange-commission/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/ferc-v-national-fuel-marketing-llc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/btg-international-inc-v-wellstat-therapeutics-corporation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/evaluating-the-capacity-market-consequences-of-alternate-resource-portfolios/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/capacity-resource-performance-in-nyiso-markets--an-assessment-of-wholesale-market-options/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-appraisal-of-dell-inc/2020-10-16T16:13:24+00:00weekly0.7http://qxclear.com/Insights/cases/in-re--alere-abbott-merger-litigation/2020-03-06T16:15:47+00:00weekly0.7http://qxclear.com/Insights/cases/argentinian-economic-crisis/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/itc-investigation-of-standard-essential-patents/2020-03-09T15:33:49+00:00weekly0.7http://qxclear.com/Insights/cases/debt-covenant-litigations-involving-caesars/2020-11-09T16:43:21+00:00weekly0.7http://qxclear.com/Insights/cases/in-re--optical-disk-drive-products-antitrust-litigation/2021-01-07T16:48:05+00:00weekly0.7http://qxclear.com/Insights/cases/securities-and-exchange-commission-v--nauman-a--aly/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/the-economic-impacts-of-the-regional-greenhouse-gas-initiative-on-northeast-and-mid-atlantic-states/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/us-airways-v-british-airways/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/evaluation-of-materiality-of-actions-constituting-default-by-an-insurer/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/patent-infringement-matter-against-e-commerce-retailer/2020-06-01T15:31:45+00:00weekly0.7http://qxclear.com/Insights/cases/allegations-of-insider-trading-against-major-shareholder-of-french-biotech-corporation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/evaluation-of-materiality-of-actions-constituting-default-by-an-insurer-6442449825/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/ticofrut-s.a.-v.-e.i.-dupont-de-nemours-and--co.-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/cashmere-and--camel-hair-manufacturers-institute-and-l.w.-packard-and--company-v.-harve-benard/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/co-options-inc.-v.-news-america-marketing/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/swan-magnetics-v.-mitsumi-electric-co.-ltd/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/wholesale-market-policy-changes-to-provider-of-last-resort-polr-program-design/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/publishing/incidence-and-costs-of-accidents-among-attention-deficit-hyperactivity-disorder-patients/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/whats-so-different-about-anxiety-disorders-such-as-phobias-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/money-cant-buy-happiness/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/attention-deficit-hyperactivity-disorder--increased-costs-for-patients-and-their-families/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-workplace-burden-of-depression--underlying-causes-recent-empirical-findings-and-future-directions/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/savings-in-direct-medical-costs-from-the-use-of-tobi-tobramycin-solution-for-inhalation-in-patients-with-cystic-fibrosis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/lifetime-medical-costs-for-women--cardiovascular-disease-diabetes-and-stress-urinary-incontinence/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/productivity-loss-due-to-irritable-bowel-syndromereply/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/l-evolution-du-regime-d-assurance-medicament-changes-in-the-drug-prescription-coverage-in-quebec/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/when-can-a-medicare-insured-group-mig-succeed-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/la-performance-des-clsc-au-quebec-local-health-clinic-performance-in-quebec/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/measuring-hospital-efficiency-in-the-presence-of-quasi-fixed-inputs--an-analysis-of-quebec-hospitals/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-impact-of-unemployment-insurance-on-job-search-productivity-the-reservation-wage-the-probability-of-re-employment-and-the-post-displacement-wage/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-effect-of-deregulation-on-employee-earnings--pilots-flight-attendants-and-mechanics-1959-1992/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-tale-of-two-taxes-a-challenge-to-hill/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/motion-picture-distribution-film-splitting-and-antitrust-policy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/motion-pictures--competition-distribution-and-efficiencies/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/using-existing-tools-to-pry-open-transmissiona-new-england-proposal/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/needed--broad-perspective-fresh-ideas/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-of-equity-capital-estimation--methodology-measurement-issues-data-and-regression-results/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/power-asset-valuation--real-options-ancillary-services-and-environmental-risks/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/at-the-electricity-resource-bazaar-lessons-from-case-studies-of-integrated-bidding-in-new-york/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/contract-paths-phase-shifters-and-efficient-electricity-trade/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/costs-of-attention-deficit-hyperactivity-disorder-adhd-in-the-us--excess-costs-of-persons-with-adhd-and-their-family-members-in-2000/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/an-analysis-of-the-diffusion-of-new-antidepressants--variety-quality-and-marketing-efforts/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/assessing-conflict-impact-and-common-methods-of-proof-in-intermediate-indirect-purchaser-class-action-litigation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-prevalence-and-effects-of-adult-attention-deficit-hyperactivity-disorder-on-work-performance-in-a-nationally-representative-sample-of-workers/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-prevalence-and-correlates-of-nonaffective-psychosis-in-the-national-comorbidity-survey-replication-ncs-r/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-impact-of-antihypertensive-drugs-on-the-number-and-risk-of-death-stroke-and-myocardial-infarction-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/dosing-patterns-treatment-costs-and-frequency-of-physician-visits-in-adults-with-cancer-receiving-erythropoietic-agents-in-managed-care-organizations/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact--and-treatment-of-anemia-in-the-elderly---clinical-epidemiological-and-economic-perspectives/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/as-reservoirs-fall-prices-should-rise/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/authorized-generic-drugs-price-competition-and-consumers-welfare/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/health-care-costs-of-adults-treated-for-attention-deficit-hyperactivity-disorder-who-received-alternative-drug-therapies/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-retrospective-claims-database-analysis-to-assess-patterns-of-interstitial-cystitis--ic-diagnosis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/decoding-developments-in-todays-electric-industry--ten-points-in-the-prism/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/hpv-prevalence-e6-sequence-variation-and-physical-state-of-hpv16-isolates-from-patients-with-cervical-cancer-in-sichuan-china/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/employees-with-fibromyalgia--medical-comorbidity-healthcare-costs-and-work-loss/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/sensation-seeking-overconfidence-and-trading-activity/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/linking-tradable-permit-systems-for-greenhouse-gas-emissions--opportunities-implications-and-challenges/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/costs-quality-of-life-and-treatment-compliance-associated-with-antibiotic-therapies-in-patients-with-cystic-fibrosis--a-review-of-the-literature/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-implications-and-uncertainties-of-obtaining-permanent-injunctive-relief-after-ebay-v.-mercexchange/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparison-of-treatment-persistence-hospital-utilization-costs-among-major-depressive-disorder-geriatric-patients-treated-with-escitalopram/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-chronic-hand-dermatitis-on-quality-of-life-work-productivity-activity-impairment-and-medical-costs/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-21st-century-interstate-electric-highway-system--connecting-consumers-and-domestic-clean-power-supplies/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-single-photon-emission-computed-tomography-spect-use-after-acute-myocardial-infarction-ami-on-cardiac-procedure-rates-and-hospital-length-of-stay/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/prevalence-referral-patterns-testing-and-surgery-in-aortic-valve-disease--leaving-women-and-elderly-patients-behind-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-impact-of-a-partnership-measurement-model-of-disease-management--improving-cardiovascular-outcomes-in-nova-scotia-icons/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/interstitial-cystitis--cost-treatment-and-co-morbidities-in-an-employed-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/algorithms-to-identify-colonic-ischemia-complications-of-constipation-and-irritable-bowel-syndrome-in-medical-claims-data--development-and-validation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-crit-study--anemia-and-blood-transfusion-in-the-critically-ill--current-clinical-practice-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-of-osteoporosis-breast-cancer-and-cardiovascular-disease-among-postmenopausal-women-in-an-employed-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/identification-of-a-claims-data-signature-and-economic-consequences-for-treatment-resistant-depression/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/switching-costs-price-sensitivity-and-health-plan-choice/2020-11-06T19:45:02+00:00weekly0.7http://qxclear.com/Insights/publishing/levaluation-de-lefficience-budgetaire-des-clsc-au-quebec-a-partir-de-la-methode-dea/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-effectiveness-quality-adjusted-life-years-and-supportive-care.-recombinant-human-erythropoietin-as-a-treatment-of-cancer-associated-anemia/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/une-analyse-du-contexte-budgetaire-de-lactivite-medicale-au-quebec-an-analysis-of-the-budgetary-context-of-medical-activity-in-quebec/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/etude-dimpact-du-projet-de-loi-sur-le-tabac-impact-report-on-the-proposed-tobacco-law/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/implementing-communitybased-longterm-care--experience-of-the-longterm-home-health-care-program/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/how-does-the-nursing-home-sector-behave--a-multiequation-model-of-nursing-home-behavior/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/angel-finance--the-other-venture-capital-in-companion-to-venture-capital/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/discount-rate-risk-and--economic-damages--practical-considerations/2020-10-26T19:02:26+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-impact-of-the-immigrant-investor-program-in-canada-english/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-impact-of-the-immigrant-investor-program-in-canada-francais/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparison-of-hospitalization-risk-and-associated-costs-among-patients-receiving-sargramostim-filgrastim-and-pegfilgrastim-for-chemotherapy-induced-neutropenia/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/modeling-for-health-care-and-other-policy-decisions--uses-roles-and-validity/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/employer-burden-of-mild-moderate-and-severe-major-depressive-disorder--mental-health-services-utilization-and-costs-and-work-performance/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/angiogenesis-inhibitor-therapies-for-metastatic-renal-cell-carcinoma--effectiveness-safety-and-treatment-patterns-in-clinical-practice-based-on-medical-chart-review/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/ensuring-a-clean-modern-electric-generating-fleet-while-maintaining-electric-system-reliability/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/perceptions-and-prescribing-considerations-among-us-psychiatrists-regarding-drugdrug-interactions-associated-with-oral-atypical-antipsychotics/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/retrospective-real-world-comparison-of-medical-visits-costs-and-adherence-between-nilotinib-and-dasatinib-in-chronic-myeloid-leukemia/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/tolerability-efficacy-and-safety-of-pegylated-liposomal-doxorubicin-in-combination-with-carboplatin-vs-gemcitabine-carboplatin-for-the-treatment-of-platinum-sensitive-recurrent-ovarian-cancer--review/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/budget-proposals-on-biosimilars-pay-for-delay-spark-controversy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-consequence-of-switching-to-citalopram-after-its-generic-entry-for-adult-patients-with-major-depressive-disorder-mdd-treated-with-escitalopram/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparing-healthcare-costs-of-medicaid-patients-with-postherpetic-neuralgia-phn-treated-with-lidocaine-patch-5-percent-versus-gabapentin-or-pregabalin/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-of-copd--relationships-between-daily-dosing-frequency-adherence-resource-use-and-costs/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/seventh-circuit-creates-uncertainty-about-401k-provider-rfps/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/societal-costs-of-prescription-opioid-abuse-dependence-and-misuse-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/copayment-level-treatment-persistence-and-health-care-utilization-in-hypertension-patients-treated-with-single-pill-combination-therapy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/epidemiologic-evaluation-of-cardiovascular-risk-in-patients-receiving-milnacipran-venlafaxine-or-amitriptyline--evidence-from-french-health-data/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/compliance-persistence-healthcare-resource-use-and-treatment-costs-associated-with-aliskiren-plus-arb-versus-ace-inhibitor-plus-arb-combination-therapy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-choice-trial--adalimumab-demonstrates-safety-fistula-healing-improved-quality-of-life-and-increased-work-productivity-in-patients-w-crohn-s/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/computerized-algorithms-for-the-identification-of-irritable-bowel-syndrome-colonic-ischemia-and-complications-of-constipation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-persistence-healthcare-utilization-and-costs-in-adult-patients-with-major-depressive-disorder--a-comparison-between-escitalopram/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comorbidity-burden-healthcare-resource-utilization-and-costs-in-chronic-gout-patients-refractory-to-conventional-urate-lowering-therapy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/average-wholesale-price--efficient-benchmark-or-conspiratorial-instrument-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/ensuring-a-clean-modern-electric-generating-fleet-while-maintaining-electric-system-reliability--summer-2011-update/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/ensuring-a-clean-modern-electric-generating-fleet-while-maintaining-electric-system-reliability--fall-2011-update/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/solar-development-incentives--status-of-colorados-solar-pv-program-practices-in-other-states-and-suggestions-for-next-steps/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/exact-and-efficient-inference-procedure-for-meta-analysis-and-its-application-to-the-analysis-of-independent-2--2-tables/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/americas-bright-future--cleaner-air-and-affordable-reliable-electricity/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/all-cause-and-potentially-disease-related-health-care-costs-associated-with-venous-thromboembolism-in-commercial-medicare-and-medicaid-beneficiaries/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/budget-impact-analysis-of-everolimus-for-the-treatment-of-hormone-receptor-positive-human-epidermal-growth-factor-receptor-2-negative-advanced-breast-cancer/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-of-dermatologic-adverse-drug-reactions-in-the-treatment-of-colorectal-non-small-cell-lung-and-head-and-neck-cancers/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/demand-response-in-capacity-markets--reliability-dispatch-and-emission-outcomes/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/re--stopeck-a-rader-m-henry-d-et-al.-cost-effectiveness-of-denosumab-vs.-zoledronic-acid-for-prevention-of-skeletal-related-events/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-medication-adherence-to-disease-modifying-drugs-on-severe-relapse-and-direct-and-indirect-costs-among-employees-with-multiple-sclerosis-in-u.s/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-practice-patterns-health-care-utilization-and-costs-in-patients-with-low-back-pain--the-long-road-to-guideline-concordant-care/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/disjunctions-of-conjunctions-cognitive-simplicity-and-consideration-sets/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/recent-average-price-trends-for-implantable-medical-devices-2007-2011/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/estimating-the-incremental-net-health-benet-of-requirements-for-cardiovascular-risk-evaluation-for-diabetes-therapies/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/budget-impact-of-pasireotide-for-the-treatment-of-cushing-s-disease-a-rare-endocrine-disorder-associated-with-considerable-comorbidities/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/clinical-outcomes-quality-of-life-and-costs-associated-with-implantation-of-vagus-nerve-stimulation-therapy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/advanced-diagnostics--innovation-reimbursement-and-coverage-challenges/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-completing-chronic-hepatitis-c-chc-treatment-on-post-therapy-healthcare-cost/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-adults-with-major-depressive-disorder-in-the-united-states-2005-and-2010/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-impact-of-implementing-a-multiple-inflammatory-biomarker-based-approach-to-identify-treat-and-reduce-cardiovascular-risk/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/healthcare-resource-use-and-costs-of-privately-insured-patients-who-switch-discontinue-or-persist-on-anti-muscarinic-therapy-for-overactive-bladder/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/evaluating-the-utility-of-existing-patient-reported-outcome-scales-in-novel-patient-populations-with-pancreatic-cancer-lung-cancer-and-myeloproliferative-neoplasms-using-medicare-current-beneficiary/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-model-to-identify-patients-at-risk-for-prescription-opioid-abuse-dependence-and-misuse/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-resource-use-and-economic-outcomes-associated-with-atypical-antipsychotic-prescriptions-in-children-and-adolescents-with-attention-deficit-hyperactivity-disorder-in-quebec/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparative-outcomes-of-everolimus-temsirolimus-and-sorafenib-as-second-targeted-therapies-for-metastatic-renal-cell-carcinoma--a-us-medical-record-review/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/budget-impact-analysis-of-everolimus-for-the-treatment-of-hormone-receptor-positive-human-epidermal-growth-factor-receptor-2-negative-her2--advanced-breast-cancer-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/sleep-quality-and-other-patient-reported-outcomes-improve-after-patients-with-psoriasis-with-suboptimal-response-to-other-systemic-therapies-are-switched-to-adalimumab--results-from-progress-an-open-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/hypoglycemia-treatment-discontinuation-and-costs-in-patients-with-type-2-diabetes-mellitus-on-oral-antidiabetic-drugs/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/deutsche-bahn-files-suit-in-german-court-seeking-1.8-billion-in-damages/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/assessment-of-time-to-clinical-response-a-proxy-for-discharge-readiness-among-hospitalized-patients-with-community-acquired-pneumonia-who-received-either-ceftaroline-fosamil-or-ceftriaxone-in-two-ph/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/assessing-the-validity-responsiveness-and-meaningfulness-of-the-hidradenitis-suppurativa-clinical-response-hiscr-as-the-clinical-endpoint-for-hidradenitis-suppurativa-treatment/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/evaluating-the-efficacy-of-sequential-biologic-therapies-for-rheumatoid-arthritis-patients-with-an-inadequate-response-to-tumor-necrosis-factor--inhibitors/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/validation-of-the-headache-impact-test-hit-6-across-episodic-and-chronic-migraine/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/measuring-the-health-status-burden-in-hemodialysis-patients-using-the-sf-36-health-survey/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/an-evaluation-of-the-effects-of-an-angiotensin-receptor-blocker-on-health-related-quality-of-life-in-patients-with-high-normal-blood-pressure-prehypertension-in-the-trial-of-preventing-hypertension/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-prescribing-decision-drivers-and-predictors-of-complete-response-following-disease-recurrence-in-gastrointestinal-stromal-tumor-patients-a-chart-extract-based-approach/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-patterns-of-endocrine-therapy-for-metastatic-hormone-receptor-positive-hrhuman-epidermal-growth-factor-receptor-2-negative-her2--breast-cancer-patients-in-the-united-states--2002-2012/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-gastrointestinal-stromal-tumor-gist-recurrence-in-patients-who-have-received-adjuvant-imatinib-therapy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/confound-it-revisiting-the-special-case-of---overdisclosure---in-the-context-of-halliburtons-price-impact-test/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-health-care-resource-utilization-and-costs-in-u.s.-patients-diagnosed-with-chronic-hepatitis-c-infection-who-received-telaprevir-or-boceprevir/2020-11-09T15:06:03+00:00weekly0.7http://qxclear.com/Insights/publishing/health-economics-outcomes-epidemiology-published-research-and-presentations/2020-06-02T14:45:40+00:00weekly0.7http://qxclear.com/Insights/publishing/economists-perspective-on-the-efficiency-defense-in-provider-consolidations--what-works-what-doesnt-work-and-what-we-still-dont-know/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-index-of-intergenerational-equity--2016/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/antitrust-private-damages-actions-in-the-united-states-canada-and-the-european-union/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/healthcare-resource-utilization-healthcare-costs-and-dose-escalation-in-psoriasis-patients-initiated-on-ustekinumab-versus-adalimumab--a-retrospective-claim-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-effectiveness-of-ceritinib-in-patients-previously-treated-with-crizotinib-in-anaplastic-lymphoma-kinase-positive-alk-non-small-cell-lung-cancer-in-canada/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/rotavirus-vaccination-in-a-medicaid-infant-population-from-four-us-states--compliance-vaccination-completion-rate-and-predictors-of-compliance/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-overall-survival-healthcare-resource-use-and-costs-in-elderly-medicare-beneficiaries-with-chronic-myeloid-leukemia-using-second-generation-tyrosine-kinase-inhibitors-as-second-lin/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/burden-of-illness-among-patients-with-fragile-x-syndrome-fxs--a-medicaid-perspective/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/risk-of-ocular-complications-in-patients-with-noninfectious-intermediate-uveitis-posterior-uveitis-or-panuveitis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-glycemic-blood-pressure-and-weight-control-in-patients-with-type-2-diabetes-mellitus-treated-with-canagliflozin-an-electronic-health-record-based-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-impact-of-expanded-use-of-biologic-therapy-for-the-treatment-of-rheumatoid-arthritis-and-crohn-s-disease-in-argentina-brazil-colombia-and-mexico/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/asas40-and-asdas-clinical-responses-in-the-ability-1-clinical-trial-translate-to-meaningful-improvements-in-physical-function-health-related-quality-of-life-and-work-productivity-in-patients-with-non/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/care-pathways-in-us-healthcare-settings--current-successes-and-limitations-and-future-challenges/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/characteristics-treatment-patterns-and-survival-among-alk-non-small-cell-lung-cancer-nsclc-patients-treated-with-crizotinib--a-chart-review-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/basal-insulin-persistence-associated-factors-and-outcomes-after-treatment-initiation-among-people-with-type-2-diabetes-mellitus-in-the-us/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-analysis-model-of-colonoscopy-preparation-using-split-dose-reduced-volume-oral-sulfate-solution-oss-and-polyethylene-glycol-with-electrolytes-solution-peg-els/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/an-indirect-comparison-and-cost-per-responder-analysis-of-adalimumab-methotrexate-and-apremilast-in-the-treatment-of-methotrexate-naive-patients-with-psoriatic-arthritis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-outcomes-health-care-resource-utilization-and-costs-of-bortezomib-and-dexamethasone-with-cyclophosphamide-or-lenalidomide-in-newly-diagnosed-multiple-myeloma/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/number-needed-to-treat-and-associated-incremental-costs-of-treatment-with-enzalutamide-versus-abiraterone-acetate-plus-prednisone-in-chemotherapy-naive-patients-with-metastatic-castration-resistant-pr2/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/individualized-prediction-of-changes-in-6-minute-walk-distance-for-patients-with-duchenne-muscular-d1/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/asas40-and-asdas-clinical-responses-in-the-ability-1-clinical-trial-translate-to-meaningful-improvem1/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-comparison-of-damage-theories-in-price-fixing-cases-in-the-united-states-canada-and-the-european-union/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/prevalence-clinical-and-economic-burden-of-mucormycosis-related-hospitalizations-in-the-united-states--a-retrospective-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/calculating-damages-in-price-fixing-cases-in-the-united-states-canada-and-the-european-union/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/use-of-statistical-sampling-in-litigation1/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/estimating-the-cost-of-capital1/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/electricity-markets-reliability-and-the-evolving-u.s.-power-system/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparative-effectiveness-research--a-pharmaceutical-industry-perspective-on-outlook-dilemmas-and-controversies/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/decision-making-with-machine-learning-in-our-modern-data-rich-health-care-industry/2020-04-07T18:26:37+00:00weekly0.7http://qxclear.com/Insights/publishing/hedge-funds--the-good-the-bad-and-the-lucky/2020-10-16T15:54:23+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-weight-change-among-patients-treated-with-glucagon-like-peptide-1-receptor-agonist-dipeptidyl-peptidase-4-inhibitor-and-sulfonylureas/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-healthcare-resource-utilization-and-costs-following-first-line-antidepressant-treatment-in-major-depressive-disorder--a-retrospective-us-claims-database-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/basal-insulin-persistence-associated-factors-and-outcomes-after-treatment-initiation--a-retrospective-database-study-among-people-with-type-2-diabetes-mellitus-in-japan/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-effectiveness-analysis-of-isavuconazole-vs.-voriconazole-as-first-line-treatment-for-invasive-a1/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-reduction-from-resolutionimprovement-of-carcinoid-syndrome-symptoms-following-treatment-with-a1/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparative-efficacy-and-safety-of-attention-deficithyperactivity-disorder-pharmacotherapies-including-guanfacine-extended-release--a-mixed-treatment-comparison/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-common-adverse-events-associated-with-metastatic-colorectal-cancer-treatment-1/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-and-healthcare-costs-among-newly-diagnosed-patients-with-chronic-myeloid-leukemia1/2020-05-21T16:00:07+00:00weekly0.7http://qxclear.com/Insights/publishing/burden-of-systemic-glucocorticoid-related-complications-in-severe-asthma1/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-effectiveness-of-biologic-disease-modifying-antirheumatic-drugs-for-the-treatment-of-rheumatoid-arthritis-after-etanercept-discontinuation-in-the-united-kingdom-france-and-germany/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/antibiotic-treatment-patterns-costs-and-resource-utilization-among-patients-with-community-acquired-pneumonia--a-us-cohort-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/a-retrospective-study-to-assess-clinical-characteristics-and-time-to-initiation-of-open-triple-therapy-among-patients-with-chronic-obstructive-pulmonary-disease-newly-established-on-longacting-mono-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/adherence-persistence-and-inpatient-utilization-among-adult-schizophrenia-patients-using-once-monthly-versus-twice-monthly-long-acting-atypical-antipsychotics/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/assessment-of-real-world-central-nervous-system-events-in-patients-with-advanced-prostate-cancer-using-abiraterone-acetate-bicalutamide-enzalutamide-or-chemotherapy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-health-care-resource-utilization-and-spending-in-medicaid-beneficiaries-initiating-second-generation-long-acting-injectable-agents-versus-oral-atypical-antipsychotics/2020-03-24T13:54:51+00:00weekly0.7http://qxclear.com/Insights/publishing/budget-impact-of-everolimus-for-the-treatment-of-progressive-well-differentiated-non-functional-neuroendocrine-tumors-of-gastrointestinal-or-lung-origin-that-are-advanced-or-metastatic/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/effect-of-adalimumab-on-visual-functioning-in-patients-with-noninfectious-intermediate-uveitis-posterior-uveitis-and-panuveitis-in-the-visual-1-and-visual-2-trials/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/corticosteroid-related-adverse-events-systematically-increase-with-corticosteroid-dose-in-noninfectious-intermediate-posterior-or-panuveitis--post-hoc-analyses-from-the-visual-1-and-visual-2-trials/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-complications-and-health-care-utilization-among-endometriosis-patients-undergoing-a-laparoscopy-or-a-hysterectomy--a-retrospective-claims-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/patterns-of-disease-monitoring-and-treatment-among-patients-with-tuberous-sclerosis-complex-related-1/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/first-line-treatment-disruption-among-post-menopausal-women-with-hrher2--metastatic-breast-cancer--a-retrospective-us-claims-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/healthcare-resource-utilization-healthcare-costs-and-dose-escalation-in-psoriasis-patients-initiated-on-ustekinumab-versus-adalimumab--a-retrospective-claim-study2/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-effectiveness-analysis-of-ocrelizumab-versus-subcutaneous-interferon-beta-1a-for-the-treatment-1/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/projecting-the-cost-utilization-and-patient-care-impact-of-prescribing-extended-release-non-abuse-deterrent-opioids-to-chronic-pain-patients/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/healthcare-resource-use-costs-and-disease-progression-associated-with-diabetic-nephropathy-in-adults-with-type-2-diabetes--a-retrospective-observational-study/2020-03-06T21:01:07+00:00weekly0.7http://qxclear.com/Insights/publishing/lost-profits-damages--principles-methods-and-applications/2020-10-26T19:23:36+00:00weekly0.7http://qxclear.com/Insights/publishing/comment-on-the-flaws-in-using-the-hypothetical-monopolist-test-from-the-payor-perspective-in-health-care-merger-cases-by-field-fisher-and-coglianese/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/joint-ventures-group-boycotts-and-volume-discounts/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/united-states-v.-energy-solutionsperspectives-on-litigating-antitrust-merger-challenges/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/survey-evidence-to-evaluate-a-marketing-claim--skye-astiana-plaintiff-v.-ben-and--jerry-s-homemade-inc.-defendant/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/government-takeovers-of-water-systems-are-costly-dont-deliver-results/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-impacts-of-the-regional-greenhouse-gas-initiative-on-nine-northeast-and-mid-atlantic-states--review-of-rggis-third-three-year-compliance-period-2015-2017/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/back-to-school--a-primer-on-university-403b-plan-litigation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-healthcare-resource-utilization-and-costs-in-patients-with-acute-myeloid-leukemia-in-commercially-insured-and-medicare-populations/2020-05-21T16:11:17+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-evaluation-of-hba1c-blood-pressure-and-weight-loss-among-patients-with-type-2-diabetes-mellitus-treated-with-canagliflozin/2020-03-24T13:41:36+00:00weekly0.7http://qxclear.com/Insights/publishing/factors-associated-with-the-number-and-size-of-renal-angiomyolipomas-in-sporadic-angiomyolipoma-saml--a-study-of-adult-patients-with-saml-managed-in-a-dutch-tertiary-referral-center/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/asthma-control-lung-function-symptoms-and-corticosteroid-sparing-after-omalizumab-initiation-in-patients-with-allergic-asthma/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/clinical-trajectories-healthcare-resource-use-and-costs-of-diabetic-nephropathy-among-patients-with-type-2-diabetes--a-latent-class-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/reimbursement-landscape-for-molecular-testing-in-non-small-cell-lung-cancer-nsclc/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-additional-costs-per-month-of-progression-free-survival-and-overall-survival--an-economic-model-comparing-everolimus-with-cabozantinib-nivolumab-and-axitinib-for-second-line-treatment-of-metasta/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/reliability-of-coded-data-to-identify-earliest-indications-of-cognitive-decline-cognitive-evaluation-and-alzheimer-s-disease-diagnosis--a-pilot-study-in-england/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/characteristics-treatment-patterns-and-economic-outcomes-of-patients-initiating-injectable-medications-for-management-of-type-2-diabetes-mellitus-in-japan/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/evaluation-of-clinical-outcomes-among-nonvalvular-atrial-fibrillation-patients-treated-with-rivaroxaban-or-warfarin-stratified-by-renal-function/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/value-of-transfusion-independence-in-severe-aplastic-anemia-from-patients-perspectives--a-discrete-choice-experiment/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-clinical-and-economic-outcomes-of-patients-with-anaplastic-lymphoma-kinase-positive-non-small-cell-lung-cancer-receiving-ceritinib--a-retrospective-observational-claims-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-risk-of-cardiovascular-events-in-psoriasis-patients-treated-with-tumor-necrosis-factor--inhibitors-versus-phototherapy--an-observational-cohort-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/singleton-v.-fifth-generation-inc/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-and-outcomes-with-subcutaneous-bortezomib-in-patients-with-relapsed-mantle-cell-lymphoma--a-retrospective-observational-study-of-patient-medical-records-from-us-community-oncology/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/dosing-patterns-and-economic-burden-of-palbociclib-drug-wastage-in-hrher2--metastatic-breast-cancer/2020-05-21T16:02:35+00:00weekly0.7http://qxclear.com/Insights/publishing/occupational-licensing-in-healthcare-and-beyond--recent-developments-in-case-law-enforcement-legislation-and-research/2021-01-06T21:59:37+00:00weekly0.7http://qxclear.com/Insights/cases/clean-water-act-section-316b-engagements/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/confidential-matter-analysis-of-environmental-contamination-claims/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/confidential-matter-determination-of-financial-solvency-tests/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/enviro-petroleum-inc.-v.-kondur-petroleum-s.a/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/ben-s.-branch-trustee-of-bank-of-new-england-corporation-v.-federal-deposit-insurance-corporation/2020-11-09T16:39:50+00:00weekly0.7http://qxclear.com/Insights/cases/honeywell-international-inc.-v.-air-products-and-chemicals/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/study-of-exchange-traded-fund-products-for-american-stock-exchange-nasd-and-american-express/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/resonate-inc.-v.-nortel-networks/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/twister-communications-network-inc.-v.-mci-worldcom-network-services-inc/2020-06-01T15:38:35+00:00weekly0.7http://qxclear.com/Insights/cases/professional-services-company--performance-rankings/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/class-action-v.-helping-hands-company-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/valassis-communications-inc.-v.-advo-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/glaxosmithkline-holdings-americas-inc.-v.-commissioner-of-the-irs/2020-10-26T20:07:37+00:00weekly0.7http://qxclear.com/Insights/cases/heuft-systemtechnik-gmbh-v.-industrial-dynamics-co.-ltd/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/securities-and-exchange-commission-v.-biopure-corporation-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/phibro-tech-inc.-v.-osmose-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/lee-conrad-v.-eps-solutions-corporation/2020-11-09T16:49:04+00:00weekly0.7http://qxclear.com/Insights/cases/cogent-systems-inc.-v.-northrop-grumman-corporation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/slm-corporation-sallie-mae-v.-j.c.-flowers-ii-l.p/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/fdic-v.-bright-first-republic-bank-of-dallas/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/commonwealth-court-building-inc.-v.-criimi-mae-services/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/national-westminster-bank-natwest-v.-us-dept.-of-justice-taxation-division/2020-10-26T13:13:19+00:00weekly0.7http://qxclear.com/Insights/cases/authorized-generics-competition-and-consumer-prices/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/boeing-satellite-systems-international-inc.-v.-ico-global-communications-operations-ltd/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/louisiana-wholesale-drug-co.-inc.-v.-sanofi-aventis/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/401k-fee-litigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/surface-transportation-board--stb-ex-parte-no.-664-sub-no.-1/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/bracco-diagnostics-inc.-v.-amersham-health-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-retek-inc.-securities-litigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/lkf-x-investments-lkf-x-capital-corporation-tax-matters-partner-v.-the-commissioner-of-internal-revenue/2020-10-26T20:13:35+00:00weekly0.7http://qxclear.com/Insights/cases/ventas-inc.-v.-hcp-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/raymond-road-associates-blue-back-square-v.-taubman-centers/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/palm-canyon-x-investments-llc-ah-investment-holdings-inc.-tax-matters-partner-v.-commissioner-of-internal-revenue-service/2020-10-26T20:17:23+00:00weekly0.7http://qxclear.com/Insights/cases/bavarian-nordic-v.-acambis-plc-inv.-no.-337-ta-550/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/american-express-v.-visa-and-mastercard-and-related-litigations/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/playtex-products-inc.-v.-procter-and--gamble-company/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/pbm-products-inc.-v.-mead-johnson/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/astrazeneca-v.-tap-pharmaceuticals-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/johnette-c.-alexander-et-al.-v.-kia-motors-america-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/minuteman-trucks-inc.-v.-hn80-corporation-and-sterling-truck-corp/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/sp-syntax-silver-point-capital-l.p.-v.-ernst-and--young-llp/2020-06-01T15:24:06+00:00weekly0.7http://qxclear.com/Insights/cases/gallus-et-al.-v.-ameriprise-financial-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/st.-jude-medical-inc.-v.-access-closure-inc/2020-06-01T15:30:49+00:00weekly0.7http://qxclear.com/Insights/cases/new-jersey-carpenters-vacation-fund-et-al.-v.-the-royal-bank-of-scotland-group-plc-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/air-products-and--chemicals-inc.-v.-airgas-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/cheetah-omni-llc-v.-verizon-services-corporation-et-al/2020-06-01T15:40:04+00:00weekly0.7http://qxclear.com/Insights/cases/bedrock-computer-technologies-llc-v.-google-inc/2020-06-01T15:32:30+00:00weekly0.7http://qxclear.com/Insights/cases/biotechnology-firm-10b-5-matter--phase-iii-testing/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/biotechnology-firm-10b-5-matter--human-testing/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/bedrock-computer-technologies-llc-v.-yahoo/2020-06-01T15:24:57+00:00weekly0.7http://qxclear.com/Insights/cases/convolve-inc.-v.-dell-inc.-western-digital-corporation-hitachi-global-storage-technologies-inc.-and-hitachi-ltd/2020-06-01T15:50:29+00:00weekly0.7http://qxclear.com/Insights/cases/vietnam-telecom-international-v.-eddie-inyang-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/the-citri-lite-company-v.-cott-beverages-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/fairview-donut-inc.-et-al.-v.-the-tdl-group-tim-hortons/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/safeco-insurance-company-of-america-et-al.-v.-aig-et-al/2020-03-09T15:29:26+00:00weekly0.7http://qxclear.com/Insights/cases/ceats-inc.-v.-continental-airlines-inc.-et-al/2020-06-01T15:19:25+00:00weekly0.7http://qxclear.com/Insights/cases/fresh-del-monte-produce-inc.-v.-del-monte-foods-co.-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/t.-jeffrey-simpson-et-al.-v.-homestore.com-inc.-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/bone-care-international-v.-roxane-labs-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/peter-claydon-v.-nestle-waters-north-america-inc.-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/martin-marietta-materials-inc.-v.-vulcan-materials-company/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/augustus-et-al.-v.-american-commercial-security-services-inc.-et-al.-abm-security-services-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/fishman-transducers-inc.-v.-stephen-paul-dba-esteban-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/galderma-laboratories-et-al.-v.-tolmar-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/ddr-holdings-llc-v.-hotels.com-lp-et-al/2020-06-01T15:51:24+00:00weekly0.7http://qxclear.com/Insights/cases/adelphia-recovery-trust-v.-bank-of-america-et-al/2020-11-09T16:39:11+00:00weekly0.7http://qxclear.com/Insights/cases/apple-v.-samsung-injunction-ruling-december-2012/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/tyco-healthcare-group-lp-et-al.-v.-ethicon-endo-surgery-inc/2020-06-01T15:52:33+00:00weekly0.7http://qxclear.com/Insights/cases/hitachi-consumer-electronics-co.-ltd.-and-hitachi-advanced-digital-inc.-v.-top-victory-electronics-taiwan-co.-ltd.-et-al/2020-06-01T15:35:44+00:00weekly0.7http://qxclear.com/Insights/cases/assessing-industry-practices-associated-with-swaps-high-yield-loans/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-optionsxpress-inc.-thomas-e.-stern-and-jonathan-i.-feldman/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/assessing-the-finances-of-the-city-of-vernon-california/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/lake-cherokee-hard-drive-technologies-llc-v.-marvell-semiconductor-inc/2020-06-01T15:36:25+00:00weekly0.7http://qxclear.com/Insights/cases/in-re--tft-lcd-flat-panel-antitrust-litigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-the-matter-of-certain-products-having-laminated-packaging-laminated-packaging-and-components-thereof/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/universal-electronics-inc.-v.-universal-remote-control-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/quantifying-energy-savings-and-emission-reductions-under-the-section-111d-carbon-pollution-standard/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/fraley-et-al.-v.-facebook-inc.-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-the-matter-of-certain-integrated-circuit-chips-and-products-containing-the-same-inv.-no.-337-ta-859/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/apple-v.-samsung-injunction-ruling-july-2014/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/apple-v.-samsung-trial-may-2014/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/apple-v.-samsung-trial-may-2014--professor-judith-chevalier/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/apple-v.-samsung-trial-may-2014--professor-tulin-erdem/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/apple-v.-samsung-trial-may-2014--professor-george-foster/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/apple-v.-samsung-trial-may-2014--professor-david-reibstein/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/simpleair-v.-google-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/united-states-of-america-v.-robert-j.-gagalis-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/veleron-holding-bv-v.-bnp-paribas-sa-et-al/2020-10-16T16:05:25+00:00weekly0.7http://qxclear.com/Insights/cases/alfa-gomma-s.p.a.-v.-veyance-technologies-inc/2020-03-09T13:41:18+00:00weekly0.7http://qxclear.com/Insights/cases/j.c.-van-apeldoorn-and-e.t.-meijer-in-their-capacity-as-trustees-in-bankruptcy-for-kpnqwest-n.v.-et-al.-v.-qwest-communications-international-inc.-qwest-et-al/2020-11-09T16:48:32+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-dole-food-company-inc.-stockholder-litigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/lightbourne-v.-cbs-interactive-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/in-the-matter-of--certain-footwear-products-investigation-number-337-ta-936/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/c5-medical-werks-llc-v.-ceramtec-gmbh/2020-07-07T12:46:32+00:00weekly0.7http://qxclear.com/Insights/cases/united-states-of-america-v.-energysolutions-inc.-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/american-tradition-institute-and-rod-lueck-v.-epel-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/state-of-north-carolina-ex-rel.-roy-cooper-attorney-general-v.-tennessee-valley-authority/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/e.-and--j.-gallo-winery-v.-encana-energy-services-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/united-states-v.-mark-david-radley-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/mount-olympus-mortgage-company-v.-anderson-et-al/2021-01-06T18:37:30+00:00weekly0.7http://qxclear.com/Insights/cases/noven-pharmaceuticals-inc.-v.-actavis-laboratories-ut-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/morgantown-ol1-llc-et-al.-v.-genon-mid-atlantic-llc-et-al/2020-11-09T16:50:31+00:00weekly0.7http://qxclear.com/Insights/cases/cotromano-et-al.-v.-united-technologies-corp.-et-al.-and-adinolfe-et-al.-v.-united-technologies-corp/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/huff-fund-investment-partnership-v.-ckx-inc/2020-10-16T16:07:21+00:00weekly0.7http://qxclear.com/Insights/cases/david-t.-stevenson-et-al.-v.-delaware-department-of-natural-resources-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/application-of-california-american-water-company-for-authorization-to-modify-conservation-and-rationing-rules-rate-design-and-other-related-issues-for-the-monterey-district/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/federal-trade-commission-et-al.-v.-penn-state-hershey-medical-center-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/maxell-ltd.-v.-zte-usa-inc/2020-02-18T20:27:20+00:00weekly0.7http://qxclear.com/Insights/cases/ftc-v.-wilhelm-wilhelmsen-et-al/2020-08-06T19:50:37+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/jack-chen/2020-11-11T17:10:20+00:00weekly0.7http://qxclear.com/Insights/publishing/effect-of-risankizumab-on-patient-reported-outcomes-in-moderate-to-severe-psoriasis-the-ultimma-1-and-ultimma-2-randomized-clinical-trials/2021-01-12T14:03:49+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-teams-study-comparing-patient-reported-outcomes-of-psoriasis-therapies-provides-data-critical-to-successful-regulatory-submissions/2021-01-12T14:04:08+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-study-provides-patient-reported-outcomes-in-support-of--labeling-claims-for-plaque-psoriasis-treatment-risankizumab/2021-01-12T14:03:16+00:00weekly0.7http://qxclear.com/careers/why-analysis-group/pro-bono/2021-01-14T15:38:29+00:00weekly0.7http://qxclear.com/news-and-events/news/senior-advisor-susan-tierney-and-principal-paul-hibbard-assess-how-a-federally-supported-clean-energy-accelerator-could-address-economic-and-climate-crises/2021-01-14T16:03:47+00:00weekly0.7http://qxclear.com/Insights/publishing/accelerating-job-growth-and-an-equitable-low-carbon-energy-transition-the-role-of-the-clean-energy-accelerator/2021-01-14T16:04:32+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/t.-jeffrey-wilks/2021-01-14T19:02:31+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-platinum-sponsor-of-nysba-antitrust-sections-annual-meeting/2021-01-14T19:11:29+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/eileen-a.-kamerick/2021-01-15T17:56:45+00:00weekly0.7http://qxclear.com/news-and-events/events/vice-president-marissa-ginn-and-associate-johanna-posch-to-present-at-oecds-workshop-on-gender-inclusive-competition-policy/2021-01-15T19:41:28+00:00weekly0.7http://qxclear.com/news-and-events/news/financial-forensics-newsletter-republishes-analysis-group-interview-with-trademark-litigation-expert-joel-steckel/2020-12-17T15:28:19+00:00weekly0.7http://qxclear.com/Insights/publishing/covid-19-and-bottom-line-impacts-in-trademark-litigation/2021-01-05T16:17:23+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-impact-of-stimulus-investment-in-advanced-energy--florida/2020-12-17T19:19:25+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-impact-of-stimulus-investment-in-advanced-energy--arizona/2020-12-17T19:24:52+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-impact-of-stimulus-investment-in-advanced-energy--pennsylvania/2020-12-17T19:31:13+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-impact-of-stimulus-investment-in-advanced-energy--nevada/2020-12-17T19:34:00+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-impact-of-stimulus-investment-in-advanced-energy--illinois/2020-12-17T19:54:03+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-impact-of-stimulus-investment-in-advanced-energy--colorado/2020-12-17T20:10:02+00:00weekly0.7http://qxclear.com/Insights/publishing/trends-in-health-service-use-and-potentially-avoidable-hospitalizations-before-alzheimers-disease-diagnosis-a-matched-retrospective-study-of-us-medicare-beneficiaries/2020-12-17T21:32:17+00:00weekly0.7http://qxclear.com/Insights/publishing/estimated-prevalence-and-incidence-of-dry-eye-disease-based-on-coding-analysis-of-a-large-all-age-united-states-health-care-system/2020-12-17T21:45:31+00:00weekly0.7http://qxclear.com/Insights/publishing/survival-motor-function-and-motor-milestones-comparison-of-avxs-101-relative-to-nusinersen-for-the-treatment-of-infants-with-spinal-muscular-atrophy-type-1/2020-12-17T22:06:12+00:00weekly0.7http://qxclear.com/Insights/cases/post-discharge-outcomes-among-hyperkalemic-patients-treated-with-and-without-sodium-polystyrene-sulfonate-in-the-inpatient-setting/2020-12-21T16:43:36+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-team-studies-post-discharge-impact-on-hyperkalemia-patients-administered-sodium-polystyrene-sulfonate-as-inpatients/2020-12-21T16:48:25+00:00weekly0.7http://qxclear.com/Insights/publishing/assessment-of-the-real-world-safety-profile-of-vedolizumab-using-the-united-states-food-and-drug-administration-adverse-event-reporting-system/2020-12-21T21:33:43+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-and-deep-molecular-response-in-chronic-phase---chronic-myeloid-leukemia-patients-treated-with-second-line-nilotinib-or-dasatinib-a-multi-country-retrospective-chart-review-study/2020-12-21T21:46:22+00:00weekly0.7http://qxclear.com/Insights/publishing/association-between-biochemical-control-and-comorbidities-in-patients-with-acromegaly-an-italian-longitudinal-retrospective-chart-review-study/2020-12-21T21:59:44+00:00weekly0.7http://qxclear.com/Insights/publishing/institutionalization-risk-and-costs-associated-with-agitation-in-alzheimers-disease/2020-12-21T22:10:41+00:00weekly0.7http://qxclear.com/Insights/publishing/matching-adjusted-indirect-comparison-of-health-related-quality-of-life-and-adverse-events-of-apalutamide-versus-enzalutamide-in-non-metastatic-castration-resistant-prostate-cancer/2020-12-21T22:25:51+00:00weekly0.7http://qxclear.com/Insights/publishing/determinants-of-meningococcal-acwy-vaccination-in-adolescents-in-the-us-completion-and-compliance-with-the-cdc-recommendations/2020-12-22T16:10:10+00:00weekly0.7http://qxclear.com/Insights/publishing/beyond-multidrug-resistance-leveraging-rare-variants-with-machine-and-statistical-learning-models-in-mycobacterium-tuberculosis-resistance-prediction/2020-12-22T16:16:10+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-teduglutide-on-quality-of-life-among-patients-with-short-bowel-syndrome-and-intestinal-failure/2020-12-22T16:43:46+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-impact-of-glycated-hemoglobin-reduction-on-treatment-intensification-and-glycated-hemoglobin-goal-attainment-in-type-2-diabetes-mellitus-patients/2020-12-22T17:00:44+00:00weekly0.7http://qxclear.com/Insights/publishing/dry-eye-disease-ranking-among-common-reasons-for-seeking-eye-care-in-a-large-us-claims-database/2020-12-22T18:29:05+00:00weekly0.7http://qxclear.com/Insights/publishing/medication-adherence-and-persistence-in-chronic-obstructive-pulmonary-disease-patients-receiving-triple-therapy-in-a-usa-commercially-insured-population/2020-12-22T18:42:28+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-and-overall-survival-among-patients-with-unresectable-stage-iii-non-small-cell-lung-cancer/2020-12-22T19:31:12+00:00weekly0.7http://qxclear.com/Insights/publishing/calcipotriol-plus-betamethasone-dipropionate-aerosol-foam-vs.-apremilast-methotrexate-acitretin-or-fumaric-acid-esters-for-the-treatment-of-plaque-psoriasis-a-matching-adjusted-indirect-comparison/2020-12-22T19:37:27+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-and-clinical-benefits-of-early-identification-of-acute-kidney-injury-using-a-urinary-biomarker/2020-12-22T19:47:38+00:00weekly0.7http://qxclear.com/Insights/publishing/long-term-benefits-of-rapid-antiretroviral-therapy-initiation-in-reducing-medical-and-overall-health-care-costs-among-medicaid-covered-patients-with-human-immunodeficiency-virus/2020-12-22T20:56:17+00:00weekly0.7http://qxclear.com/careers/why-analysis-group/diversity--inclusion/2021-01-15T21:45:23+00:00weekly0.7http://qxclear.com/Insights/publishing/rapid-initiation-of-antiretroviral-therapy-following-diagnosis-of-human-immunodeficiency-virus-among-patients-with-commercial-insurance-coverage2/2020-12-23T21:41:17+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-effectiveness-of-pembrolizumab-for-the-adjuvant-treatment-of-resected-high-risk-stage-iii-melanoma-in-the-united-states/2020-12-23T21:56:08+00:00weekly0.7http://qxclear.com/Insights/publishing/matching-adjusted-indirect-comparisons-of-annualized-bleeding-rate-and-utilization-of-bay-94-9027-versus-three-recombinant-factor-viii-agents-for-prophylaxis-in-patients-with-severe-hemophilia-a/2020-12-23T22:24:58+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-impact-of-stimulus-investment-in-advanced-energy--texas/2020-12-24T00:03:03+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-impact-of-stimulus-investment-in-advanced-energy--michigan/2020-12-24T00:21:12+00:00weekly0.7http://qxclear.com/Insights/publishing/association-of-antipsychotic-treatment-switching-in-patients-with-schizophrenia-bipolar-and-major-depressive-disorders/2020-12-28T20:05:02+00:00weekly0.7http://qxclear.com/Insights/publishing/medication-adherence-in-patients-with-asthma-using-once-daily-versus-twice-daily-icslabas/2020-12-28T20:15:10+00:00weekly0.7http://qxclear.com/Insights/publishing/characterizing-real-world-use-of-tiotropium-in-asthma-in-the-usa/2020-12-28T21:18:45+00:00weekly0.7http://qxclear.com/Insights/publishing/dupilumab-versus-cyclosporine-for-the-treatment-of-moderate-to-severe-atopic-dermatitis-in-adults-indirect-comparison-using-the-eczema-area-and-severity-index/2020-12-28T21:28:39+00:00weekly0.7http://qxclear.com/Insights/publishing/a-budget-impact-analysis-of-the-introduction-of-copanlisib-for-treatment-of-relapsed-follicular-lymphoma-in-the-united-states/2020-12-28T21:38:10+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-impact-of-stimulus-investment-in-advanced-energy2/2020-12-29T16:49:03+00:00weekly0.7http://qxclear.com/Insights/publishing/disease-severity-and-minimal-clinically-important-differences-in-clinical-outcome-assessments-for-alzheimers-disease-clinical-trials/2020-12-29T19:23:00+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-of-non-infectious-inflammatory-eye-disease-niied-in-a-commercially-insured-population-in-the-united-states/2020-12-29T19:42:55+00:00weekly0.7http://qxclear.com/Insights/publishing/comorbidities-and-survival-in-patients-with-lipodystrophy-an-international-chart-review-study/2020-12-30T21:50:32+00:00weekly0.7http://qxclear.com/Insights/publishing/racial-disparities-in-treatment-patterns-and-outcomes-among-patients-with-multiple-myeloma-a-seer-medicare-analysis/2020-12-30T22:02:49+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-offsets-in-the-treatment-journeys-of-patients-with-relapsedrefractory-multiple-myeloma/2020-12-30T22:18:51+00:00weekly0.7http://qxclear.com/Insights/publishing/indirect-costs-associated-with-premature-mortality-among-those-with-veno-occlusive-diseasesinusoidal-obstruction-syndrome-with-multiorgan-dysfunction-post-hematopoietic-stem-cell-transplant/2020-12-30T22:33:01+00:00weekly0.7http://qxclear.com/Insights/publishing/adverse-medical-conditions-across-treatment-options-in-patients-with-psoriasis-a-claims-based-analysis/2020-12-31T18:03:43+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-again-recognized-among-the-leading-global-economics-consultancies-by-global-competition-review2/2021-01-05T20:13:47+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-again-recognized-among-the-leading-global-economics-consultancies-by-global-competition-review2/2021-01-05T20:07:40+00:00weekly0.7http://qxclear.com/Insights/publishing/apportioning-value-in-patent-portfolio-license-and-sale-agreements/2021-01-06T14:45:57+00:00weekly0.7http://qxclear.com/news-and-events/news/framework-for-patent-valuation-apportionment-in-infringement-cases-proposed-by-analysis-group-consultants/2021-01-06T14:45:26+00:00weekly0.7http://qxclear.com/news-and-events/news/professor-david-grabowski-of-harvard-medical-school-and-analysis-group-vice-president-brian-ellman-discuss-covid-19-litigation-involving-elder-care-facilities/2021-01-06T16:39:21+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/amitabh-chandra/2021-01-07T19:45:25+00:00weekly0.7http://qxclear.com/Insights/ag-feature/deal-metrics/2020-03-02T17:50:09+00:00weekly0.7http://qxclear.com/Insights/ag-feature/health-care-bulletin/2020-03-02T17:50:23+00:00weekly0.7http://qxclear.com/Insights/ag-feature/energy-and-environment/2020-03-02T17:50:29+00:00weekly0.7http://qxclear.com/careers/why-analysis-group/career-path/2020-08-07T18:10:26+00:00weekly0.7http://qxclear.com/Insights/ag-feature/when-specialized-expertise-is-required/2020-03-02T17:51:35+00:00weekly0.7http://qxclear.com/Insights/ag-feature/internal/2020-03-02T17:50:57+00:00weekly0.7http://qxclear.com/Insights/videos/susan-tierney---opportunities-and-solutions-in-the-global-energy-market/2018-11-16T16:13:14+00:00weekly0.7http://qxclear.com/Insights/videos/sarah-cullinan---why-analysis-group/2018-11-16T16:12:56+00:00weekly0.7http://qxclear.com/Insights/videos/pro-bono-work-at-analysis-group/2018-11-16T16:12:31+00:00weekly0.7http://qxclear.com/Insights/videos/pierre-cremieux---how-we-work/2018-11-16T16:03:01+00:00weekly0.7http://qxclear.com/Insights/videos/paul-greenberg---pharmaceutical-off-label-promotion/2018-11-16T16:02:35+00:00weekly0.7http://qxclear.com/Insights/videos/noam-kirson---why-analysis-group/2018-11-16T16:01:58+00:00weekly0.7http://qxclear.com/Insights/videos/martha-samuelson--yale-school-of-management-leaders-forum-values/2018-11-16T15:59:13+00:00weekly0.7http://qxclear.com/Insights/videos/martha-samuelson---yale-school-of-management-leaders-forum-developing-talent/2018-11-16T15:55:05+00:00weekly0.7http://qxclear.com/Insights/videos/martha-samuelson---yale-school-of-management-leaders-forum-culture/2018-11-16T15:54:37+00:00weekly0.7http://qxclear.com/Insights/videos/martha-samuelson---our-culture-of-collaboration/2018-11-16T15:54:07+00:00weekly0.7http://qxclear.com/Insights/videos/liz-milsark---why-analysis-group/2018-11-16T15:53:21+00:00weekly0.7http://qxclear.com/Insights/videos/john-jarosz---delivering-expert-testimony-on-intellectual-property-valuation/2018-11-16T15:52:27+00:00weekly0.7http://qxclear.com/Insights/videos/jill-linberg---why-analysis-group/2018-11-16T15:50:53+00:00weekly0.7http://qxclear.com/Insights/videos/eric-davis---why-analysis-group/2018-11-16T15:48:53+00:00weekly0.7http://qxclear.com/Insights/videos/edward-snyder--pierre-cremieux---the-macro--and-microcommonality-tests/2018-11-16T15:48:23+00:00weekly0.7http://qxclear.com/Insights/videos/edward-snyder---do-common-issues-predominate/2018-11-16T15:47:35+00:00weekly0.7http://qxclear.com/Insights/videos/carla-mulhern---patent-litigation-before-the-international-trade-commission-itc/2018-11-16T15:47:01+00:00weekly0.7http://qxclear.com/Insights/videos/bruce-strombom---market-conflicts-leading-to-subprime-mortgage-litigation/2018-11-16T15:46:42+00:00weekly0.7http://qxclear.com/Insights/videos/bruce-deal---the-intersection-of-economic-analysis-and-public-policy/2018-11-16T15:46:30+00:00weekly0.7http://qxclear.com/Insights/videos/brian-gorin---an-innovative-approach-to-strategy/2018-11-16T15:16:27+00:00weekly0.7http://qxclear.com/Insights/ag-feature/settlement-in-microsoft-iowa-litigation/2020-03-02T17:51:17+00:00weekly0.7http://qxclear.com/Insights/ag-feature/infrastructure/2020-03-02T17:50:41+00:00weekly0.7http://qxclear.com/Insights/ag-feature/news/2018-10-05T20:23:06+00:00weekly0.7http://qxclear.com/Insights/ag-feature/q-and-a/2020-03-02T17:51:07+00:00weekly0.7http://qxclear.com/forums-and-bulletins/health-care-bulletins/health-care-bulletin-fall-2013/2020-02-06T21:30:27+00:00weekly0.7http://qxclear.com/forums-and-bulletins/forums/analysis-group-forum-fall-2014/2020-02-06T21:29:26+00:00weekly0.7http://qxclear.com/forums-and-bulletins/health-care-bulletins/health-care-bulletin-winter-2018/2020-02-06T21:30:33+00:00weekly0.7http://qxclear.com/forums-and-bulletins/health-care-bulletins/health-care-bulletin-fall-2016/2019-03-28T18:04:48+00:00weekly0.7http://qxclear.com/forums-and-bulletins/health-care-bulletins/health-care-bulletin-winterspring-2012/2018-11-09T23:10:01+00:00weekly0.7http://qxclear.com/forums-and-bulletins/health-care-bulletins/health-care-bulletin-fall-2015/2018-11-01T14:21:41+00:00weekly0.7http://qxclear.com/forums-and-bulletins/forums/analysis-group-forum-spring-2017/2019-07-03T15:51:29+00:00weekly0.7http://qxclear.com/forums-and-bulletins/forums/energy-infrastructure/2018-11-06T14:34:12+00:00weekly0.7http://qxclear.com/careers/what-we-do/meet-the-alliance-team/2020-08-07T18:09:21+00:00weekly0.7http://qxclear.com/careers/what-we-do/meet-the-lcd-team/2020-12-21T19:36:27+00:00weekly0.7http://qxclear.com/forums-and-bulletins/forums/analysis-group-forum-2015-year-in-review/2019-12-13T19:32:32+00:00weekly0.7http://qxclear.com/forums-and-bulletins/forums/forum-winter-2013/2019-12-13T19:50:20+00:00weekly0.7http://qxclear.com/forums-and-bulletins/forums/analysis-group-forum-summer-2013/2018-11-01T14:15:36+00:00weekly0.7http://qxclear.com/forums-and-bulletins/forums/analysis-group-forum-fallwinter-2013/2018-11-09T23:08:02+00:00weekly0.7http://qxclear.com/forums-and-bulletins/health-care-bulletins/health-care-bulletin-fall-2014/2020-02-06T21:30:30+00:00weekly0.7http://qxclear.com/careers/join-us/how-to-apply-analyst/2020-12-21T19:48:52+00:00weekly0.7http://qxclear.com/careers/join-us/how-to-apply-associate/2020-12-21T19:49:03+00:00weekly0.7http://qxclear.com/Insights/ag-feature/a-diverse-health-care-practice-videos/2019-06-17T19:57:34+00:00weekly0.7http://qxclear.com/careers/what-we-do/pro-bono/2020-12-21T19:38:14+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/jacques-cremer/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/practices/data-science-and--statistical-modeling/data-visualization-real-time-analyses-and--interactive-platforms/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/data-science-and--statistical-modeling/econometric-modeling/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/data-science-and--statistical-modeling/machine-learning/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/data-science-and--statistical-modeling/natural-language-processing/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/data-science-and--statistical-modeling/predictive-analytics-and--optimization/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/practices/data-science-and--statistical-modeling/statistical-sampling/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/tulin-erdem/2020-04-01T13:02:46+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/nina-maar/2020-03-16T16:49:59+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/david-s.-abrams/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/anthony-t.-losasso/2020-02-21T14:46:55+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/annie-guerin/2020-11-06T18:11:30+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/marie-helene-lafeuille/2020-02-06T23:00:29+00:00weekly0.7http://qxclear.com/Insights/publishing/economics--overview/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/exclusionary-practices--the-economics-of-monopolisation-and-abuse-of-dominance/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economics-of-biosimilar-drugs-and-new-considerations-in-intellectual-property-and-antitrust-litigation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/resource-adequacy-and-wholesale-market-structure-for-a-future-low-carbon-power-system-in-california/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comments-on-certification-of-new-interstate-natural-gas-pipeline-facilities/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/how-natural-experiments-can-help-in-estimating-damages/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/online-and-offline-retail-distribution--introduction/2020-05-01T14:06:15+00:00weekly0.7http://qxclear.com/Insights/publishing/the-assessment-of-mergers-in-online-and-offline-retail-sales--are-new-tools-needed-for-the-economists-toolbox-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/competitive-assessment-of-digital-comparison-platforms--in-search-of-consensus/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/systematic-bailout-guarantees-and-tacit-coordination/2020-10-26T19:27:07+00:00weekly0.7http://qxclear.com/Insights/publishing/excessive-pricing--towards-clarity-and-economic-coherence/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/stand-alone-private-antitrust-damages--how-should-competition-authorities-react-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/cryptocurrencies-demystified-and-the-secs-regulatory-stance/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-rise-of-biosimilars-and-the-future-of-healthcare-intellectual-property/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/cases/in-re--appraisal-of-solera-holdings-inc/2020-10-16T16:12:50+00:00weekly0.7http://qxclear.com/Insights/cases/collins-et-al.-v.-city-of-milwaukee-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/marfin-investment-group-holdings-s.a.-alexandros-bakatselos-and-others-v.-republic-of-cyprus/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/predicting-the-essentiality-of-standard-essential-patents/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/supporting-a-national-coverage-determination-request-for-an-innovative-cancer-treatment/2020-07-02T13:54:45+00:00weekly0.7http://qxclear.com/Insights/cases/retrospective-study-of-medication-adherence-among-adults-with-metastatic-colorectal-cancer/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-lauren-kindler-to-discuss-the-latest-updates-on-patent-infringement-litigation/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-peter-rybolt-to-discuss-trademark-infringement-litigation/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-researchers-to-present-at-icpe-2018/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-emily-cotton-to-discuss-economic-assistance-at-various-stages-of-hart-scott-rodino/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--managing-principal-john-jarosz-to-discuss-tcl-v.-ericsson-frand-decision/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--managing-principal-john-jarosz-to-discuss-daubert-motion-and-patent-challenges/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--managing-principal-jeff-kinrich-to-discuss-expert-witness-testimony-on-damages-in-ip-litigation/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--managing-principal-alan-white-to-participate-in-panel-discussion-on-transfer-pricing/2020-10-26T19:35:48+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-sponsors-2018-competition-law-fall-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-niall-macmenamin-to-discuss-lost-profits-damages-calculations/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-sponsors-neca-s-2018-fuels-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-lauren-hunt-to-participate-in-panel-discussion-of-securities-fraud/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/ispor-asia-pacific-2018/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/ceo-and-chairman-martha-samuelson-to-participate-in-panel-discussion-at-gcr-live-merger-control-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/vice-president-brian-ellman-to-participate-in-panel-on-responding-to-data-breaches/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar-managing-principal-richard-mortimer-to-participate-in-panel-discussion-on-biosimilars/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-provides-support-in-blocked-marine-company-merger/2020-08-06T19:49:34+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-announces-recent-promotions-and-welcomes-a-new-consultant-and-affiliates/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/delaware-chancery-court-cites-analysis-group-academic-affiliate-r.-glenn-hubbards-valuation-figure-in-solera-merger-appraisal-ruling/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/online-advertising-article-authored-by-academic-affiliates-anja-lambrecht-and-catherine-tucker-receives-prestigious-american-marketing-association-odell-award/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/city-of-milwaukee-settles-stop-and-frisk-lawsuit-in-which-analysis-group-collaborated-with-the-aclu/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/overview-of-pharmaceutical-market-definition-and-pricing-in-the-eu-provided-by-analysis-group-experts-in-emea-review/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-health-care-consultants-present-at-pharmacoepidemiology-and-drug-safety-conference--2018/2020-03-25T21:43:25+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-team-publishes-article-on-new-economic-considerations-for-biosimilar-drug-intellectual-property-and-antitrust-litigation/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/key-issues-for-californias-cap-and-trade-system-analyzed-by-analysis-group-consultants/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/white-paper-on-the-future-of-californias-power-system-released-by-analysis-group-senior-advisor/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-expert-comments-on-natural-gas-pipeline-policy-to-federal-energy-regulatory-commission/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-client-republic-of-cyprus-secures-favorable-ruling-in-international-arbitration/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/aba-appoints-vice-president-mihran-yenikomshian-as-big-data-committee-co-chair/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/article-on-gene-therapy-cites-study-coauthored-by-analysis-group-consultants/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-consultants-publish-articles-on-competition-in-online-and-offline-retail/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-health-care-consultant-presents-at-ispor-asia-pacific-2018/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/issues-pertinent-to-cryptocurrency-regulation-explored-in-article-by-analysis-group-consultants/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-collaborates-on-retrospective-study-of-medication-adherence-among-adults-with-metastatic-colorectal-cancer/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-announces-recent-promotions-and-welcomes-a-new-consultant-and-affiliates/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-works-with-aclu-in-stop-and-frisk-litigation-against-the-city-of-milwaukee/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/Insights/publishing/causation-and-the-role-of-the-damages-expert/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/aba-publishes-article-by-analysis-group-vice-president-peter-rybolt-on-the-role-of-the-damages-expert/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/article-by-analysis-group-consultants-explores-class-certification-in-pharmaceutical-antitrust-cases/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/the-state-of-pharma-class-certification-after-asacol/2020-10-16T15:18:23+00:00weekly0.7http://qxclear.com/Insights/ag-feature/catherine-tucker-event-summary/2018-12-20T21:46:14+00:00weekly0.7http://qxclear.com/Insights/publishing/political-advertising-and-election-results/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--new-landscape-in-ip-damages-discussed-by-vice-president-andrew-clarke/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/Insights/publishing/collective-exclusion/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/collective-exclusion-explored-in-new-paper-by-analysis-group-vice-president-claudio-calcagno/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/assessing-the-effect-of-mergers-on-labor-markets/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/effects-of-mergers-on-labor-markets-detailed-in-article-by-analysis-group-consultants/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/health-care-cost-impact-of-continued-anticoagulation-with-rivaroxaban-vs-aspirin-for-prevention-of-recurrent-symptomatic-vte-in-the-einstein-choice-trial-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/costs-of-anticoagulation-drug-rivaroxaban-compared-with-aspirin-in-study-supported-by-analysis-group-team/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/new-approach-to-qalyfying-the-value-of-a-treatment-coauthored-by-analysis-group-experts/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/assessing-utility-values-for-treatment-related-health-states-of-acute-myeloid-leukemia-in-the-united-states/2020-10-16T16:33:11+00:00weekly0.7http://qxclear.com/news-and-events/news/risk-of-stroke-in-the-absence-of-atrial-fibrillation-studied-by-research-team-including-analysis-group-health-care-experts/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/risk-of-ischemic-stroke-in-patients-newly-diagnosed-with-heart-failure-focus-on-patients-without-atrial-fibrillation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-client-prevails-in-market-manipulation-lawsuit/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/us-commodity-futures-trading-commission-v.-donald-r.-wilson-and-drw-investments-llc/2020-10-16T15:58:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-consultants-join-panels-at-the-new-york-state-bar-association-antitrust-law-section-meeting/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/Insights/publishing/effectiveness-and-safety-of-anticoagulants-for-the-treatment-of-venous-thromboembolism-in-patients-with-cancer2/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-recognized-as-a-leading-global-economics-consultancy-by-global-competition-review/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-recognized-as-a-leading-global-economics-consultancy-by-global-competition-review/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/six-analysis-group-articles-nominated-for-the-2019-concurrences-antitrust-writing-awards/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/economics-of-online-competition-explored-by-analysis-group-in-new-guide-published-by-global-competition-review/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/european-union--two-sided-markets-platforms-and-network-effects/2020-05-01T14:07:33+00:00weekly0.7http://qxclear.com/Insights/publishing/united-states--e-commerce-economics-market-power-and-enforcement-in-vertical-markets/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/cases/kenneth-woo-v.-phillip-roman--company-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/christopher-llop/2020-11-25T16:21:20+00:00weekly0.7http://qxclear.com/news-and-events/news/icann-releases-final-report-by-analysis-group-in-the-independent-review-of-the-security-and-stability-advisory-committee/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-sponsors-energy-bar-association-western-chapter-annual-meeting/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-to-sponsor-intellectual-property-institute/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/news/bankruptcy-research-reviewed-in-law360-by-analysis-group-experts/2020-11-09T17:18:02+00:00weekly0.7http://qxclear.com/Insights/publishing/3-aspects-of-value-preservation-for-restructuring-cos/2020-11-09T16:57:53+00:00weekly0.7http://qxclear.com/news-and-events/news/ada-highlights-analysis-group-research-on-strategies-for-overcoming-psychological-insulin-resistance-in-type-2-diabetes-patients/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/identifying-solutions-to-psychological-insulin-resistance-an-international-study/2021-01-07T18:58:28+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/marc-zenner/2020-11-09T14:48:40+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-anita-chawla-to-participate-in-diagnostic-coverage--reimbursement-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/Insights/publishing/characteristics-of-patients-with-psoriatic-arthritis-receiving-secukinumab-and-reasons-for-initiation-a-us-retrospective-medical-chart-review/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/factors-associated-with-more-frequent-diagnostic-tests-and-procedures-in-patients-with-irritable-bowel-syndrome/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-treatment-patterns-and-clinical-outcomes-in-advanced-gastrointestinal-neuroendocrine-tumors-gi-net-a-multicenter-retrospective-chart-review-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/characterization-of-patients-with-ankylosing-spondylitis-receiving-secukinumab-and-reasons-for-initiating-treatment-a-us-physician-survey-and-retrospective-medical-chart-review/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/clinical-burden-of-asynchrony-in-patients-with-asthma-when-using-metered-dose-inhalers-for-control/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-outcomes-post-transition-to-once-every-3-months-paliperidone-palmitate-in-patients-with-schizophrenia-within-us-commercial-plans/2020-03-24T13:47:10+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-and-clinical-outcomes-in-advanced-lung-neuroendocrine-tumors-in-real-world-settings-a-multicenter-retrospective-chart-review-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/observational-study-of-characteristics-and-clinical-outcomes-of-dutch-patients-with-tuberous-sclerosis-complex-and-renal-angiomyolipoma-treated-with-everolimus/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-among-adults-with-adhd-receiving-long-acting-therapy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/study-on-employment-and-gdp-effects-of-investment-in-new-spectrum-for-5g-wireless-networks-published-by-analysis-group-research-team/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/concomitant-use-of-psychotropic-medication-with-stimulants-for-the-treatment-of-adhd-in-children-and-adolescents-a-retrospective-insurance-claims-study-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/development-of-predictive-risk-models-for-major-adverse-cardiovascular-events-among-patients-with-type-2-diabetes-mellitus-using-health-insurance-claims-data/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/incidence-of-catheter-related-complications-among-japanese-patients-with-central-venous-catheters-as-well-as-patients-with-short-bowel-syndrome/2020-11-09T15:21:42+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/robert-w.-platt/2020-06-08T20:12:07+00:00weekly0.7http://qxclear.com/Insights/ag-feature/a-closer-look-at-appraisal-outcomes/2019-10-01T18:49:32+00:00weekly0.7http://qxclear.com/Insights/publishing/causation-and-harm-in-data-breach-litigation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/legaltech-news-highlights-analysis-group-article-proposing-new-framework-for-evaluating-causation-and-harm-in-data-breach-litigation/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/health-care-burden-and-treatment-patterns-in-commercially-insured-children-with-chronic-idiopathicspontaneous-urticaria-a-real-world-study-in-the-united-states2/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/removal-of-ineligible-outcome-cases-reduces-confounding/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-economic-outcomes-during-time-on-treatment-among-patients-who-initiated-sunitinib-or-pazopanib-as-first-targeted-therapy-for-advanced-renal-cell-carcinoma-a-retrospective-analysis-of-medicare-claims-data/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/retrospective-cohort-study-comparing-the-risk-of-severe-hepatotoxicity-in-hospitalized-patients-treated-with-echinocandins-for-invasive-candidiasis-in-the-presence-of-confounding-by-indication/2020-03-25T21:34:00+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-hidradenitis-suppurativa-on-work-loss-indirect-costs-and-income/2020-10-06T20:53:29+00:00weekly0.7http://qxclear.com/Insights/publishing/postsurgical-treatment-landscape-and-economic-burden-of-locoregional-and-distant-recurrence-in-patients-with-operable-nonmetastatic-melanoma/2020-03-20T21:34:37+00:00weekly0.7http://qxclear.com/Insights/publishing/stage-iii-melanoma-incidence-and-impact-of-transitioning-to-the-8th-ajcc-staging-system-a-us-population-based-study/2020-03-20T21:29:43+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-effectiveness-of-midostaurin-in-the-treatment-of-newly-diagnosed-flt3-mutated-acute-myeloid-leukemia-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/epilepsy-treatment-patterns-among-patients-with-tuberous-sclerosis-complex/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/efficacy-of-antiepileptic-drugs-in-the-adjunctive-treatment-of-refractory-partial-onset-seizures-meta-analysis-of-pivotal-trials/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/budget-impact-analysis-of-comprehensive-genomic-profiling-in-patients-with-advanced-non-small-cell-lung-cancer/2020-02-21T16:02:33+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-noam-kirson-joins-panel-on-industry-adoption-of-digital-solutions-to-improve-product-development/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/andrzej-andy-skrzypacz/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/publishing/burden-of-infections-among-chronic-myeloid-leukemia-patients-receiving-dasatinib-or-nilotinib/2020-05-21T16:07:33+00:00weekly0.7http://qxclear.com/Insights/publishing/number-needed-to-treat-analysis-of-clinical-progression-in-patients-with-metastatic-castration-resistant-prostate-cancer-in-the-strive-and-terrain-trials/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-duration-healthcare-resource-utilization-and-costs-among-chemotherapy-naive-patients/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-burden-of-non-infectious-intraocular-inflammatory-eye-diseases-a-systematic-literature-review/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-abuse-of-prescription-opioids/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-psoriasis-with-high-comorbidity-among-privately-insured-patients-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/short-term-rehospitalizations-in-young-adults-with-schizophrenia-treated-with-once-monthly-paliperidone-palmitate-or-oral-atypical-antipsychotics-a-retrospective-analysis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-treatment-patterns-among-patients-with-colorectal-cancer-treated-with-trifluridinetipiracil-and-regorafenib/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/burden-of-disease-associated-with-a-copd-eosinophilic-phenotype/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/effects-of-systemic-corticosteroids-on-blood-eosinophil-counts-in-asthma-real-world-data/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/ftc-hearings-on-antitrust-issues-in-labor-markets-detailed-in-article-by-analysis-group-consultants/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/antitrust-in-labor-markets-insights-from-the-ftc-hearings-on-competition-and-consumer-protection-in-the-21st-century/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/nori-mehta/2020-12-17T21:32:17+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/ben-samuels/2020-02-06T23:00:53+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-outcomes-in-patients-with-metastatic-castration-resistant-prostate-cancer/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-humanistic-burden-of-postpartum-depression-a-systematic-literature-review/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/adherence-to-rivaroxaban-versus-apixaban-among-patients-with-non-valvular-atrial-fibrillation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-long-term-direct-and-indirect-economic-burden-among-parkinsons-disease-caregivers-in-the-united-states/2020-11-09T15:14:37+00:00weekly0.7http://qxclear.com/Insights/publishing/health-characteristics-of-patients-with-asthma-copd-and-asthma-copd-overlap-in-the-nhanes-database/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparative-efficacy-of-treatments-for-previously-treated-advanced-or-metastatic-non-small-cell-lung-cancer/2020-09-25T18:20:09+00:00weekly0.7http://qxclear.com/Insights/publishing/is-time-to-progression-associated-with-post-progression-survival-in-previously-treated-metastatic-non-small-cell-lung-cancer-with-braf-v600e-mutation/2020-09-25T18:21:21+00:00weekly0.7http://qxclear.com/Insights/publishing/comparative-efficacy-of-first-line-ceritinib-and-crizotinib-in-advanced-or-metastatic-anaplastic-lymphoma-kinase-positive-non-small-cell-lung-cancer/2020-09-25T18:24:21+00:00weekly0.7http://qxclear.com/Insights/publishing/cms-hospital-readmission-reduction-program-and-anticoagulants-received-following-a-total-hip-and-knee-arthroplasty-discharge/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-comorbidity-burden-of-hidradenitis-suppurativa-in-the-united-states-/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comparative-effectiveness-of-nab-paclitaxel-plus-gemcitabine-vs-folfirinox-in-metastatic-pancreatic-cancer/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/economic-burden-of-depression-treatment-for-medicaid-beneficiaries-detailed-in-article-coauthored-by-analysis-group-consultants/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/medicaid-spending-burden-among-beneficiaries-with-treatment-resistant-depression/2021-01-07T16:57:33+00:00weekly0.7http://qxclear.com/news-and-events/news/economic-models-of-workplace-discrimination-outlined-in-analysis-group-article-on-law360/2020-04-21T21:53:44+00:00weekly0.7http://qxclear.com/Insights/publishing/how-workplace-disparities-may-arise-an-economic-outline/2020-04-21T21:52:20+00:00weekly0.7http://qxclear.com/Insights/publishing/the-risk-of-recurrent-vte-and-major-bleeding-in-a-commercially-insured-population-of-cancer-patients-treated-with-anticoagulation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/changes-health-related-quality-of-life-long-term-eltrombopag-treatment-adults-persistentchronic-immune-thrombocytopenia/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/description-of-baseline-characteristics-of-pediatric-allergic-asthma-patients-including-those-initiated-on-omalizumab/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/predictors-and-clinical-outcomes-of-treatment-intensification-in-patients-with-type-2-diabetes-uncontrolled-on-basal-insulin-in-a-real-world-setting/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/genotype-and-lifetime-burden-of-disease-in-hypertrophic-cardiomyopathy-insights-from-the-sarcomeric-human-cardiomyopathy-registry-share/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/ben-landsberg/2020-02-06T23:00:53+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-experts-participate-in-transmission-and-clean-energy-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-carcinoid-syndrome-symptoms-and-long-term-use-of-somatostatin-analogs-on-quality-of-life-in-patients-with-carcinoid-syndrome/2020-03-25T21:35:40+00:00weekly0.7http://qxclear.com/Insights/publishing/monitoring-of-hematologic-cardiac-and-hepatic-function-in-post-menopausal-women-with-hrher2--metastatic-breast-cancer/2020-05-21T16:09:33+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-patterns-and-healthcare-resource-utilization-in-patients-with-flt3-mutated-and-wild-type-acute-myeloid-leukemia/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/short-term-costs-associated-with-non-medical-switching-in-autoimmune-conditions/2020-11-09T15:15:11+00:00weekly0.7http://qxclear.com/Insights/publishing/healthcare-resource-utilization-in-patients-with-metastatic-melanoma/2020-03-20T21:32:10+00:00weekly0.7http://qxclear.com/Insights/publishing/patterns-of-treatment-and-braf-testing-with-immune-checkpoint-inhibitors-and-targeted-therapy/2020-03-20T21:33:37+00:00weekly0.7http://qxclear.com/Insights/publishing/economics-of-excessive-pricing-an-application-to-the-pharmaceutical-industry/2020-05-01T14:10:50+00:00weekly0.7http://qxclear.com/news-and-events/news/potential-hazards-of-competition-policy-enforcement-in-european-pharmaceutical-market-outlined-in-article-by-analysis-group-consultants/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-groups-sue-tierney-to-testify-on-climate-change-and-the-electric-industry-before-senate-committee/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/news-and-events/events/principal-paul-hibbard-to-join-roundtable-on-electricity-wholesale-market-design/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/nicholas-van-niel/2020-02-06T23:00:53+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/alix-duhaime-ross/2020-07-28T20:35:42+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/esther-mills/2020-09-09T19:31:38+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-anita-chawla-to-join-panel-on-payment-and-reimbursement-at-personalized-medicine-summit/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/william-p.-rogerson/2020-03-09T15:48:48+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-announces-consultant-promotions-2018/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-collaborates-on-study-on-the-estimated-costs-of-using-comprehensive-genomic-profiling-in-anticancer-therapy/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/estimated-cost-of-anticancer-therapy-directed-by-comprehensive-genomic-profiling-in-a-single-center-study/2020-07-02T13:46:55+00:00weekly0.7http://qxclear.com/news-and-events/news/costs-and-effectiveness-of-overlapping-emissions-policies-evaluated-by-analysis-group-experts/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/ghg-cap-and-trade-implications-for-effective-and-efficient-climate-policy-in-oregon/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/erisa-health-care-litigation-related-to-deductibles-and-out-of-pocket-expenses/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/hospital-erisa-class-action-matter/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/practices/erisa/erisa-health-care-claims/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/Insights/cases/key-issues-facing-californias-ghg-cap-and-trade-system-for-20212030/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-announces-that-richard-levin-saul-pannell-have-joined-the-firms-board-of-directors/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-announces-that-richard-levin-saul-pannell-have-joined-the-firms-board-of-directors/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-announces-consultant-promotions---2018/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-laura-comstock-joins-panel-discussion-of-the-price-impact-rule-following-halliburton-ii/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--manager-kristof-zetenyi-to-participate-in-panel-discussion-of-statistical-sampling/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--ip-valuation-and-damages-discussed-by-managing-principal-justin-mclean/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-affiliates-contribute-to-ftc-hearings-on-competition-and-consumer-protection-in-the-21st-century/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/principal-paul-hibbard-evaluates-carbon-dioxide-benefits-resulting-from-altagas-acquisition-of-washington-gas-and-light/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/merger-of-altagas-ltd.-and-wgl-holdings-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/news-and-events/news/greenhouse-gas-emission-measures-prepared-for-wellesley-municipal-light-plant/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/wellesley-municipal-light-plant-greenhouse-gas-emission-reduction-study/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/news-and-events/news/canada-revenue-agency-prevails-in-tax-dispute-over-charitable-contributions/2020-10-26T19:31:49+00:00weekly0.7http://qxclear.com/Insights/cases/v.-ross-morrison-v.-her-majesty-the-queen/2020-10-26T20:26:01+00:00weekly0.7http://qxclear.com/news-and-events/news/managing-principal-james-signorovitch-wins-award-for-research-presentation-at-ispor-europe-2018/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-james-signorovitch-to-participate-in-ispor-boston-chapter-discussion-on-statistical-significance-testing/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/Insights/ag-feature/tirole-event-summary---english/2018-12-20T18:11:43+00:00weekly0.7http://qxclear.com/Insights/ag-feature/tirole-event-summary---french/2018-12-03T16:24:35+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/giuseppe-buglione/2020-02-06T23:00:53+00:00weekly0.7http://qxclear.com/news-and-events/news/pursuing-lost-sales-in-different-types-of-cases-discussed-by-analysis-group-experts-in-abas-landslide-digital-magazine/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/the-ability-to-achieve-lost-sales-as-a-consideration-in-damages-analyses-under-different-legal-frameworks/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/abas-business-law-today-runs-two-part-series-from-analysis-group-on-analyzing-cost-behavior-when-calculating-damages/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/analysis-of-cost-behavior-when-calculating-damages-part-1-understanding-costs-analysis-of-cost-behavior-when-calculating-damages-part-2-analyzing-avoided-costs/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/ashecon-profiles-manager-yao-lu-on-careers-in-health-economics-consulting/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-managing-principal-lisa-pinheiro-discusses-the-value-of-data-science/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/vice-president-jipan-xie-discusses-importance-of-evidence-based-on-surrogate-outcomes-for-drug-reimbursement-approval/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/senior-advisor-susan-f.-tierney-contributes-to-the-2018-update-of-the-epas-endangerment-finding-for-greenhouse-gases/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/viacom-international-inc.-v.-mga-entertainment-inc/2021-01-06T18:21:07+00:00weekly0.7http://qxclear.com/practices/antitrust-competition/classcollective-actions/2020-02-06T23:20:41+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/thomas-mcgahee/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/michael-melvin/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/noam-kirson/2020-12-29T19:23:00+00:00weekly0.7http://qxclear.com/experts-and-consultants/principals/jimmy-royer/2020-12-22T16:16:10+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/stephanie-lee/2020-02-06T23:01:40+00:00weekly0.7http://qxclear.com/Insights/cases/sanjiv-goel-md-inc.-v.-blue-shield-of-california/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/margie-daniel-et-al.-v.-ford-motor-company/2021-01-06T18:26:12+00:00weekly0.7http://qxclear.com/Insights/cases/paul-b.-butler-v.-porsche-cars-north-america-inc/2021-01-06T18:21:41+00:00weekly0.7http://qxclear.com/Insights/publishing/patent-damages-in-us-courts--overview-of-current-state-of-play/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/trademark-confusion-and-the-confusing-eveready-survey/2020-07-07T12:41:12+00:00weekly0.7http://qxclear.com/Insights/publishing/smart-contracts-and--their-potential-tax-implications/2020-10-26T19:27:52+00:00weekly0.7http://qxclear.com/Insights/publishing/the-poste-italiane-decision-by-the-italian-competition-authority--sorting-out-non-replicability/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--manager-shogo-hamasaki-to-discuss-patent-infringement-reasonable-royalty-damages/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-sponsors-annual-uscanada-energy-trade-and--technology-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-sponsors-annual-pantheon-dina-awards-ceremony-2018/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-sponsors-reception-at-28th-annual-golden-state-antitrust-unfair-competition-and-privacy-law-institute/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-sponsors-2018-neca-power-markets-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-kevin-gold-to-participate-in-panel-discussion-of-securities-class-actions/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-senior-consultants-to-present-at-erisa-litigation-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--managing-principal-carla-mulhern-discusses-itc-section-337-investigations/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-health-care-consultants-present-at-ispor-europe-2018/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/news/consultants-explore-analyses-used-in-mortgage-based-false-claims-act-matters-in-law360-article/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/ceo-martha-samuelson-coauthors-recap-most-favored-nation-workshop-in-aba-antitrust-newsletter/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/president-and-ceo-martha-samuelson-shares-leadership-insights-at-yale-leaders-forum/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/president-and-ceo-martha-samuelson-interviewed-on-the-firms-expertise-and-growth/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-honored-as-a-best-place-to-work-in-glassdoors-2015-national-survey/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-partners-discuss-firm-culture-and-leadership-at-mit-event/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/ip-experts-at-analysis-group-contribute-to-iam-yearbook-2019/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/resources-for-the-future-welcomes-analysis-group-senior-advisor-susan-tierney-as-new-board-chair/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/article-on-trademark-confusion-and-the-equally-confusing-use-of-eveready-surveys-coauthored-by-analysis-group-consultants/2020-07-07T12:43:41+00:00weekly0.7http://qxclear.com/news-and-events/news/potential-tax-implications-of-smart-contracts-discussed-in-new-article-by-analysis-group-consultants/2020-10-26T19:32:19+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-vice-president-claudio-calcagno-discusses-economic-considerations-in-the-poste-italiane-antitrust-matter/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-recognized-as-a-top-women-led-business-in-massachusetts-for-sixth-consecutive-year/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-health-care-consultants-present-at-2018-ispor-europe-conference/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-recognized-as-a-top-women-led-business-in--massachusetts-for-sixth-consecutive-year/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/Insights/videos/crystal-pike-and-kenneth-weinstein---using-data-in-suspicious-order-monitoring-of-opioids/2018-10-23T15:23:02+00:00weekly0.7http://qxclear.com/Insights/videos/eric-wu-and-min-yang---patient-reported-outcomes/2018-11-15T19:08:04+00:00weekly0.7http://qxclear.com/Insights/videos/lisa-pinheiro-and-jimmy-royer---using-machine-learning-in-economic-consulting/2018-10-31T15:53:38+00:00weekly0.7http://qxclear.com/Insights/videos/noam-kirson---balancing-drug-pricing-with-value/2018-11-29T16:48:15+00:00weekly0.7http://qxclear.com/Insights/videos/paul-greenberg---a-diverse-health-care-practice/2018-10-23T15:47:25+00:00weekly0.7http://qxclear.com/Insights/videos/richard-mortimer---the-competitive-landscape-for-biosimilars/2018-11-08T19:49:58+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/dominick-latremouille-viau/2020-11-24T22:30:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/annie-guerin/2020-12-31T18:03:43+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/andree-anne--fournier/2020-02-06T23:01:40+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/marie-helene-lafeuille/2020-12-30T22:18:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/francois-laliberte/2020-12-28T21:18:45+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--managing-principal-to-participate-in-panel-discussion-on-the-antitrust-implications-of-blockchain-technology/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/forums-and-bulletins/forums/analysis-group-forum-summer-2018/2018-11-20T20:01:09+00:00weekly0.7http://qxclear.com/Insights/publishing/up-or-down-the-price-effects-of-mergers-of-intermediaries/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/effects-of-intermediaries-in-merger-analysis-detailed-in-new-article-by-analysis-group-consultants/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/debbie-goldschmidt/2020-11-13T22:31:20+00:00weekly0.7http://qxclear.com/Insights/ag-feature/finding-true-north-in-recent-delaware-appraisal-cases-is-it-the-market-or-the-model/2019-06-21T18:15:26+00:00weekly0.7http://qxclear.com/news-and-events/news/study-of-california-nurse-staffing-law-provides-insights-for-similar-ballot-initiatives-writes-analysis-group-health-economist-emi-terasawa/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/question-1-a-cautionary-tale-from-california-guest-viewpoint/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/antiepileptic-drug-titration-and-related-health-care-resource-use-and-costs/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/the-prospective-economic-impact-of-once-monthly-paliperidone-palmitate-versus-oral-atypical-antipsychotics-in-medicaid-patients-with-schizophrenia/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-niall-macmenamin-to-discuss-lost-profits-damages-calculations-2019/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-use-of-omalizumab-in-patients-with-chronic-idiopathicspontaneous-urticaria-in-the-united-states/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/risk-factors-health-care-resource-utilization-and-costs-associated-with-nonadherence-to-antiretrovirals-in-medicaid-insured-patients-with-hiv/2020-03-24T13:10:32+00:00weekly0.7http://qxclear.com/Insights/publishing/elotuzumab-plus-lenalidomide-and-dexamethasone-in-relapsedrefractory-multiple-myeloma/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/time-to-treatment-intensification-after-monotherapy-failure-and-its-association-with-subsequent-glycemic-control-among-93515-patients-with-type-2-diabetes/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/health-care-resource-utilization-and-costs-associated-with-transitioning-to-3-month-paliperidone-palmitate/2020-03-25T21:37:23+00:00weekly0.7http://qxclear.com/Insights/publishing/reliability-of-coded-data-to-identify-earliest-indications-of-cognitive-decline-cognitive-evaluation-and-alzheimers-disease-diagnosis/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/comorbidities-and-prescribed-medications-in-patients-with-or-without-dry-eye-disease-a-population-based-study/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/forums-and-bulletins/health-care-bulletins/health-care-bulletin-winterspring-2019/2019-03-26T14:15:18+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-and-monitoring-patterns-among-premenopausal-women-with-hrher2--advanced-breast-cancer/2020-05-21T15:58:53+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-analysis-healthcare-costs-relative-risk-hyperprolactinemia-associated-antipsychotic-treatments-united-states/2020-05-21T16:10:24+00:00weekly0.7http://qxclear.com/Insights/publishing/identifying-subpopulation-higher-likelihoods-early-response-treatment-heterogeneous-rare-disease/2020-03-06T21:07:20+00:00weekly0.7http://qxclear.com/Insights/publishing/a-review-of-long-term-toxicity-of-antiretroviral-treatment-regimens-and-implications-for-an-aging-population/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/clinical-outcomes-of-prolonged-anticoagulation-with-rivaroxaban-after-unprovoked-venous-thromboembolism/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/retrospective-study-tolerability-effectiveness-adjunctive-antihypertensive-drugs-patients-inadequate-response-initial-treatment/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/progression-free-survival-with-endocrine-based-therapies-progression-non-steroidal-aromatase-inhibitor/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/rebecca-scott/2020-09-11T19:32:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/oscar-patterson-lomba/2020-12-04T20:44:25+00:00weekly0.7http://qxclear.com/news-and-events/news/rule-of-reason-approach-to-data-security-value-proposed-by-analysis-group-experts-in-aba-newsletter/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/how-much-is-data-security-worth/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/senior-advisor-susan-tierney-testifies-before-senate-energy-committee-on-climate-change-and-the-electricity-sector/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/testimony-supporting-new-connecticut-power-plant-filed-by-analysis-group-consultant/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/priyanka-bobbili/2020-12-22T19:31:12+00:00weekly0.7http://qxclear.com/news-and-events/news/new-article-coauthored-by-analysis-group-consultants-details-the-possibilities-and-consequences-of-applying-ai-to-health-care-data/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/combining-the-power-of-artificial-intelligence-with-the-richness-of-healthcare-claims-data-opportunities-and-challenges/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-affiliate-provides-testimony-in-house-judiciary-hearings-on-health-care-markets/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/principals/richard-a--mortimer/2020-09-25T20:55:35+00:00weekly0.7http://qxclear.com/news-and-events/news/recent-trends-in-cartel-fining-examined-in-article-by-analysis-group-experts/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/challenges-and-pitfalls-in-cartel-fining/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/advances-in-data-science-applications-presented-by-analysis-group-experts/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/keith-hylton/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/viviana-garcia-horton/2021-01-12T14:04:08+00:00weekly0.7http://qxclear.com/Insights/publishing/patient-and-oncologist-preferences-for-the-treatment-of-adults-with-advanced-soft-tissue-sarcoma/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/managing-principal-aaron-yeater-testifies-on-damages-claims-in-copyright-infringement-jury-trial/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/lovepop-inc.-vs.-paper-pop-cards-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-anjali-oza-to-discuss-the-use-of-survey-evidence-in-intellectual-property-litigation/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-welcomes-new-affiliates-and-announces-senior-level-promotions/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-welcomes-new-affiliates-and-announces-senior-level-promotions/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/william-m.-zoffer/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/videos/elliott-west---why-analysis-group/2019-03-25T14:50:27+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-principal-samuel-weglein-to-co-chair-gcr-live-4th-annual-cartels/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-authors-win-2019-antitrust-writing-award-for-economics/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-consultants-honored-with-2019-concurrences-antitrust-writing-award/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/granite-bridge-environmental-benefits-of-system-expansion/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/damages-estimate-provided-by-managing-principal-keith-r.-ugone-accepted-in-ip-patent-infringement-jury-trial/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/oil-dri-corporation-of-america-v.-nestle-purina-petcare-company/2020-06-01T15:33:44+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-affiliate-testifies-in-successful-utility-merger-in-south-carolina/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/south-carolina-electric--gas-company-preliminary-injunction-hearing-and-rate-proceeding/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/news-and-events/news/forbes-survey-ranks-analysis-group-as-a-top-firm-for-legal-and-litigation-consulting/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-principal-antoine-chapsal-at-gcr-live-8th-annual-telecoms-media--technology/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-vice-president-claudio-calcagno-to-speak-at-legal-businesss-corporate-and-ma-summit/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/Insights/cases/kt-engcore-corporation-v.-asi-corporation-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/experts-and-consultants/senior-advisors/howard-g--birnbaum/2020-12-07T21:03:53+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/hannah-bliss/2020-10-26T16:39:09+00:00weekly0.7http://qxclear.com/news-and-events/news/rushing-to-close-njs-nuclear-power-plants-could-be-a-costly-mistake-according-to-senior-advisor-susan-tierney/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/james-trautman/2020-03-10T13:52:15+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--managing-principal-michael-holland-to-join-panel-discussion-of-the-price-impact-rule-following-halliburton-ii/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/Insights/cases/us-senate-committee-hearing-to-examine-the-electricity-sector-in-a-changing-climate/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/samuel-weglein/2020-11-10T14:32:52+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/ted-davis/2020-02-06T23:01:08+00:00weekly0.7http://qxclear.com/experts-and-consultants/principals/todd-schatzki/2020-08-26T19:37:59+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/michael-kuehn/2020-02-06T23:01:40+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/anne-catherine-faye/2020-02-06T23:00:29+00:00weekly0.7http://qxclear.com/experts-and-consultants/french/martin-cloutier/2020-02-06T23:00:29+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/eli-bartov/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-consultants-publish-study-results-on-risk-of-recurrent-blood-clots-and-major-bleeding-among-younger-cancer-patients/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/the-risk-of-recurrent-vte-and-major-bleeding-in-a-commerciallyinsured-population-of-cancer-patients-treated-with-anticoagulation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-andrew-clarke-to-discuss-the-itc-landscape/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-sponsors-new-england-energy-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/jeff-bodington/2020-11-09T14:52:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/charlotte-wright/2020-10-28T13:46:17+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-impacts-of-reallocating-spectrum-to-5g/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/research-on-employment-and-gdp-effects-of-investment-in-new-spectrum-for-5g-wireless-networks-published-by-analysis-group-team/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-sponsors-2019-competition-law-spring-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-affiliate-catherine-tucker-examines-antitrust-concerns-with-online-advertising/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/online-advertising-and-antitrust-network-effects-switching-costs-and-data-as-an-essential-facility/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-affiliate-edward-rock-opines-on-use-of-reverse-termination-fees-in-delaware-chancery-court/2020-05-22T19:41:55+00:00weekly0.7http://qxclear.com/Insights/cases/vintage-rodeo-parent-llc-et-al.-v.-rent-a-center-inc/2020-05-22T19:38:21+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/devin-reilly/2020-02-06T23:00:53+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-sponsors-2019-canadian-economics-association-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/zhou-zhou/2020-12-30T22:02:49+00:00weekly0.7http://qxclear.com/Insights/publishing/scarcity-market-power-and-prices-at-slot-constrained-airports-evidence-from-mexico-city/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/impacts-of-airport-congestion-on-airfares-examined-in-paper-by-analysis-group-experts/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/philippe-thompson-leduc/2020-12-30T21:50:32+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/atang-gilika/2021-01-08T18:42:15+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-mark-gustafson-to-discuss-the-effective-use-of-statistical-evidence-in-class-action-litigation/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/catherine-gendron-saulnier/2020-07-28T20:35:42+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-ahmer-nabi-to-discuss-erisa-litigation/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-announces-recent-promotions-and-welcomes-new-consultant-and-affiliates/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-announces-recent-promotions-and-welcomes-new-consultant-and-affiliates/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-coauthored-research-into-clinical-inertia-in-diabetes-treatment-receiving-international-attention/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/authors-contribution-effect-of-delayed-treatment-intensification-on-glycemic-control-in-the-real-world/2021-01-07T18:57:53+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-health-care-consultants-present-at-ispor-2019/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/wei-gao/2020-12-23T22:24:58+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-client-wins-dismissal-in-international-arbitration-case/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/saab-et-al.-v.-the-republic-of-cyprus/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/irina-pivneva/2020-12-22T18:29:05+00:00weekly0.7http://qxclear.com/Insights/publishing/erisa-litigation-involving-target-date-funds/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/returning-back-to-school-an-update-on-university-retirement-plan-litigation/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-consultants-contribute-erisa-scholarship-to-aba-business-law-compilation/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--managing-principal-marc-van-audenrode-joins-dentons-partners-to-speak-on-long-arm-jurisdiction-in-eu-and-us/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-starz-stockholder-litigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/news-and-events/events/vice-president-na-dawson-joins-panel-on-the-competitive-effects-of-multisided-platforms/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/conference--vice-president-emmanuel-frot-to-speak-on-panel-entitled-competition-authorities-which-judicial-review/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-energy-consultants-participate-in-crri-regulation-and-competition-conference-2019/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/news/whos-who-legal-names-analysis-group-competition-economists-as-future-leaders-in-north-america/2020-10-27T13:20:21+00:00weekly0.7http://qxclear.com/Insights/videos/james-signorovitch---rare-diseases/2019-06-14T13:28:39+00:00weekly0.7http://qxclear.com/Insights/videos/patrick-lefebvre---the-value-of-real-world-evidence-in-drug-approval-and-marketing-processes/2019-06-14T13:42:59+00:00weekly0.7http://qxclear.com/Insights/videos/dave-nellesen---what-are-dossiers/2019-06-14T13:47:22+00:00weekly0.7http://qxclear.com/news-and-events/news/managing-principal-rebecca-kirk-fair-recognized-among-notable-women-competition-professionals/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/punam-anand-keller/2020-11-03T14:00:24+00:00weekly0.7http://qxclear.com/news-and-events/news/managing-principal-gaurav-jetley-and-coauthor-provide-new-insights-on-the-relationship-of-competition-and-profitability-in-merger-arbitrage/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/competition-scale-and-hedge-fund-performance-evidence-from-merger-arbitrage/2020-03-16T16:29:54+00:00weekly0.7http://qxclear.com/news-and-events/news/senior-advisor-susan-tierney-discusses-carbon-pricing-report-on-nyiso-podcast/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/joshua-wasser-et-al.-v.-all-market-inc/2020-06-01T15:18:16+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-sponsors-and-presents-at-annual-uscanada-energy-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-to-sponsor-and-present-at-new-england-energy-summit/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/dina-mayzlin/2020-03-16T16:52:20+00:00weekly0.7http://qxclear.com/Insights/cases/discovery-communications-inc.-acquisition-of-scripps-networks-interactive-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-recognized-as-a-top-women-led-business-in-massachusetts/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-recognized-as-a-top-women-led-business-in-massachusetts-for-seventh-consecutive-year/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/why-does-the-consumer-welfare-standard-work-matching-methods-to-markets/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-authors-explore-the-economic-rationale-for-the-consumer-welfare-standard-in-antitrust-and-merger-reviews/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-announces-partnership-to-enable-research-of-blood-disease-in-china/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-announces-collaboration-to-advance-hematology-research-in-china/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-academic-affiliates-contribute-to-2nd-annual-harvard-law-antitrust-conference/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/events/vice-president-divya-mathur-moderates-aba-panel-exploring-the-role-of-consumer-data-in-the-digital-economy/2020-07-22T21:15:48+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/antoinette-schoar/2020-10-02T21:17:00+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-principal-todd-schatzki-to-speak-on-eba-energizer-panel/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/Insights/publishing/fercs-certification-of-new-interstate-natural-gas-facilities-revising-the-1999-policy-statement-for-21st-century-conditions/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/senior-advisor-susan-tierney-responds-to-proposed-revision-of-fercs-1999-natural-gas-pipeline-policy-statement-with-independent-report/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-groups-maria-garibotti-joins-nysba-panel-on-exclusive-dealing/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/Insights/publishing/employed-for-higher-pay-how-medicare-payment-rules-affect-hospital-employment-of-physicians/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-research-traces-impact-of-medicare-rules-on-hospital-billings-and-physician-employment/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-again-ranked-a-top-place-to-work-by-the-boston-globe/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-appraisal-of-jarden-corp/2020-10-16T15:56:48+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-valuation-experts-testimony-noted-in-delaware-chancery-opinion/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-promotes-mark-gustafson-to-principal/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-promotes-mark-gustafson-to-principal/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-sponsors-a-conference-on-machine-learning-econometrics-at-the-36th-meeting-of-the-canadian-econometric-study-group/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/fuel-and-energy-security-in-new-york-state-an-assessment-of-winter-operational-risks-for-a-power-system-in-transition/2020-07-24T12:52:38+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-team-assesses-winter-fuel-and-energy-security-of-new-yorks-electric-grid-for-nyiso/2020-07-24T12:51:32+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-experts-testimony-helps-alibaba-secure-successful-settlement-of-ipo-related-securities-litigation/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-alibaba-group-holding-limited-securities-litigation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/matthew-gentzkow/2020-03-09T13:35:05+00:00weekly0.7http://qxclear.com/careers/what-we-do/meet-the-humira-team/2020-06-29T22:19:52+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-helps-client-win-summary-judgment-in-erisa-case/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/news-and-events/news/expropriation-risk-in-venezuelan-arbitration-awards-examined-by-analysis-group/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/the-venezuela-awards-dealing-with-expropriation-risk/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/data-pinpoints-expert-valuation-differences-in-del.-appraisals/2020-10-16T15:52:45+00:00weekly0.7http://qxclear.com/news-and-events/news/valuation-gap-in-delaware-appraisal-cases-analyzed-by-vice-president-michael-cliff/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-senior-consultants-to-present-at-erisa-litigation-conference-2019/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/Insights/publishing/categorising-trajectories-individual-item-changes-north-star-ambulatory-assessment/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/data-science-team-from-analysis-group-describes-real-world-disease-progression-for-duchenne-muscular-dystrophy/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-sponsors-2019-northeast-energy-and-commerce-association-neca-power-markets-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-health-care-consultants-present-at-ispor-europe-2019/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-health-care-consultants-present-at-ispor-europe-2019/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-sears-holdings-corporation-et-al.-chapter-11-bankruptcy-proceedings/2020-11-09T16:48:09+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-nine-west-holdings-inc.-et-al.-chapter-11-bankruptcy-proceedings/2020-11-09T16:47:49+00:00weekly0.7http://qxclear.com/news-and-events/news/managing-principal-rebecca-kirk-fair-speaks-about-empowering-female-coworkers-at-mit-sloan-global-womens-conference/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-gaurav-jetley-to-join-panel-discussion-of-fair-value/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/james-r.-hille/2020-03-09T13:34:43+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-helps-client-win-summary-judgment-in-erisa-case/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/scalia-v.-wpn-corp.-et-al/2021-01-05T21:56:57+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--manager-elizabeth-milsark-to-discuss-fcc-blocking-of-unwanted-robocalls/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-manager-publishes-study-on-impact-of-womens-health-clinic-closures-on-fertility/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/the-impact-of-womens-health-clinic-closures-on-fertility/2021-01-05T21:56:25+00:00weekly0.7http://qxclear.com/news-and-events/news/gao-report-on-drug-price-negotiations-assessed-by-analysis-group-experts/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/gao-report-illuminates-insurer-influence-on-drug-discounts/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/how-purchase-probability-scales-can-shed-light-on-consumer-purchase-intentions/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/article-on-the-use-of-purchase-probability-scales-to-predict-consumer-purchase-intentions-published-by-analysis-group-vice-president/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/ted-laguerre/2020-10-26T17:19:45+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/daria-z.-killebrew/2020-10-26T17:11:34+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/lucia-antras/2020-08-07T21:12:17+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-expert-helps-sec-obtain-settlement-in-securities-fraud-case/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/securities-and-exchange-commission-v.-john-t.-place-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/news-and-events/news/energy-experts-from-analysis-group-document-impacts-of-a-groundbreaking-proposal-for-carbon-pricing-in-new-york/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/clean-energy-in-new-york-state-the-role-and-economic-impacts-of-a-carbon-price-in-nyisos-wholesale-electricity-markets/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-sponsors-necas-2019-fuels-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/Insights/cases/alberta-electric-system-operator-proceedings-for-capacity-market-design-and-implementation/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-consultants-analyze-section-230-immunity-and-liability-for-sharing-economy-platforms-in-law360-article/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/evaluating-section-230-liability-in-the-sharing-economy/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/edward-b.-rock/2020-05-22T19:47:52+00:00weekly0.7http://qxclear.com/news-and-events/events/vice-president-eric-korman-joins-panel-on-market-power-analysis-and-transmission-availability/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-samuel-weglein-to-join-workshop-on-competition-in-labor-markets/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/murray-beach/2020-11-09T14:52:18+00:00weekly0.7http://qxclear.com/Insights/publishing/guiding-principles-in-setting-cartel-sanctions/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/cases/bayer-cropscience-ag-and-bayer-cropscience-nv-v.-dow-agrosciences-llc-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--principal-jimmy-royer-to-discuss-blockchains-and-smart-contracts/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/news/prof.-ray-ball-analysis-group-affiliate-awarded-2019-wharton-jacobs-levy-prize-for-quantitative-financial-innovation/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/events/principal-paul-hibbard-to-join-power-generation-panel-at-maine-natural-gas-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/careers/join-us/recruiting-events/2020-12-21T19:49:13+00:00weekly0.7http://qxclear.com/forums-and-bulletins/forums/analysis-group-forum-spring-2019/2019-07-05T12:57:45+00:00weekly0.7http://qxclear.com/Insights/ag-feature/evaluating-the-but-for-world-surveys-experiments-and-market-data/2019-12-20T18:52:45+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-peter-hess-to-discuss-class-action-and-complex-litigation/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/news/managing-principal-john-jarosz-submits-testimony-in-itc-enforcement-action/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/in-the-matter-of-certain-magnetic-data-storage-tapes-and-cartridges-containing-the-same-inv.-no.-337-ta-1012/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/jacob-e.-gersen/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-to-cosponsor-new-york-state-bar-association-annual-mergers-program/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-to-present-at-icpe-2019/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-health-care-consultants-present-at-pharmacoepidemiology-and-drug-safety-conference-2019/2020-03-25T21:41:37+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-repeats-as-one-of-vaults-best-consulting-firms-to-work-for-2019/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-expert-cited-in-court-opinion-denying-certification-in-consumer-class-action/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/toby-schechner-et-al.-v.-whirlpool-corporation/2020-06-01T13:50:06+00:00weekly0.7http://qxclear.com/news-and-events/events/mark-berberian-to-present-at-the-international-arbitration-workshop-and-conference-in-armenia/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-alumnus-appointed-head-of-prominent-israeli-bank/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/christopher-ody/2020-02-06T23:00:53+00:00weekly0.7http://qxclear.com/Insights/publishing/summary-of-the-federal-trade-commission-workshop/2021-01-05T22:23:26+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-team-publishes-summary-of-federal-trade-commission-workshop/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-pro-bono-team-supports-partners-in-health-study-of-health-care-reform-in-lesotho/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/cynthia-zhengyun-qi/2020-08-25T21:24:11+00:00weekly0.7http://qxclear.com/Insights/cases/panjing-dongxing-oil-well-measure-service-co.-ltd.-v.-petrochina-inc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/jonathan-reuter/2020-05-22T19:47:52+00:00weekly0.7http://qxclear.com/news-and-events/news/seven-analysis-group-consultants-named-as-top-expert-witnesses-in-the-iam-patent-1000/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-experts-examine-damages-models-in-hilsley-v.-ocean-spray-for-fdlis-top-food-and-drug-cases/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/hilsley-v.-ocean-spray-cranberries-inc/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/is-delaware-s-antitakeover-statute-unconstitutional--further-analysis-and-a-reply-to-symposium-participants/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/is-delaware-s-antitakeover-statute-unconstitutional--evidence-from-1988-2008/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/test/2019-07-02T15:33:41+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-vice-president-mark-gustafson-to-speak-at-class-action-conference-2019/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/news/effect-of-occupational-laws-on-health-care-competition-explored-by-analysis-group-consultants/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/occupational-license-laws-may-hurt-health-care-competition/2021-01-06T22:00:20+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-affiliate-submits-expert-report-in-sec-v.-elon-musk/2020-07-30T14:56:45+00:00weekly0.7http://qxclear.com/Insights/cases/us-securities-and-exchange-commission-vs.-elon-musk/2020-07-30T15:18:59+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--managing-principal-rebecca-kirk-fair-to-join-webinar-on-navigating-antitrust-laws/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/news/law360-interviews-analysis-groups-jeff-cohen-on-investment-arbitration-transparency/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-mark-gustafson-to-discuss-automotive-class-action-and-product-liability-litigation/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/Insights/cases/analysis-group-teams-pro-bono-analysis-of-towing-fees-and-their-economic-impact-on-the-poor/2020-02-27T19:03:14+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-teams-pro-bono-analysis-of-towing-fees-and-their-economic-impact-on-the-poor/2020-02-27T19:04:52+00:00weekly0.7http://qxclear.com/news-and-events/news/energy-center-supported-by-analysis-group-testimony-wins-approval/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/nte-connecticut-llc-application-for-a-certificate-of-environmental-compatibility-and-public-need/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/publishing/fuel-mix-and-greenhouse-gas-emissions-of-municipal-electric-light-plants-in-massachusetts/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/study-of-decarbonization-efforts-in-mass.-authored-by-analysis-group-consultants-shows-a-path-forward-for-other-states/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/news-and-events/news/study-of-decarbonization-efforts-in-mass.-authored-by-analysis-group-consultants-shows-a-path-forward-for-other-states/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-john-q.-hammons-fall-2006-llc/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/news-and-events/events/webinar--vice-president-jee-yeon-lehmann-to-participate-in-panel-discussion-of-no-poach-litigation/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/joseph-cavicchi/2020-11-24T16:05:56+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-welcomes-electricity-markets-economic-expert-joe-cavicchi-to-the-firm/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/use-of-economics-and-econometrics-in-britned-to-calculate-follow-on-damages-examined-by-analysis-group-experts/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/economics-overview-2019/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-welcomes-electricity-markets-economic-expert-joe-cavicchi-to-the-firm/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/Insights/videos/rebecca-kirk-fair-and-claudio-calcagno---platform-economics-and-vertical-restraints/2019-08-05T18:51:13+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/daniel-snow/2020-05-22T19:47:52+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/ihbdh-and-analysis-group-convene-scientific-advisory-board-for-niche-chinas-first-comprehensive-blood-disease-research-platform/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/gary-m.-lawrence/2020-02-06T22:57:19+00:00weekly0.7http://qxclear.com/Insights/ag-feature/new-amcp-format-for-formulary-submissions/2020-01-07T17:18:39+00:00weekly0.7http://qxclear.com/Insights/publishing/analyzing-country-risk-premium-in-icsid-awards/2020-03-09T13:51:22+00:00weekly0.7http://qxclear.com/news-and-events/news/transparency-in-international-arbitration-awards-analyzed-by-analysis-group-consultants/2020-03-06T16:16:22+00:00weekly0.7http://qxclear.com/news-and-events/events/principal-paul-hibbard-to-moderate-panel-and-present-at-euci-conference-on-natural-gas-decarbonization/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/news/version-4.1-of-amcp-format-for-formulary-submissions-updates-guidelines-for-communicating-information-on-new-products-and-uses-to-payers/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/mihir-desai/2020-10-26T16:01:02+00:00weekly0.7http://qxclear.com/news-and-events/events/teleconference--pharmaceutical-acquisitions-discussed-by-managing-principal-rebecca-kirk-fair/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/Insights/publishing/time-to-move-away-from-old-precedents-in-ferc-pipeline-reviews/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/senior-advisor-susan-tierney-publishes-op-ed-recommending-ferc-update-1999-gas-pipeline-policy-statement/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/vice-president-jee-yeon-lehmanns-coauthored-study-on-birth-order-is-the-journal-of-human-resources-most-read-article-for-2019/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-vice-president-joshua-white-to-join-panel-at-concurrences-international-mergers-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-rebecca-kirk-fair-to-join-antitrust-law-panel-discussion-at-nysba-annual-meeting/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/Insights/cases/analysis-group-team-joins-partners-in-health-for-pro-bono-data-analysis-in-lesotho/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/Insights/cases/u.s.-v.-boustani-et-al/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-vice-president-claudio-calcagno-to-join-panel-at-gcr-telecoms-media--technology-conference/2020-02-06T23:12:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-vice-president-divya-mathur-and-affiliate-anindya-ghose-to-join-aba-panel-on-antitrust-data-privacy-and-data-protection/2020-07-22T21:12:05+00:00weekly0.7http://qxclear.com/news-and-events/news/securities-fraud-jury-trial-ending-with-acquittal-features-testimony-from-analysis-group-expert/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/importance-of-firm-culture-mentoring-and-giving-back-underscored-by-analysis-group-ceo-martha-samuelson-for-mit-sloan-school-of-management/2020-03-12T17:46:43+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-again-recognized-among-the-leading-global-economics-consultancies-by-global-competition-review/2020-02-06T23:13:54+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-again-recognized-among-the-leading-global-economics-consultancies-by-global-competition-review/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/amazon-inc.--subsidiaries-v.-commissioner-of-internal-revenue/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/experts-and-consultants/managing-principals/sueyoung-min/2020-05-22T19:47:52+00:00weekly0.7http://qxclear.com/news-and-events/news/five-analysis-group-articles-nominated-for-the-2020-concurrences-antitrust-writing-awards/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-appraisal-of-panera-bread-company/2020-02-06T23:08:15+00:00weekly0.7http://qxclear.com/news-and-events/news/delaware-chancery-court-cites-analysis-group-affiliates-valuation-in-ruling-on-panera-acquisition/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-consultants-analyze-effect-of-appraisals-on-arbitrage-spread/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/Insights/publishing/appraisal-challenges-and-benefits-to-target-shareholders-through-narrowing-arbitrage-spread/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/forums-and-bulletins/health-care-bulletins/health-care-bulletin-winter-2019-2020/2020-05-11T14:54:29+00:00weekly0.7http://qxclear.com/Insights/publishing/the-development-of-health-technology-assessment-in-asia-current-status-and-future-trends/2020-02-06T23:15:12+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-team-coauthors-study-on-health-technology-assessment-in-asia/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-manager-christopher-ody-is-co-author-of-one-of-the-10-most-read-health-affairs-articles-of-2019/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/vice-presidents/douglas-frank/2020-06-05T12:46:59+00:00weekly0.7http://qxclear.com/Insights/publishing/temporal-and-geographic-variation-in-the-incidence-of-alzheimers-disease-diagnosis-in-the-us-between-2007-and-2014/2021-01-07T18:52:17+00:00weekly0.7http://qxclear.com/news-and-events/news/significant-regional-variation-in-alzheimers-disease-diagnosis-rates-observed-in-analysis-group-study/2020-02-06T23:10:51+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/w.-michael-hanemann/2020-05-22T19:47:52+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-to-sponsor-and-present-at-tpminds-americas-in-february/2020-10-26T19:35:11+00:00weekly0.7http://qxclear.com/Insights/publishing/direct-and-indirect-cost-of-obesity-among-the-privately-insured-in-the-united-states-a-focus-on-the-impact-by-type-of-industry/2020-02-18T18:51:40+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-team-coauthors-research-on-direct-and-indirect-cost-of-obesity-among-the-privately-insured-in-united-states/2020-02-18T18:50:49+00:00weekly0.7http://qxclear.com/news-and-events/events/principal-todd-schatzki-to-join-electric-utility-panel-at-eba-midwest-annual-meeting/2020-02-20T18:25:12+00:00weekly0.7http://qxclear.com/Insights/cases/sony-music-entertainment-et-al-v-cox-communications-inc-et-al/2021-01-07T14:49:49+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-experts-testify-in-music-labels-copyright-infringement-suit-against-a-file-sharing-platform/2020-02-26T18:15:36+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-consultants-to-join-panel-discussions-at-uic-john-marshall-law-schools-digital-platforms-event/2020-02-25T14:54:23+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-consultants-to-present-on-the-economics-of-open-source-technology-at-indian-competition-law-conference/2020-07-22T21:13:22+00:00weekly0.7http://qxclear.com/news-and-events/news/damages-framework-under-landmark-international-arbitration-ruling-outlined-by-analysis-group-consultants/2020-03-06T16:30:20+00:00weekly0.7http://qxclear.com/Insights/publishing/in-all-probability-an-economic-reading-of-damages-under-factory-at-chorzow/2020-10-13T17:11:08+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-receives-the-robert-g.-sproul-jr.-award-recognized-by-the-lawyers-committee-for-civil-rights-for-pro-bono-work/2020-02-27T14:42:02+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-consultants-to-host-panel-session-on-digital-platforms/2020-02-28T20:18:58+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-receives-the-robert-g.-sproul-jr.-award-from-lccr-for-pro-bono-work/2020-02-28T15:34:06+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/veronica-huan/2020-10-26T16:59:11+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-welcomes-new-affiliates-and-announces-senior-level-promotions2/2020-05-22T19:52:15+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-welcomes-new-affiliates-and-announces-senior-level-promotions2/2020-05-22T19:47:52+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/jing-zhao/2020-12-02T22:21:44+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-anita-chawla-to-present-at-the-business-of-personalized-medicine-summit-2020/2020-03-06T22:13:29+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/david-a.-glick/2020-03-10T17:39:13+00:00weekly0.7http://qxclear.com/news-and-events/events/vice-president-divya-mathur-to-moderate-aba-teleseminar-on-digital-platforms-and-competition-enforcement/2020-03-11T16:39:17+00:00weekly0.7http://qxclear.com/news-and-events/news/senior-advisor-susan-tierney-testifies-before-house-energy-subcommittee-on-modernizing-the-national-gas-act/2020-03-12T17:59:46+00:00weekly0.7http://qxclear.com/Insights/cases/ts-media-inc.-et-al.-v.-public-broadcasting-service/2020-03-12T20:56:36+00:00weekly0.7http://qxclear.com/news-and-events/news/pbs-wins-suit-against-former-host-tavis-smiley-with-support-from-analysis-group-marketing-expert/2020-03-12T21:00:17+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/micah-officer/2020-03-18T15:14:54+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/rebecca-burne/2020-12-03T21:18:42+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/bruno-emond/2020-12-23T21:41:17+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/jia-zhong/2020-08-31T17:34:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/rachel-bhak/2020-12-28T21:38:10+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/weiguang-xue/2020-03-27T21:14:35+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-senior-advisor-susan-tierney-to-discuss-fercs-natural-gas-pipeline-policies-in-payne-institute-webinar/2020-04-01T18:04:31+00:00weekly0.7http://qxclear.com/Insights/publishing/vertical-relationships-horizontal-effects-the-evolving-debate-on-vertical-labor-market-restraints/2020-05-18T16:28:18+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-team-publishes-research-on-the-debate-over-the-appropriate-treatment-of-vertical-labor-market-restraints/2020-05-18T16:36:53+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/stuart-madnick/2020-05-19T12:52:49+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/david-grabowski/2021-01-06T16:39:21+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/patrick-gagnon/2020-12-31T18:03:43+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-manager-michael-schreck-to-join-webcast-on-risk-management-in-the-food-and-beverage-industry/2020-05-21T15:17:00+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-launches-webinar-series-with-discussion-of-pharmaceutical-innovation-in-the-context-of-covid-19/2020-05-21T15:54:02+00:00weekly0.7http://qxclear.com/Insights/publishing/great-recession-holds-mortgage-crisis-lessons-for-today/2020-05-21T20:21:06+00:00weekly0.7http://qxclear.com/news-and-events/news/lessons-from-great-recession-could-inform-covid-19-mortgage-litigation-matters-according-to-analysis-group-team-in-law360/2020-05-21T20:30:10+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-senior-advisor-susan-tierney-to-join-virtual-panel-on-role-of-natural-gas-in-new-englands-electricity-sector/2020-05-26T14:22:41+00:00weekly0.7http://qxclear.com/Insights/publishing/energy-security-improvements-impact-assessment/2020-04-15T20:22:02+00:00weekly0.7http://qxclear.com/news-and-events/news/proposed-energy-market-rules-for-new-england-evaluated-by-analysis-group-consultants/2020-04-15T20:35:12+00:00weekly0.7http://qxclear.com/news-and-events/events/principal-jimmy-royer-to-discuss-maximizing-benefits-and-avoiding-pitfalls-of-blockchain-and-smart-contract-use-in-the-supply-chain/2020-05-05T12:06:04+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/kramer-holle/2020-10-26T16:56:22+00:00weekly0.7http://qxclear.com/news-and-events/news/npr-interviews-analysis-group-affiliate-anupam-b.-jena-on-the-less-obvious-consequences-of-covid-19/2020-04-21T13:33:06+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/keri-pearlson/2020-08-06T20:30:55+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/ishita-rajani/2020-04-21T21:57:09+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/senthuran-sen-raveendranathan/2020-11-09T16:31:00+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/joseph-maloney/2020-10-26T17:21:35+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/david-c.-chan-jr/2020-04-24T15:12:36+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/alex-fiore/2020-04-28T18:52:29+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/us-societal-economic-burden-of-an-inherited-kidney-disease-estimated-at-$710-billion/2020-04-30T13:32:58+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-article-estimates-the-us-societal-economic-burden-of-a-genetic-kidney-disease/2020-04-30T14:43:57+00:00weekly0.7http://qxclear.com/Insights/publishing/the-societal-economic-burden-of-autosomal-dominant-polycystic-kidney-disease-in-the-united-states/2020-10-16T16:42:17+00:00weekly0.7http://qxclear.com/Insights/publishing/implications-of-energy-ratings-for-residential-real-estate-markets2/2020-05-01T15:42:57+00:00weekly0.7http://qxclear.com/news-and-events/news/principal-todd-schatzki-coauthors-white-paper-evaluating-whether-household-energy-rating-disclosure-requirements-in-residential-property-listings-help-achieve-energy-efficiency-goals/2020-05-01T15:48:17+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-antoine-chapsal-joins-panel-to-discuss-implications-of-cmas-amazondeliveroo-merger-decision/2020-05-04T14:34:43+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/della-cummings/2020-10-26T16:51:45+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-managing-principal-noam-kirson-to-host-ispor-webinar-on-pricing-new-drugs-in-the-context-of-covid-19/2020-05-04T18:31:31+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/carlos-chiapa/2020-05-04T20:21:57+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/first-quantitative-assessment-of-treatments-for-non-muscle-invasive-bladder-cancer-after-bacillus-calmette-guerin-bcg-therapy-published-in-european-urology-oncology/2020-05-06T13:26:08+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-study-assesses-efficacy-and-safety-of-non-muscle-invasive-bladder-cancer-treatments/2020-05-06T13:28:35+00:00weekly0.7http://qxclear.com/Insights/publishing/evidence-based-assessment-of-current-and-emerging-bladder-sparing-therapies-for-non-muscle-invasive-bladder-cancer-after-bacillus-calmette-guerin-therapy-a-systematic-review-and-meta-analysis/2020-05-06T13:39:20+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/bertrand-meyer/2020-05-07T19:20:30+00:00weekly0.7http://qxclear.com/Insights/publishing/powering-through--and-beyond--the-crisis/2020-05-08T14:25:04+00:00weekly0.7http://qxclear.com/news-and-events/news/stimulus-spending-on-electricity-grid-may-help-economy-recover-according-to-senior-advisor-susan-tierney-in-utility-dive-op-ed/2020-05-08T14:30:15+00:00weekly0.7http://qxclear.com/Insights/cases/lincoln-electric-co.-et-al.-v.-harbor-freight-tools-usa-inc/2020-05-11T16:14:18+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-managing-principal-jeffrey-kinrich-to-discuss-implications-of-sargon-on-recent-cases/2020-05-08T19:05:39+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/nick-joseph-pudar/2020-05-12T18:56:54+00:00weekly0.7http://qxclear.com/Insights/cases/apple-inc.-v.-qualcomm-inc.-antitrust/2020-12-28T18:08:38+00:00weekly0.7http://qxclear.com/Insights/cases/qualcomm-inc.-v.-apple-inc.-patent-infringement/2020-05-18T18:53:09+00:00weekly0.7http://qxclear.com/Insights/cases/in-the-matter-of-certain-mobile-electronic-devices-and-radio-frequency-and-processing-components-thereof-inv.-no.-337-ta-1093/2020-05-13T20:19:10+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/merike-kaeo/2020-06-01T20:55:50+00:00weekly0.7http://qxclear.com/Insights/publishing/covid-19s-strain-on-hospitals-may-necessitate-more-relief/2020-06-05T12:51:17+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-team-assesses-the-financial-impact-of-covid-19-on-us-hospitals/2020-06-05T12:50:27+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/kerri-leonhardt/2020-11-09T16:30:20+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/angie-graves/2020-05-29T15:12:14+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-john-jarosz-and-vice-president-douglas-frank-to-discuss-impacts-of-the-coronavirus-pandemic-and-covid-19-on-intellectual-property-case-remedies/2020-06-05T12:46:59+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-managing-principal-dov-rothman-to-discuss-the-effect-of-the-pandemic-on-the-failing-firm-defense/2020-06-08T18:40:55+00:00weekly0.7http://qxclear.com/news-and-events/news/research-on-economic-benefits-of-clearing-spectrum-for-5g-networks-published-by-analysis-group/2020-06-02T16:39:30+00:00weekly0.7http://qxclear.com/Insights/publishing/5g-infrastructure-buildout-and-the-economic-impact-of-faster-clearing-of-c-band-spectrum-in-the-united-states/2020-07-01T13:12:54+00:00weekly0.7http://qxclear.com/forums-and-bulletins/forums/analysis-group-forum-2020/2020-10-21T16:23:07+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-launches-webinar-series-on-life-sciences-topics-with-discussion-of-pharmaceutical-innovation/2020-06-03T16:48:30+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-managing-principal-rebecca-kirk-fair-to-discuss-the-effects-of-the-pandemic-on-vertical-mergers/2020-06-09T20:11:09+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/alex-robinson/2020-06-10T19:44:36+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-team-re-examines-killer-acquisitions-in-the-digital-economy-in-competition-policy-international-article/2020-06-11T16:39:46+00:00weekly0.7http://qxclear.com/Insights/publishing/remember-stacker-another-look-at-killer-acquisitions-in-the-digital-economy/2020-07-15T19:56:30+00:00weekly0.7http://qxclear.com/news-and-events/news/eight-analysis-group-consultants-named-as-top-expert-witnesses-in-the-iam-patent-1000/2020-07-01T21:19:48+00:00weekly0.7http://qxclear.com/Insights/cases/snmp-research-international-et-al.-v.-nortel-networks-et-al/2021-01-07T14:49:23+00:00weekly0.7http://qxclear.com/Insights/publishing/valuing-firms-in-a-world-of-pandemic-induced-bankruptcies/2020-11-09T17:00:12+00:00weekly0.7http://qxclear.com/news-and-events/news/valuation-challenges-for-chapter-11-filers-impacted-by-the-coronavirus-pandemic-examined-by-affiliate-edward-morrison-and-analysis-group-consultants/2020-11-09T17:18:34+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/rozi-kepes/2020-06-26T16:40:37+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-supports-effort-to-understand-risks-associated-with--reopening-quebecs-economy/2020-07-09T19:42:53+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-supports-effort-to-assess-risks-from-novel-coronavirus-on-reopening-quebecs-economy/2020-06-30T12:38:26+00:00weekly0.7http://qxclear.com/Insights/publishing/qualified-renters-need-not-apply-race-and-voucher-discrimination-in-the-metro-boston-rental-housing-market/2020-09-04T15:41:00+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-teams-pro-bono-research-uncovers-high-levels-of-discrimination-against-black-and-low-income-renters-in-boston/2020-07-01T13:12:03+00:00weekly0.7http://qxclear.com/news-and-events/news/in-new-york-times-analysis-group-affiliate-anupam-b.-jena-explores-what-coronavirus-researchers-can-learn-from-economists/2020-07-01T19:44:58+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-hosts-webinar-with-mit-professor-andrew-lo-on-financing-covid-19-treatments/2020-07-06T19:26:06+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-sponsors-annual-new-york-state-bar-association-summer-merger-program/2020-07-06T20:32:03+00:00weekly0.7http://qxclear.com/news-and-events/events/vice-president-joseph-cavicchi-to-teach-course-on-fundamentals-of-capacity-markets/2020-07-08T13:50:27+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/phil-hall-partyka/2020-08-27T14:05:01+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/french/2020-07-09T19:43:05+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/masha-zhdanava/2020-08-18T15:29:16+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/matt-farber/2020-07-13T12:58:40+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/melissa-rutzen/2020-10-28T13:46:17+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/mark-deyong/2020-07-13T19:01:08+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/aaron-kelley/2020-06-17T13:18:39+00:00weekly0.7http://qxclear.com/Insights/publishing/carbon-pricing-for-new-england-context-key-factors-and-impacts/2020-06-24T20:10:54+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-assesses-potential-impacts-of-carbon-pricing-for-the-new-england-power-generators-association/2020-06-24T20:08:01+00:00weekly0.7http://qxclear.com/news-and-events/events/vice-president-mihran-yenikomshian-to-discuss-the-challenges-of-contact-tracing-on-aba-panel/2020-07-14T21:35:26+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/arun-sundararajan/2020-09-28T17:03:13+00:00weekly0.7http://qxclear.com/Insights/publishing/survey-says-tips-on-getting-over-the-daubert-hurdle/2020-08-05T13:12:04+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-team-provides-tips-on-surviving-daubert-challenges-to-survey-evidence-admissions-in-court/2020-08-05T13:04:04+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-maureen-chakraborty-to-join-panel-for-securities-litigation-workshop/2020-07-20T20:20:46+00:00weekly0.7http://qxclear.com/Insights/publishing/calif.-pay-for-delay-law-lacks-nuance/2020-10-16T15:11:05+00:00weekly0.7http://qxclear.com/news-and-events/news/vice-president-stephen-fink-and-affiliate-anupam-b.-jena-consider-implications-of-californias-reverse-payment-law-on-market-definition-in-pharmaceutical-antitrust-litigation/2020-07-22T18:02:57+00:00weekly0.7http://qxclear.com/Insights/publishing/suicidal-ideation-and-attempts-in-the-united-states-of-america-among-stimulant-treated-non-stimulant-treated-and-untreated-patients-with-a-diagnosis-of-attention-deficithyperactivity-disorder/2020-07-23T14:18:42+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/charles-wu/2020-10-29T17:50:29+00:00weekly0.7http://qxclear.com/news-and-events/events/affiliate-peter-golder-to-join-mccarthy-institute-discussion-of-supreme-courts-booking.com-decision/2020-07-27T21:49:50+00:00weekly0.7http://qxclear.com/news-and-events/news/mit-professor-andrew-lo-discusses-financing-a-covid-19-cure-in-symposium-webinar/2020-07-28T15:30:36+00:00weekly0.7http://qxclear.com/Insights/cases/alliance-des-professionnels-et-des-professionnelles-de-la-ville-de-quebec-et-al.-v.-la-procureure-generale-du-quebec/2020-07-28T20:28:43+00:00weekly0.7http://qxclear.com/news-and-events/news/managing-principal-marc-van-audenrode-testifies-in-successful-defense-of-quebec-pension-law/2020-07-28T20:35:42+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/christopher-f.-noe/2020-07-30T15:17:37+00:00weekly0.7http://qxclear.com/Insights/cases/william-r.-kruse-v.-synapse-wireless-inc/2020-07-30T14:48:33+00:00weekly0.7http://qxclear.com/news-and-events/news/chancery-court-cites-analysis-group-experts-valuation-in-delaware-appraisal-action/2020-07-30T14:47:38+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-the-application-of-transource-maryland-llc-for-a-certificate-of-public-convenience-and-necessity/2020-07-29T16:56:48+00:00weekly0.7http://qxclear.com/news-and-events/news/senior-advisor-susan-tierney-testifies-in-transource-marylands-transmission-line-application/2020-07-29T16:59:03+00:00weekly0.7http://qxclear.com/Insights/publishing/economics--overview-measurement-error-bias-in-overcharge-calculations-global-competition-review-europe-middle-east-and-africa-antitrust-review-2021-july-2020/2020-10-13T18:00:22+00:00weekly0.7http://qxclear.com/news-and-events/news/in-gcrs-emea-antitrust-review-2021-analysis-group-experts-explore-the-potential-effect-of-measurement-error-on-overcharge-estimates/2020-07-30T16:19:26+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/hadrien-vasdeboncoeur/2020-07-30T21:25:53+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-ranked-as-a-top-arbitration-expert-witness-firm-by-global-arbitration-review/2020-07-31T15:58:08+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-based-analysis-can-be-useful-in-calif.-contract-disputes/2021-01-06T18:20:32+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-team-outlines-cost-based-framework-for-developing-enforceable-liquidated-damages-provisions-in-california-contracts-in-law360-article/2020-08-21T13:08:50+00:00weekly0.7http://qxclear.com/Insights/publishing/utility-energy-efficiency-program-performance-from-a-climate-change-perspective-a-comparison-of-structural-and-behavioral-programs/2020-08-31T15:51:04+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-team-assesses-behavioral-energy-efficiency-programs-economic-performance-and-impact-on-climate-change/2020-08-31T15:52:26+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-assessment-of-clinical-outcomes-among-first-line-sunitinib-patients-with-clear-cell-metastatic-renal-cell-carcinoma-mrcc-by-the-international-mrcc-database-consortium-risk-group/2020-08-20T18:44:22+00:00weekly0.7http://qxclear.com/Insights/publishing/new-survey-methods-may-assess-tm-dilution-with-more-detail/2021-01-05T17:58:46+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-team-assesses-survey-methodologies-developed-to-determine-impacts-of-trademark-dilution-caused-by-blurring-in-article-for-law360/2020-09-03T20:22:10+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-analysis-of-hemophilia-patients-in-china-a-single-centers-experience/2020-08-19T19:48:25+00:00weekly0.7http://qxclear.com/Insights/publishing/adherence-to-heart-failure-management-medications-following-cardiac-resynchronization-therapy/2020-08-19T20:04:39+00:00weekly0.7http://qxclear.com/Insights/publishing/grading-and-management-of-cytokine-release-syndrome-in-patients-treated-with-tisagenlecleucel-in-the-juliet-trial/2020-09-25T18:16:52+00:00weekly0.7http://qxclear.com/Insights/publishing/accounting-for-the-coronavirus/2020-08-11T13:42:41+00:00weekly0.7http://qxclear.com/news-and-events/news/accountants-challenges-from-the-coronavirus-pandemic-explored-in-analysis-group-article/2020-08-11T13:45:49+00:00weekly0.7http://qxclear.com/news-and-events/news/senior-analysts-blog-about-analysis-groups-data-driven-pro-bono-work-with-social-innovation-forum/2020-08-12T13:36:44+00:00weekly0.7http://qxclear.com/Insights/publishing/expediting-ma-deal-processes-via-negotiations-vs.-auctions/2020-08-14T18:15:24+00:00weekly0.7http://qxclear.com/news-and-events/news/newly-compiled-dataset-provides-timely-insights-into-the-ma-deal-process-according-to-an-analysis-group-article-in-law360/2020-08-14T18:16:04+00:00weekly0.7http://qxclear.com/Insights/publishing/model-of-short--and-long-term-outcomes-of-emicizumab-prophylaxis-treatment-for-persons-with-hemophilia-a/2020-08-18T15:31:57+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-of-treatment-resistant-depression-in-privately-insured-u.s.-patients-with-physical-conditions/2020-08-18T15:33:33+00:00weekly0.7http://qxclear.com/Insights/publishing/innovation-competition-assessment-by-competition-authorities/2020-08-18T16:33:13+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-analyzes-competition-authorities-assessments-of-the-impact-of-mergers-on-innovation-competition/2020-08-18T16:55:56+00:00weekly0.7http://qxclear.com/Insights/publishing/a-review-of-two-regulatory-approved-anti-cd19-car-t-cell-therapies-in-diffuse-large-b-cell-lymphoma-why-are-indirect-treatment-comparisons-not-feasible/2020-09-25T18:15:12+00:00weekly0.7http://qxclear.com/Insights/publishing/estimation-of-total-costs-in-pediatric-and-young-adult-patients-with-relapsed-or-refractory-acute-lymphoblastic-leukemia-receiving-tisagenlecleucel-from-a-u.s.-hospitals-perspective/2020-08-18T18:15:03+00:00weekly0.7http://qxclear.com/Insights/publishing/estimation-of-total-costs-in-patients-with-relapsed-or-refractory-diffuse-large-b-cell-lymphoma-receiving-tisagenlecleucel-from-a-us-hospitals-perspective/2020-08-18T19:32:35+00:00weekly0.7http://qxclear.com/Insights/publishing/successful-health-care-provider-strategies-to-overcome-psychological-insulin-resistance-in-united-states-and-canada/2020-08-18T20:05:56+00:00weekly0.7http://qxclear.com/Insights/publishing/comparative-safety-and-efficacy-of-ozanimod-versus-fingolimod-for-relapsing-multiple-sclerosis/2020-08-18T20:17:47+00:00weekly0.7http://qxclear.com/Insights/cases/assessing-market-needs-to-evaluate-natural-gas-pipeline-development/2020-08-04T14:18:24+00:00weekly0.7http://qxclear.com/Insights/cases/assessing-the-environmental-impact-of-the-siting-of-a-natural-gas-power-plant/2020-08-07T15:44:44+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/philipp-tillmann/2020-08-06T19:50:37+00:00weekly0.7http://qxclear.com/news-and-events/events/vice-president-mihran-yenikomshian-to-discuss-strategies-for-data-breach-class-action-litigation-in-knowledge-group-webinar/2020-07-14T13:32:13+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-client-express-scripts-defeats-class-certification-in-major-case-regarding-epipen-costs/2020-09-11T16:36:59+00:00weekly0.7http://qxclear.com/Insights/cases/in-re-epipen-erisa-litigation/2020-09-11T19:32:51+00:00weekly0.7http://qxclear.com/news-and-events/events/vice-president-mihran-yenikomshian-to-join-aba-panel-on-contact-tracing-and-privacy/2020-09-14T21:31:39+00:00weekly0.7http://qxclear.com/news-and-events/events/principal-paul-hibbard-to-join-naruc-webinar-on-decarbonization/2020-09-15T12:49:41+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-of-illness-among-commercially-insured-patients-with-systemic-sclerosis-with-interstitial-lung-disease-in-the-usa-a-claims-data-analysis/2020-11-09T15:16:34+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-among-commercially-insured-patients-with-systemic-sclerosis-in-the-united-states/2020-11-09T15:22:27+00:00weekly0.7http://qxclear.com/Insights/publishing/modeling-the-potential-impact-of-abuse-deterrent-opioids-on-medical-resource-utilization/2020-09-15T18:37:08+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-outcomes-of-long-term-prednisone-and-deflazacort-use-in-patients-with-duchenne-muscular-dystrophy-experience-at-a-single-large-care-center/2020-09-02T17:36:06+00:00weekly0.7http://qxclear.com/Insights/publishing/costs-associated-with-renal-and-cardiovascular-events-among-patients-with-type-2-diabetes-mellitus-and-nephropathy-a-cost-model-based-on-the-credence-clinical-trial/2020-09-02T20:00:01+00:00weekly0.7http://qxclear.com/Insights/publishing/burden-of-crohns-disease-in-the-united-states-long-term-healthcare-and-work-loss-related-costs/2020-09-02T20:38:13+00:00weekly0.7http://qxclear.com/Insights/publishing/healthcare-resource-utilization-and-costs-associated-with-inflammatory-bowel-disease-among-patients-with-chronic-inflammatory-diseases-a-retrospective-cohort-study/2020-09-03T18:48:32+00:00weekly0.7http://qxclear.com/Insights/publishing/in-hospital-therapy-for-heart-failure-with-reduced-ejection-fraction-in-the-united-states/2020-09-03T15:21:47+00:00weekly0.7http://qxclear.com/Insights/publishing/prognostic-factors-for-changes-in-the-timed-4-stair-climb-in-patients-with-duchenne-muscular-dystrophy-and-implications-for-measuring-drug-efficacy-a-multi-institutional-collaboration/2020-09-03T15:47:19+00:00weekly0.7http://qxclear.com/Insights/publishing/suitability-of-external-controls-for-drug-evaluation-in-duchenne-muscular-dystrophy/2020-09-03T16:00:57+00:00weekly0.7http://qxclear.com/Insights/publishing/a-longitudinal-assessment-of-the-impact-of-endometriosis-on-patients-salary-growth-and-risk-of-leaving-the-workforce/2020-09-03T16:12:33+00:00weekly0.7http://qxclear.com/Insights/publishing/healthcare-resource-utilization-and-costs-associated-with-postpartum-depression-among-commercially-insured-households/2020-09-03T18:25:28+00:00weekly0.7http://qxclear.com/Insights/publishing/projecting-the-long-term-economic-impact-of-once-monthly-paliperidone-palmitate-versus-oral-atypical-antipsychotics-in-medicaid-patients-with-schizophrenia/2020-09-03T18:47:11+00:00weekly0.7http://qxclear.com/Insights/publishing/costs-and-treatment-patterns-among-patients-with-atopic-dermatitis-using-advanced-therapies-in-the-united-states-analysis-of-a-retrospective-claims-database/2020-09-03T19:34:18+00:00weekly0.7http://qxclear.com/news-and-events/events/senior-advisor-susan-tierney-to-speak-on-roundtable-at-ferc-carbon-pricing-conference/2020-09-25T19:57:44+00:00weekly0.7http://qxclear.com/Insights/publishing/cardiac-arrhythmia-detection-outcomes-among-patients-monitored-with-the-zio-patch-system-a-systematic-literature-review/2020-09-25T20:55:35+00:00weekly0.7http://qxclear.com/Insights/publishing/clinical-and-economic-burden-of-patients-with-chronic-hepatitis-c-with-versus-without-antiviral-treatment-in-japan-an-observational-cohort-study-using-hospital-claims-data/2020-11-09T15:17:25+00:00weekly0.7http://qxclear.com/Insights/publishing/an-investigation-into-the-durability-of-glycemic-control-in-patients-with-type-ii-diabetes-initiated-on-canagliflozin-or-sitagliptin-a-real-world-analysis-of-electronic-medical-records/2020-09-28T17:32:43+00:00weekly0.7http://qxclear.com/Insights/publishing/development-of-risk-models-for-major-adverse-chronic-renal-outcomes-among-patients-with-type-2-diabetes-mellitus-using-insurance-claims-a-retrospective-observational-study/2020-09-28T18:16:44+00:00weekly0.7http://qxclear.com/Insights/publishing/transparency-in-health-economic-modeling-options-issues-and-potential-solutions/2020-09-28T18:32:14+00:00weekly0.7http://qxclear.com/Insights/publishing/assessment-of-work-loss-associated-with-prescription-related-opioid-use-disorder-a-retrospective-analysis-of-claims-data/2020-09-28T19:26:13+00:00weekly0.7http://qxclear.com/news-and-events/news/economic-benefits-of-stimulus-spending-on-advanced-energy-technologies-in-california-assessed-by-analysis-group-experts/2020-09-29T13:04:08+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-impact-of-stimulus-investment-in-advanced-energy/2020-10-06T22:29:01+00:00weekly0.7http://qxclear.com/Insights/publishing/which-method-is-for-you-not-all-surveys-are-made-the-same/2020-10-01T15:14:42+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-consultants-provide-guidance-on-survey-methodology-selection/2020-09-21T20:15:35+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-hosts-webinar-with-harvard-medical-school-professor-anupam-jena-on-the-physician-economist/2020-09-22T20:09:09+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/corey-lang/2020-10-15T13:11:17+00:00weekly0.7http://qxclear.com/Insights/publishing/how-pharma-cos.-can-evaluate-alliance-agreements-validity/2020-09-23T19:59:16+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-authors-discuss-ways-to-evaluate-whether-pharma-companies-alliance-agreements-meet-courtroom-validity-standards-in-law360-article/2020-09-23T19:58:25+00:00weekly0.7http://qxclear.com/Insights/publishing/weighing-the-benefits-how-much-weight-will-your-survey-have-in-court/2020-08-24T20:22:47+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-consultants-offer-advice-on-designing-strong-and-reliable-surveys-for-use-in-litigation-settings/2020-08-24T20:29:57+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/nathaniel-good/2020-08-24T21:27:04+00:00weekly0.7http://qxclear.com/news-and-events/events/vice-president-minh-p.-doan-to-present-on-tying-damages-to-theory-of-liability-in-price-premium-class-action-litigation/2020-08-26T15:26:23+00:00weekly0.7http://qxclear.com/Insights/publishing/an-economic-evaluation-of-risankizumab-versus-other-biologic-treatments-of-moderate-to-severe-plaque-psoriasis-in-japan/2020-08-25T20:23:32+00:00weekly0.7http://qxclear.com/Insights/publishing/comparative-efficacy-of-jak-inhibitors-for-moderate-to-severe-rheumatoid-arthritis-a-network-meta-analysis/2020-08-25T21:24:51+00:00weekly0.7http://qxclear.com/news-and-events/news/qualcomm-prevails-in-federal-appeals-court-in-ftc-case-featuring-analysis-group-expert-testimony/2020-08-25T21:30:10+00:00weekly0.7http://qxclear.com/Insights/cases/federal-trade-commission-v.-qualcomm-inc/2020-08-25T21:37:19+00:00weekly0.7http://qxclear.com/Insights/publishing/achieving-western-states-greenhouse-gas-ghg-reduction-objectives--least-cost-compliance-in-a-constantly-evolving-policy-environment/2020-08-27T14:25:13+00:00weekly0.7http://qxclear.com/news-and-events/news/environmental-and-economic-criteria-for-reducing-ghg-emissions-analyzed-in-analysis-group-white-paper/2020-08-27T14:24:45+00:00weekly0.7http://qxclear.com/news-and-events/events/ceo-and-chairman-martha-samuelson-to-join-virtual-gcr-panel-on-mergers-in-the-us/2020-08-26T20:47:04+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-consultants-contribute-erisa-scholarship-to-aba-business-law-compilation2/2020-08-27T13:49:49+00:00weekly0.7http://qxclear.com/Insights/publishing/erisa-litigation-involving-health-and-welfare-plans/2020-10-01T15:37:20+00:00weekly0.7http://qxclear.com/Insights/publishing/back-to-school--three-years-later-an-update-on-university-retirement-plan-litigation/2020-10-01T15:36:45+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/michal-k.-popiel/2020-08-27T14:38:10+00:00weekly0.7http://qxclear.com/Insights/publishing/use-of-home-health-and-other-healthcare-delivery-pathways-among-privately-insured-patients-with-and-without-treatment-resistant-depression/2020-08-27T17:56:11+00:00weekly0.7http://qxclear.com/Insights/publishing/impact-of-simultaneous-versus-sequential-initiation-of-basal-insulin-and-glucagon-like-peptide-1-receptor-agonists-on-hba1c-in-type-2-diabetes-a-retrospective-observational-study/2020-08-27T17:55:01+00:00weekly0.7http://qxclear.com/Insights/publishing/burden-of-illness-among-patients-with-severe-aplastic-anemia-who-have-had-insufficient-response-to-immunosuppressive-therapy-a-multicenter-retrospective-chart-review-study/2020-08-27T18:15:22+00:00weekly0.7http://qxclear.com/Insights/publishing/prevalence-and-economic-burden-of-hyperkalemia-in-the-united-states-medicare-population/2020-08-31T17:34:12+00:00weekly0.7http://qxclear.com/Insights/cases/dolby-international-ab-ge-video-compression-llc-and-koninklijke-philips-nv-v.-mas-elektronik-aktiengesellschaft/2020-11-17T16:50:21+00:00weekly0.7http://qxclear.com/news-and-events/news/managing-principal-john-jarosz-provides-expert-testimony-on-behalf-of-licensors-in-hevc-advances-h.265-patent-pool-in-patent-infringement-and-frand-case/2020-11-17T16:51:07+00:00weekly0.7http://qxclear.com/Insights/publishing/antiproliferative-effects-of-telotristat-ethyl-in-patients-with-neuroendocrine-tumors-the-teleace-real-world-chart-review-study/2020-09-01T14:11:11+00:00weekly0.7http://qxclear.com/Insights/publishing/retrospective-analysis-of-comorbidities-and-treatment-burden-among-patients-with-hiv-infection-in-a-us-medicaid-population/2020-09-04T15:01:26+00:00weekly0.7http://qxclear.com/Insights/publishing/financing-drug-innovation-in-the-us-current-framework-and-emerging-challenges/2020-09-04T15:39:56+00:00weekly0.7http://qxclear.com/Insights/publishing/assessing-the-potential-cost-effectiveness-of-a-gene-therapy-for-the-treatment-of-hemophilia-a/2020-09-04T18:54:04+00:00weekly0.7http://qxclear.com/Insights/publishing/matching-adjusted-indirect-comparison-of-the-efficacy-of-apalutamide-and-enzalutamide-with-adt-in-the-treatment-of-non-metastatic-castration-resistant-prostate-cancer/2020-09-04T19:17:12+00:00weekly0.7http://qxclear.com/Insights/publishing/an-assessment-of-weight-change-associated-with-the-initiation-of-a-protease-or-integrase-strand-transfer-inhibitor-in-patients-with-human-immunodeficiency-virus/2020-09-04T20:20:48+00:00weekly0.7http://qxclear.com/Insights/publishing/egfr-mutation-testing-and-treatment-decisions-in-patients-progressing-on-first--or-second-generation-epidermal-growth-factor-receptor-tyrosine-kinase-inhibitors/2020-09-04T20:29:16+00:00weekly0.7http://qxclear.com/Insights/publishing/hospital-utilization-rates-following-antipsychotic-dose-reduction-in-mood-disorders-implications-for-treatment-of-tardive-dyskinesia/2020-09-04T20:57:16+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-supports-successful-orphan-drug-designation-by-the-fda-of-kiniksas-rilonacept-for-the-treatment-of-pericarditis/2020-09-09T15:37:58+00:00weekly0.7http://qxclear.com/Insights/cases/prevalence-of-pericarditis-for-orphan-drug-designation-application/2020-09-09T15:43:38+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-clinical-outcomes-of-pazopanib-immediately-after-discontinuation-of-immunotherapy-for-advanced-renal-cell-carcinoma/2020-09-09T20:28:53+00:00weekly0.7http://qxclear.com/Insights/publishing/predictors-of-chemoradiotherapy-versus-single-modality-therapy-and-overall-survival-among-patients-with-unresectable-stage-iii-non-small-cell-lung-cancer/2020-09-09T20:58:49+00:00weekly0.7http://qxclear.com/Insights/publishing/adherence-to-national-comprehensive-cancer-network-guidelines-for-brca-testing-among-high-risk-breast-cancer-patients-a-retrospective-chart-review-study/2020-09-10T14:23:58+00:00weekly0.7http://qxclear.com/Insights/publishing/an-economic-evaluation-of-pembrolizumab-versus-other-adjuvant-treatment-strategies-for-resected-high-risk-stage-iii-melanoma-in-the-usa/2020-09-10T14:58:36+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-effectiveness-of-pembrolizumab-with-axitinib-as-first-line-treatment-for-advanced-renal-cell-carcinoma/2020-09-10T15:41:50+00:00weekly0.7http://qxclear.com/Insights/publishing/individual-contribution-in-team-contests/2020-09-10T15:35:09+00:00weekly0.7http://qxclear.com/Insights/publishing/economics-of-excessive-pricing-an-application-to-the-pharmaceutical-industry2/2020-09-10T15:40:39+00:00weekly0.7http://qxclear.com/Insights/publishing/key-strategies-for-overcoming-psychological-insulin-resistance-in-adults-with-type-2-diabetes-the-uk-subgroup-in-the-emotion-study/2020-09-10T16:45:40+00:00weekly0.7http://qxclear.com/Insights/publishing/right-ventricular-dysfunction-and-the-effect-of-defibrillator-implantation-in-patients-with-nonischemic-systolic-heart-failure/2020-12-15T21:31:55+00:00weekly0.7http://qxclear.com/Insights/publishing/myocardial-fibrosis-and-the-effect-of-primary-prophylactic-defibrillator-implantation-in-patients-with-non-ischemic-systolic-heart-failuredanish-mri/2020-12-15T21:42:16+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-of-spinal-muscular-atrophy-in-the-united-states-a-contemporary-assessment/2020-12-15T22:12:36+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-team-publishes-real-world-evidence-in-sequencing-of-radium-223-radiotherapy-for-patients-with-metastatic-castration-resistant-prostate-cancer/2020-10-22T13:00:08+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-rebecca-kirk-fair-to-moderate-aba-antitrust-panel-on-algorithmic-pricing/2020-10-22T15:06:22+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/ella-x.-du/2020-12-09T23:04:09+00:00weekly0.7http://qxclear.com/news-and-events/news/academic-affiliate-laurence-c.-baker-elected-to-national-academy-of-medicine/2020-11-04T17:33:12+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/channing-verbeck-jr/2020-11-04T18:46:26+00:00weekly0.7http://qxclear.com/Insights/publishing/matching-adjusted-indirect-comparisons-of-the-efficacy-and-safety-of-acalabrutinib-versus-other-targeted-therapies-in-relapsedrefractory-mantle-cell-lymphoma/2020-11-04T20:58:15+00:00weekly0.7http://qxclear.com/Insights/publishing/influence-of-patient-reported-outcomes-on-the-treatment-effect-of-deferasirox-film-coated-and-dispersible-tablet-formulations-in-the-eclipse-trial-a-post-hoc-mediation-analysis/2020-11-04T21:33:56+00:00weekly0.7http://qxclear.com/Insights/publishing/the-rate-of-occurrence-healthcare-resource-use-and-costs-of-adverse-events-among-metastatic-non-small-cell-lung-cancer-patients-treated-with-first--and-second-generation-epidermal-growth-factor-receptor-tyrosine-kinase-inhibitors/2020-11-04T22:00:58+00:00weekly0.7http://qxclear.com/Insights/publishing/key-factors-for-overcoming-psychological-insulin-resistance-an-examination-of-patient-perspectives-through-content-analysis/2020-11-04T22:26:16+00:00weekly0.7http://qxclear.com/news-and-events/events/principal-paul-hibbard-to-speak-at-new-england-energy-summit/2020-11-05T14:44:53+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/michael-scott-kinch/2020-11-05T22:13:51+00:00weekly0.7http://qxclear.com/practices/tax/tax-related-valuation/2020-10-26T21:25:34+00:00weekly0.7http://qxclear.com/practices/tax/transaction-analysis/2020-10-26T21:25:43+00:00weekly0.7http://qxclear.com/practices/tax/transfer-pricing/2020-10-26T21:25:51+00:00weekly0.7http://qxclear.com/news-and-events/events/vice-president-andrea-okie-to-moderate-aba-webinar-on-antitrust-litigation-strategy-for-two-sided-platforms-following-amex/2020-10-26T18:35:27+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/michaela-johnson/2020-12-29T19:42:55+00:00weekly0.7http://qxclear.com/news-and-events/events/principal-paul-hibbard-to-speak-at-annual-uscanada-energy-conference/2020-10-27T15:20:23+00:00weekly0.7http://qxclear.com/Insights/publishing/state-vs.-local-management-of-pension-assets-effects-of-the-massachusetts-chapter-68-public-pension-reform/2021-01-05T22:22:09+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-study-evaluates-impacts-of-massachusetts-pension-reforms-on-local-public-pension-systems/2020-10-28T16:19:25+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/return-on-massachusetts-public-pension-reform-estimated-to-be-$321-million--according-to-new-study-from-analysis-group-published-in-the-journal-of-retirement/2020-10-28T13:03:51+00:00weekly0.7http://qxclear.com/Insights/cases/fantasy-cookie-corporation-et-al.-v.-harold-rothman-et-al/2020-10-28T13:42:24+00:00weekly0.7http://qxclear.com/Insights/cases/us-securities-and-exchange-commission-v.-penn-west-petroleum-ltd.-et-al/2020-10-28T13:46:17+00:00weekly0.7http://qxclear.com/Insights/cases/jeffrey-i.-golden-v.-omelveny--myers-llp-et-al/2021-01-06T18:25:33+00:00weekly0.7http://qxclear.com/news-and-events/news/using-cecl-to-record-credit-losses-during-the-pandemic-examined-in-article-by-analysis-group-accounting-experts/2020-10-29T15:33:53+00:00weekly0.7http://qxclear.com/Insights/publishing/allowances-for-loan-losses-under-the-transition-to-cecl-during-the-pandemic/2020-10-29T15:34:16+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-rebecca-kirk-fair-to-join-antitrust-panel-at-aba-antitrusts-fall-forum/2020-10-28T19:13:13+00:00weekly0.7http://qxclear.com/Insights/cases/technical-review-of-source-code-in-telephone-consumer-protection-act-tcpa-litigation/2020-10-28T20:06:21+00:00weekly0.7http://qxclear.com/Insights/publishing/climate-change-impact-and-resilience-study--phase-ii-an-assessment-of-climate-change-impacts-on-power-system-reliability-in-new-york-state/2020-10-30T15:14:02+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-team-led-by-principal-paul-hibbard-assesses-impacts-of-climate-change-on-power-system-reliability-in-new-york-state/2020-10-30T15:13:44+00:00weekly0.7http://qxclear.com/careers/why-analysis-group/benefits/2020-12-02T20:12:38+00:00weekly0.7http://qxclear.com/news-and-events/news/new-york-fed-research-conference-on-fintech-features-analysis-group-managing-principal-lisa-pinheiro-on-big-data-and-machine-learning/2020-10-29T21:53:42+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-to-sponsor-northeast-energy-and-commerce-association-neca-annual-power-markets-conference/2020-11-02T16:00:06+00:00weekly0.7http://qxclear.com/Insights/publishing/assessing-patient-preferences-for-treatment-decisions-for-new-direct-acting-antiviral-daa-therapies-for-chronic-hepatitis-c-virus-infections/2020-09-29T19:02:01+00:00weekly0.7http://qxclear.com/Insights/publishing/clinical-outcomes-of-first-line-sunitinib-followed-by-immuno-oncology-checkpoint-inhibitors-in-patients-with-metastatic-renal-cell-carcinoma/2020-09-29T19:22:44+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-healthcare-resource-utilization-related-to-migraine-treatment-failure-a-panel-based-chart-review-in-france-germany-italy-and-spain/2020-09-29T19:42:54+00:00weekly0.7http://qxclear.com/Insights/publishing/migraine-related-healthcare-resource-use-in-the-emergency-department-setting-a-panel-based-chart-review-in-france-germany-italy-and-spain/2020-09-29T20:22:22+00:00weekly0.7http://qxclear.com/Insights/publishing/epilepsy-impaired-functioning-and-quality-of-life-in-patients-with-tuberous-sclerosis-complex/2020-09-29T20:53:51+00:00weekly0.7http://qxclear.com/Insights/publishing/development-of-a-classifier-to-identify-patients-with-probable-lennox-gastaut-syndrome-in-health-insurance-claims-databases-via-random-forest-methodology/2020-10-01T21:13:25+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/kannan-srinivasan/2020-10-02T16:35:12+00:00weekly0.7http://qxclear.com/Insights/publishing/postdischarge-health-care-costs-and-readmission-in-patients-with-hyperkalemia-related-hospitalizations/2020-10-05T15:44:19+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-team-publishes-research-on-the-economic-burden-of-hyperkalemia/2020-10-05T15:53:09+00:00weekly0.7http://qxclear.com/Insights/cases/innovation-sciences-llc-v.-amazon.com-inc.-et-al/2020-10-05T18:46:44+00:00weekly0.7http://qxclear.com/news-and-events/news/testimony-provided-by-senior-advisor-keith-r.-ugone-in-amazon-patent-infringement-suit-win-related-to-echo-and-alexa-technology/2020-10-05T18:46:04+00:00weekly0.7http://qxclear.com/Insights/publishing/validation-of-an-ambient-measurement-system-ams-for-physical-activities-in-a-paediatric-population/2020-10-05T20:53:43+00:00weekly0.7http://qxclear.com/Insights/publishing/comparative-effectiveness-of-non-cisplatin-first-line-therapies-for-metastatic-urothelial-carcinoma-phase-2-imvigor210-study-versus-us-patients-treated-in-the-veterans-health-administration/2020-10-05T21:08:01+00:00weekly0.7http://qxclear.com/Insights/publishing/number-needed-to-treat-and-cost-per-remitter-for-biologic-treatments-of-crohns-disease-in-japan/2020-10-05T21:17:24+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-aaron-yeater-to-moderate-webinar-on-antitrust-in-digital-advertising/2020-10-06T17:47:09+00:00weekly0.7http://qxclear.com/news-and-events/news/cartel-enforcement-across-five-eu-commissioners-terms-tracked-by-analysis-group-competition-experts/2020-10-11T19:57:22+00:00weekly0.7http://qxclear.com/Insights/publishing/a-commissioners-history-of-cartel-enforcement-in-europe-multidimensional-comparison-of-administrations2/2020-10-11T19:58:22+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-treatment-patterns-among-patients-with-advanced-gastric-cancer-in-russia-a-chart-review-study/2020-10-06T21:07:32+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-antoine-chapsal-to-discuss-merger-control-guidelines-in-concurrences-webinar/2020-10-08T19:41:06+00:00weekly0.7http://qxclear.com/Insights/publishing/regulatory-considerations-for-cost-effective-integration-of-electric-vehicle-charging-infrastructure/2020-10-13T17:48:41+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-energy-economists-identify-key-regulatory-factors-in-cost-effective-electric-vehicle-infrastructure-development/2020-10-13T17:50:09+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/renee-richardson-gosline/2020-10-12T16:28:23+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-antoine-chapsal-to-present-at-concurrences-annual-antitrust-conference/2020-10-28T15:31:04+00:00weekly0.7http://qxclear.com/news-and-events/events/vice-president-david-toniatti-to-speak-at-aba-networking-webinar/2020-10-13T16:23:47+00:00weekly0.7http://qxclear.com/news-and-events/news/professor-anupam-jena-of-harvard-medical-school-and-massachusetts-general-hospital-discusses-the-physician-economists-unique-perspective/2020-10-13T17:32:30+00:00weekly0.7http://qxclear.com/Insights/publishing/treatment-of-metastatic-castration-resistant-prostate-cancer-with-radium-223-a-retrospective-study-at-a-us-tertiary-oncology-center/2020-10-14T19:41:04+00:00weekly0.7http://qxclear.com/news-and-events/news/study-by-analysis-group-team-analyzes-sequencing-of-radium-223-treatment-for-prostate-cancer/2020-10-14T19:43:25+00:00weekly0.7http://qxclear.com/Insights/cases/in-the-matter-of-skipjack-offshore-energy-llcs-qualified-offshore-wind-projects-compliance-with-conditions-approved-in-2017/2020-10-15T13:08:43+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-expert-supports-regulatory-approval-of-skipjacks-turbine-selection-for-its-offshore-wind-project-at-maryland-evidentiary-hearing/2020-10-15T13:11:17+00:00weekly0.7http://qxclear.com/Insights/cases/evaluation-of-a-fraud-detection-system/2020-08-24T14:33:39+00:00weekly0.7http://qxclear.com/experts-and-consultants/managers/igor-karagodsky/2020-08-21T16:55:42+00:00weekly0.7http://qxclear.com/news-and-events/events/principal-paul-hibbard-to-present-at-annual-neca-conference/2020-09-18T13:34:31+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-gaurav-jetley-and-affiliate-david-denis-to-join-penn-law-webinar-on-maes/2020-10-19T18:12:41+00:00weekly0.7http://qxclear.com/Insights/publishing/paper-trail-working-papers-and-recent-scholarship/2021-01-06T21:59:02+00:00weekly0.7http://qxclear.com/Insights/cases/abbvie-inc.s-acquisition-of-allergan-plc/2020-11-09T21:27:59+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-economists-discuss-recent-scholarship-on-health-care-pricing-in-an-article-for-the-abas-antitrust-source/2020-11-10T14:32:52+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-recognized-as-top-women-led-business-in-massachusetts-for-eighth-consecutive-year/2020-11-10T18:56:26+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-recognized-as-a-top-women-led-business-in-massachusetts2/2020-11-10T19:00:51+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-promotes-michael-cliff-stephen-fink-and-annie-guerin-to-managing-principal/2020-11-12T14:00:02+00:00weekly0.7http://qxclear.com/news-and-events/press-releases/analysis-group-promotes-michael-cliff-stephen-fink-and-annie-guerin-to-managing-principal/2020-11-12T13:59:03+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-marc-van-audenrode-to-join-panel-addressing-competition-and-sustainability-in-the-eu/2020-11-12T17:20:50+00:00weekly0.7http://qxclear.com/Insights/publishing/when-the-wind-doesnt-blow-the-limits-of-intermittent-resources-and-battery-storage-in-the-decarbonization-of-new-englands-power-system-under-increased-electrification/2020-11-13T18:04:10+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-economists-electricity-journal-article-assesses-new-englands-ability-to-harness-and-store-sufficient-electricity-from-intermittent-resources-to-meet-decarbonization-requirements/2020-11-13T15:25:30+00:00weekly0.7http://qxclear.com/Insights/publishing/healthcare-resource-utilization-and-costs-associated-with-venous-thromboembolism-in-cancer-patients-treated-with-anticoagulants/2020-11-13T21:43:28+00:00weekly0.7http://qxclear.com/Insights/publishing/effects-of-upadacitinib-on-patient-reported-outcomes-results-from-select-beyond/2020-11-13T22:21:07+00:00weekly0.7http://qxclear.com/Insights/publishing/upadacitinib-improves-patient-reported-outcomes-in-patients-with-rheumatoid-arthritis-and-inadequate-response-to-conventional-synthetic-disease-modifying-antirheumatic-drugs-results-from-select-next/2020-11-13T22:31:20+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-and-quality-of-life-burden-of-anemia-on-patients-with-ckd-on-dialysis-a-systematic-review/2020-11-13T22:39:04+00:00weekly0.7http://qxclear.com/Insights/cases/mv3-partners-llc-v.-roku-inc.-et-al/2021-01-06T22:41:02+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-witnesses-testify-in-rokus-successful-patent-infringement-defense/2020-11-16T17:03:02+00:00weekly0.7http://qxclear.com/news-and-events/events/analysis-group-hosts-webinar-on-covid-19-litigation-with-harvard-medical-school-professor-david-grabowski/2020-11-18T21:22:29+00:00weekly0.7http://qxclear.com/Insights/cases/obeslo-et-al.-v.-great-west-capital-management-et-al/2020-11-20T20:50:41+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-lisa-pinheiro-to-speak-on-artificial-intelligence-at-cfa-quebec-webinar/2020-11-23T15:16:12+00:00weekly0.7http://qxclear.com/news-and-events/events/principal-paul-hibbard-to-speak-at-euci-decarbonization-event/2020-11-23T20:24:37+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-of-switching-to-different-biologic-therapies-among-tumor-necrosis-factor-inhibitor-experienced-patients-with-psoriatic-arthritis/2020-11-23T22:11:46+00:00weekly0.7http://qxclear.com/Insights/publishing/matching-adjusted-indirect-comparison-of-blinatumomab-vs.-inotuzumab-ozogamicin-for-adults-with-relapsedrefractory-acute-lymphoblastic-leukemia/2020-11-23T22:19:38+00:00weekly0.7http://qxclear.com/Insights/publishing/validation-of-the-atopic-dermatitis-control-tool-adct-using-a-longitudinal-survey-of-biologic-treated-patients-with-atopic-dermatitis/2020-11-23T22:28:53+00:00weekly0.7http://qxclear.com/Insights/publishing/health-care-resource-utilization-and-costs-associated-with-corticosteroid-use-in-patients-with-castration-resistant-prostate-cancer-an-administrative-claims-analysis/2020-11-23T22:39:30+00:00weekly0.7http://qxclear.com/Insights/publishing/adverse-events-associated-with-cumulative-corticosteroid-use-in-patients-with-castration-resistant-prostate-cancer-an-administrative-claims-analysis/2020-11-24T22:00:29+00:00weekly0.7http://qxclear.com/Insights/publishing/healthcare-costs-of-stroke-and-major-bleeding-in-patients-with-atrial-fibrillation-treated-with-non-vitamin-k-antagonist-oral-anticoagulants/2020-11-24T22:09:24+00:00weekly0.7http://qxclear.com/Insights/publishing/the-effect-of-implantable-cardioverter-defibrillator-in-patients-with-diabetes-and-non-ischaemic-systolic-heart-failure/2020-11-24T22:17:39+00:00weekly0.7http://qxclear.com/Insights/publishing/tyrosine-kinase-inhibitor-therapy-treatment-and-discontinuation-in-patients-with-chronic-myeloid-leukemia-in-chronic-phase-in-the-united-states-a-clinical-practice-perspective/2020-11-24T22:30:12+00:00weekly0.7http://qxclear.com/Insights/publishing/direct-absenteeism-and-disability-cost-burden-of-obesity-among-privately-insured-employees-a-comparison-of-healthcare-industry-versus-other-major-industries-in-the-united-states/2020-11-24T22:49:29+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-effectiveness-and-tolerability-of-pazopanib-as-first-targeted-therapy-in-metastatic-renal-cell-carcinoma-a-retrospective-chart-review-in-latin-america/2020-11-25T21:00:53+00:00weekly0.7http://qxclear.com/Insights/publishing/us-integrated-delivery-networks-perspective-on-economic-burden-of-patients-with-treatment-resistant-depression-a-retrospective-matched-cohort-study/2020-11-25T21:37:27+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/kumar-venkataraman/2020-11-30T21:11:30+00:00weekly0.7http://qxclear.com/news-and-events/events/principal-paul-hibbard-to-join-panel-on-electricity-market-redesign/2020-12-01T14:16:21+00:00weekly0.7http://qxclear.com/news-and-events/news/analysis-group-collaborates-with-haitis-gheskio-research-and-treatment-facility-on-six-pro-bono-hivaids-treatment-studies-presented-at-the-aids-2020-virtual-conference/2020-12-01T16:52:28+00:00weekly0.7http://qxclear.com/Insights/publishing/is-clinician-impression-of-depression-symptom-severity-associated-with-incremental-economic-burden-in-privately-insured-us-patients-with-treatment-resistant-depression/2020-12-01T22:29:21+00:00weekly0.7http://qxclear.com/news-and-events/events/ceo-and-chairman-martha-s.-samuelson-to-speak-on-global-class-action-panel-at-concurrencesnyu-stern-conference/2020-12-02T13:41:03+00:00weekly0.7http://qxclear.com/Insights/publishing/burden-of-treatment-resistant-depression-in-medicare-a-retrospective-claims-database-analysis/2020-12-02T15:54:16+00:00weekly0.7http://qxclear.com/Insights/publishing/consideration-of-potential-drug-drug-interactions-in-selection-of-fda-approved-drugs-indicated-for-prostate-cancer/2021-01-07T16:59:16+00:00weekly0.7http://qxclear.com/Insights/publishing/are-medicaid-coverage-gaps-associated-with-higher-health-care-resource-utilization-and-costs-in-patients-with-schizophrenia/2020-12-02T16:31:47+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-and-health-related-quality-of-life-associated-with-current-treatments-for-anaemia-in-patients-with-ckd-not-on-dialysis-a-systematic-review/2020-12-02T16:39:45+00:00weekly0.7http://qxclear.com/Insights/publishing/mild-traumatic-brain-injury-in-the-united-states-demographics-brain-imaging-procedures-health-care-utilization-and-costs/2020-12-02T16:52:52+00:00weekly0.7http://qxclear.com/experts-and-consultants/affiliated-experts/charles-h.-grice/2020-12-02T18:19:23+00:00weekly0.7http://qxclear.com/Insights/publishing/systematic-literature-review-of-clinical-trials-of-endocrine-therapies-for-premenopausal-women-with-metastatic-hr-her2--breast-cancer/2020-12-02T20:45:37+00:00weekly0.7http://qxclear.com/Insights/publishing/risk-assessment-and-prediction-of-td-incidence-in-psychiatric-patients-taking-concomitant-antipsychotics-a-retrospective-data-analysis/2020-12-02T20:50:53+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-analysis-of-switching-patients-with-schizophrenia-from-oral-risperidone-or-oral-paliperidone-to-once-monthly-paliperidone-palmitate/2020-12-02T21:01:04+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-adherence-in-patients-with-metastatic-colorectal-cancer-treated-with-trifluridine-plus-tipiracil-or-regorafenib/2020-12-02T21:09:57+00:00weekly0.7http://qxclear.com/Insights/publishing/predictors-of-high-cost-patients-with-noninfectious-inflammatory-eye-diseases/2020-12-02T21:20:01+00:00weekly0.7http://qxclear.com/Insights/publishing/health-care-burden-of-bronchopulmonary-dysplasia-among-extremely-preterm-infants/2020-12-02T22:21:44+00:00weekly0.7http://qxclear.com/Insights/publishing/adjuvant-therapy-versus-watch-and-wait-post-surgery-for-stage-iii-melanoma-a-multicountry-retrospective-chart-review/2020-12-03T21:18:42+00:00weekly0.7http://qxclear.com/Insights/publishing/modeling-the-impact-of-real-world-adherence-to-once-daily-qd-versus-twice-daily-bid-non-vitamin-k-antagonist-oral-anticoagulants-on-stroke-and-major-bleeding-events-among-non-valvular-atrial-fibrillation-patient/2020-12-03T21:28:37+00:00weekly0.7http://qxclear.com/Insights/publishing/the-burden-of-tardive-dyskinesia-secondary-to-antipsychotic-medication-use-among-patients-with-mental-disorders/2020-12-03T21:42:55+00:00weekly0.7http://qxclear.com/Insights/publishing/federal-government-interest-patent-disclosures-for-recent-top-selling-drugs/2020-12-03T21:49:34+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-impact-of-non-medical-switching-from-originator-biologics-to-biosimilars-a-systematic-literature-review/2020-12-03T22:00:23+00:00weekly0.7http://qxclear.com/Insights/publishing/factors-that-impact-a-patients-experience-when-undergoing-single-photon-emission-computed-tomography-myocardial-perfusion-imaging-spect-mpi-in-the-us-a-survey-of-patients-imaging-center-staff-and-physicians/2020-12-03T22:10:18+00:00weekly0.7http://qxclear.com/Insights/publishing/comparative-efficacy-of-first-line-ceritinib-and-crizotinib-in-advanced-or-metastatic-anaplastic-lymphoma-kinase-positive-non-small-cell-lung-cancer-an-adjusted-indirect-comparison-with-external-controls/2020-12-03T22:16:30+00:00weekly0.7http://qxclear.com/Insights/publishing/effectiveness-of-first-line-treatments-in-metastatic-squamous-non-small-cell-lung-cancer/2020-12-04T20:44:25+00:00weekly0.7http://qxclear.com/Insights/publishing/risk-models-for-prediction-of-implantable-cardioverter-defibrillator-benefit-insights-from-the-danish-trial/2020-12-04T20:59:11+00:00weekly0.7http://qxclear.com/Insights/publishing/cost-implications-of-anticoagulation-strategies-after-percutaneous-coronary-intervention-among-patients-with-atrial-fibrillation-a-pioneer-af-pci-analysis/2020-12-04T21:43:51+00:00weekly0.7http://qxclear.com/Insights/publishing/healthcare-resource-utilization-and-costs-associated-with-venous-thromboembolism-recurrence-in-patients-with-cancer/2020-12-04T22:43:03+00:00weekly0.7http://qxclear.com/Insights/publishing/retrospective-study-on-the-association-of-biomarkers-with-real-world-outcomes-of-omalizumab-treated-patients-with-allergic-asthma/2020-12-04T22:56:24+00:00weekly0.7http://qxclear.com/news-and-events/events/managing-principal-jeffrey-kinrich-to-speak-at-beverly-hills-bar-association-event/2020-12-07T16:02:17+00:00weekly0.7http://qxclear.com/Insights/publishing/measuring-the-impact-of-air-pollution-on-health-care-costs/2021-01-07T18:54:06+00:00weekly0.7http://qxclear.com/news-and-events/news/environmental-protection-agency-underestimating-health-costs-tied-to-air-pollution-by-as-much-as-40-according-to-analysis-group-study-in-health-affairs/2020-12-07T21:03:53+00:00weekly0.7http://qxclear.com/Insights/publishing/long-term-omalizumab-outcomes-in-chronic-idiopathic-urticaria-a-real-world-study/2021-01-07T16:56:58+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-modelling-of-costs-associated-with-outcomes-reported-for-type-2-diabetes-mellitus-t2dm-patients-in-the-canvas-and-empa-reg-cardiovascular-outcomes-trials/2020-12-08T15:43:12+00:00weekly0.7http://qxclear.com/Insights/publishing/do-family-policies-reduce-gender-inequality-evidence-from-60-years-of-policy-experimentation/2020-12-08T16:17:39+00:00weekly0.7http://qxclear.com/news-and-events/news/impact-of-family-policies-on-gender-inequality-in-austria-studied-in-nber-paper-coauthored-by-associate-johanna-posch/2020-12-08T16:20:33+00:00weekly0.7http://qxclear.com/Insights/publishing/the-economic-burden-of-nocturia-on-the-u.s.-health-care-system-and-society-a-national-health-and-nutrition-examination-survey-analysis/2020-12-09T17:04:42+00:00weekly0.7http://qxclear.com/Insights/publishing/second-line-rituximab-bendamustine-versus-rituximab-gemcitabine-oxaliplatin-in-diffuse-large-b-cell-lymphoma-in-the-real-world/2020-12-09T18:34:56+00:00weekly0.7http://qxclear.com/Insights/publishing/analysis-of-real-world-treatment-patterns-healthcare-resource-utilization-and-costs-between-octreotide-and-lanreotide-among-patients-with-neuroendocrine-tumors/2020-12-09T20:08:12+00:00weekly0.7http://qxclear.com/Insights/publishing/insights-into-the-natural-history-of-metachromatic-leukodystrophy-from-interviews-with-caregivers/2020-12-09T20:15:15+00:00weekly0.7http://qxclear.com/Insights/publishing/assessment-of-change-in-quality-of-life-carcinoid-syndrome-symptoms-and-healthcare-resource-utilization-in-patients-with-carcinoid-syndrome/2020-12-09T20:24:46+00:00weekly0.7http://qxclear.com/Insights/publishing/healthcare-resource-utilization-and-costs-of-adverse-events-among-patients-with-metastatic-urothelial-cancer-in-usa/2020-12-09T20:33:40+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-of-relapse-after-hematopoietic-stem-cell-transplantation-hsct-in-patients-with-acute-myeloid-leukemia-aml-a-retrospective-claims-based-analysis/2020-12-09T20:49:56+00:00weekly0.7http://qxclear.com/Insights/publishing/suitability-of-natural-history-data-for-external-controls-in-duchenne-muscular-dystrophy/2020-12-09T22:03:37+00:00weekly0.7http://qxclear.com/Insights/publishing/the-role-of-provider-characteristics-on-the-hepatitis-a-and-b-vaccination-status-of-adults-in-the-united-states-during-2007-2015/2020-12-09T22:52:52+00:00weekly0.7http://qxclear.com/Insights/publishing/economic-burden-of-relapserecurrence-in-patients-with-major-depressive-disorder/2020-12-09T22:51:54+00:00weekly0.7http://qxclear.com/Insights/publishing/indirect-treatment-comparison-of-nivolumab-versus-observation-or-ipilimumab-as-adjuvant-therapy-in-resected-melanoma-using-pooled-clinical-trial-data/2020-12-09T23:04:09+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-durability-of-relapse-rate-reduction-in-patients-with-multiple-sclerosis-receiving-fingolimod-for-up-to-3years-a-retrospective-us-claims-database-analysis/2020-12-10T22:25:35+00:00weekly0.7http://qxclear.com/Insights/publishing/comparison-of-time-to-next-treatment-health-care-resource-utilization-and-costs-in-patients-with-chronic-lymphocytic-leukemia-initiated-on-front-line-ibrutinib-or-chemoimmunotherapy/2020-12-11T19:24:34+00:00weekly0.7http://qxclear.com/Insights/publishing/adherence-healthcare-resource-utilization-and-costs-in-medicaid-beneficiaries-with-schizophrenia-transitioning-from-once-monthly-to-once-every-3-months-paliperidone-palmitate/2020-12-11T19:43:59+00:00weekly0.7http://qxclear.com/Insights/publishing/real-world-incidence-of-inflammatory-bowel-disease-among-patients-with-other-chronic-inflammatory-diseases-treated-with-interleukin-17a-or-phosphodiesterase-4-inhibitors/2020-12-11T22:09:29+00:00weekly0.7http://qxclear.com/practices/tax/2020-10-26T21:25:26+00:00weekly0.8http://qxclear.com/policy/website-privacy-statement/2020-12-31T15:59:06+00:00weekly0.8http://qxclear.com/policy/terms-of-use/2020-12-31T15:59:57+00:00weekly0.8http://qxclear.com/forums-and-bulletins/forum/2020-06-04T16:00:05+00:00weekly0.8http://qxclear.com/forums-and-bulletins/health-care-bulletin/2020-09-04T14:24:01+00:00weekly0.8http://qxclear.com/policy/franceclientprivacy/2020-12-31T16:19:11+00:00weekly0.8http://qxclear.com/policy/california-consumer-privacy-actprivacy-notice-for-california-residents/2020-12-31T16:02:21+00:00weekly0.8http://qxclear.com/practices/data-science-and--statistical-modeling/2021-01-13T14:37:28+00:00weekly0.8http://qxclear.com/careers/join-us/2020-12-21T19:48:43+00:00weekly0.8http://qxclear.com/policy/uk-privacy-policy/2020-12-31T16:19:43+00:00weekly0.8http://qxclear.com/policy/belgiumclientprivacy/2020-12-31T16:19:27+00:00weekly0.8http://qxclear.com/careers/faqs/2020-12-30T21:09:08+00:00weekly0.8http://qxclear.com/contact-us/contact-us-thank-you/2018-10-01T12:11:34+00:00weekly0.8http://qxclear.com/careers/what-we-do/2020-09-02T19:23:37+00:00weekly0.8http://qxclear.com/practices/bankruptcy--insolvency/2020-11-09T20:15:59+00:00weekly0.8http://qxclear.com/about/our-work/2021-01-15T00:56:50+00:00weekly0.8http://qxclear.com/about/our-approach/2021-01-15T00:57:36+00:00weekly0.8http://qxclear.com/practices/transaction-and--governance-litigation/2020-10-26T14:17:47+00:00weekly0.8http://qxclear.com/practices/technology/2020-12-28T15:26:01+00:00weekly0.8http://qxclear.com/practices/accounting/2020-11-02T14:16:22+00:00weekly0.8http://qxclear.com/practices/surveys-and--experimental-studies/2020-10-26T14:17:36+00:00weekly0.8http://qxclear.com/practices/strategy-policy-and--analytics/2020-11-05T21:49:43+00:00weekly0.8http://qxclear.com/practices/valuation/2020-10-26T14:17:52+00:00weekly0.8http://qxclear.com/practices/epidemiology-and--biostatistics/2020-10-26T14:16:47+00:00weekly0.8http://qxclear.com/practices/energy-environment/2020-10-26T14:16:42+00:00weekly0.8http://qxclear.com/practices/damages/2020-10-26T14:13:44+00:00weekly0.8http://qxclear.com/practices/health-care/2020-10-26T14:17:00+00:00weekly0.8http://qxclear.com/practices/government-and--corporate-investigations/2020-10-26T14:16:54+00:00weekly0.8http://qxclear.com/practices/antitrust-competition/2020-10-26T14:13:44+00:00weekly0.8http://qxclear.com/practices/erisa/2020-10-26T14:16:50+00:00weekly0.8http://qxclear.com/practices/privacy-and--data-security/2021-01-13T14:43:51+00:00weekly0.8http://qxclear.com/practices/securities-financial-products-and--institutions/2020-11-05T22:06:53+00:00weekly0.8http://qxclear.com/practices/media-entertainment-and--communications/2020-10-26T14:17:19+00:00weekly0.8http://qxclear.com/practices/international-arbitration/2020-10-26T14:17:11+00:00weekly0.8http://qxclear.com/practices/labor-and--employment/2020-10-26T14:17:14+00:00weekly0.8http://qxclear.com/practices/intellectual-property/2020-10-26T14:17:08+00:00weekly0.8http://qxclear.com/practices/insurance/2020-10-26T14:17:04+00:00weekly0.8http://qxclear.com/experts-and-consultants/chinese/2018-11-02T15:07:25+00:00weekly0.8http://qxclear.com/experts-and-consultants/french/2018-11-02T15:07:35+00:00weekly0.8http://qxclear.com/experts-and-consultants/managers/2020-03-02T18:26:12+00:00weekly0.8http://qxclear.com/experts-and-consultants/managing-principals/2018-11-02T15:06:30+00:00weekly0.8http://qxclear.com/experts-and-consultants/senior-advisors/2018-11-01T04:10:11+00:00weekly0.8http://qxclear.com/experts-and-consultants/vice-presidents/2018-11-02T15:07:08+00:00weekly0.8http://qxclear.com/about/locations/2021-01-15T00:59:37+00:00weekly0.8http://qxclear.com/practices/commercial-disputes/2020-10-26T14:16:21+00:00weekly0.8http://qxclear.com/practices/class-certification/2020-11-19T15:26:57+00:00weekly0.8http://qxclear.com/experts-and-consultants/principals/2018-11-02T15:06:56+00:00weekly0.8http://qxclear.com/careers/why-analysis-group/2020-12-21T19:38:26+00:00weekly0.8http://qxclear.com/experts-and-consultants/affiliated-experts/2018-11-02T03:33:39+00:00weekly0.8http://qxclear.com/about/2020-01-20T15:48:42+00:00weekly0.9http://qxclear.com/Insights/2020-11-19T15:22:40+00:00weekly0.9http://qxclear.com/experts-and-consultants/2018-12-26T19:30:55+00:00weekly0.9http://qxclear.com/careers/2020-12-21T19:35:47+00:00weekly0.9http://qxclear.com/practices/2020-10-26T14:15:11+00:00weekly0.9http://qxclear.com/news-and-events/2020-06-24T12:20:07+00:00weekly0.9http://qxclear.com/search-results/2018-12-26T19:33:10+00:00weekly0.9http://qxclear.com/forums-and-bulletins/2018-12-26T19:32:16+00:00weekly0.9http://qxclear.com/contact-us/2019-08-19T20:24:50+00:00weekly0.9http://qxclear.com/policy/2020-12-31T15:57:17+00:00weekly0.9http://qxclear.com/Error/2019-08-16T02:38:24+00:00weekly0.9http://qxclear.com/sign-up/2018-12-26T19:34:19+00:00weekly0.9http://qxclear.com/sign-up-thank-you/2018-11-15T16:24:47+00:00weekly0.9http://qxclear.com/error404/2020-06-29T22:54:23+00:00weekly0.9http://qxclear.com/2021-01-11T17:24:09+00:00weekly1